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Abstract 
The main objective of this work was to gain novel information on the catalytic mechanism of Foot-
and-Mouth Disease Virus 3C protease (FMDV 3Cpro) using ensemble and single-molecule 
fluorescence techniques. This was done to aid FMDV 3Cpro inhibitor development. FMDV is the 
causative agent of foot-and-mouth disease which affects cloven-hoofed animals, such as cattle and 
sheep, and can cause substantial losses to farmers as well as whole economies. 
Fluorescence anisotropy (FA) on ensemble level and fluorescence resonance energy transfer 
(FRET) on single-molecule level were used to probe the interactions of FMDV 3Cpro with its peptide 
substrates. The main focus of previous work has been on the substrate cleavage specificity of the 
3Cpro. Therefore, the FA assays done here – using fluorescein-labelled and unlabelled peptide 
substrates – gave new insights into the substrate binding specificity of the enzyme. 
 Single-molecule fluorescence experiments, in solution and with surface-immobilised 
enzyme, were done to probe the interaction of FMDV 3Cpro with FRET-labelled peptide substrates. It 
was demonstrated that single-molecule sensitivity could be reached, and that the peptide 
HiLyte488-APAKQLLC(HiLyte647)FDLLKK is a suitable FMDV 3Cpro substrate for single-molecule 
fluorescence experiments. Single-molecule TIRF (smTIRF) was used to look at the interaction of this 
FRET peptide with surface-immobilised FMDV 3Cpro, and it was shown that the enzyme retains its 
biological function after surface attachment. Furthermore, the smTIRF experiments yielded novel 
and detailed information on the catalytic mechanism of the protease, and the single-molecule data 
was shown to be consistent with existing ensemble results as well as ensemble fluorescence data 
obtained here. 
This work is the first demonstration of single-molecule level experiments on FMDV 3Cpro. A 
quick and convenient smTIRF protocol was developed, and the experiments done using this protocol 
yielded novel information on the mechanism of the enzyme. This information will undoubtedly be a 
step towards more rational FMDV 3Cpro inhibitor design. 
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FCS  Fluorescence correlation spectroscopy 
Flu  Fluorescein 
FMDV  Foot-and-mouth disease virus 
Fmoc  9-fluorenylmethoxycarbonyl 
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FRET  Fluorescence (or Förster) resonance energy transfer 
GdmCl  Guanidinium chloride 
GFP  Green fluorescent protein 
Gln  Glutamine (Q) 
Glu  Glutamic acid (E) 
Gly  Glycine (G) 
GSH  Glutathione 
HAV  Hepatitis A virus 
HBTU  2-(1-Benzotriazol-1-yl)-1,1,3,3-tetramethylmethyluronium- hexafluorophosphate 
HEPES  N-2-Hydroxyethylpiperazine-N'-2-ethanesulphonic acid 
His  Histidine (His) 
HIV  Human immunodeficiency virus 
HL  HiLyte 
HPLC  High-performance liquid chromatography 
HRV  Human rhinovirus 
HSA  Human serum albumin 
IDA  Iminodiacetic acid 
IMAC  Immobilised metal affinity chromatography 
IRES  Internal ribosome entry site 
LC/MS  Liquid chromatography / mass spectrometry 
Leu  Leucine (L) 
LSCFM  Laser scanning confocal fluorescence microscopy 
Lys  Lysine (K) 
MALDI  Matrix-assisted laser desorption ionisation 
MCS  Multichannel scaler 
MeOH  Methanol 
Mmt  Monomethoxytrityl 
mRNA  Messenger RNA 
MW  Molecular weight 
NEM  N-ethylmaleimide 
NHS ester N-hydroxysuccinimidyl ester 
NMM  N-methylmorpholine 
NMP  N-methyl-2 pyrrolidone 
NSOM  Near-field scanning optical microscopy 
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NTA  Nitrilotriacetic acid 
PBS  Phosphate buffered saline 
PCH  Photon counting histogram 
PEEK  Polyether ether ketone 
PEG  Polyethylene glycol 
Phe  Phenylalanine (F) 
Pro  Proline (P) 
PTFE  Polytetrafluoroethylene 
PV  Polio virus 
QD  Quantum dot 
R6G  Rhodamine 6G 
RNA  Ribonucleic acid 
SDS-PAGE Sodium dodecyl sulphate polyacrylamide gel electrophoresis 
Ser  Serine (S) 
smFRET  Single-molecule FRET 
smTIRF  Single-molecule TIRF 
SPAD  Single-photon avalanche diode 
SPPS  Solid phase peptide synthesis 
Stat3 protein Signal transducer and activator of transcription 3 protein 
TBME  Tert-butyl methyl ether 
TCEP  Tris(2-carboxyethyl)phosphine 
tert-Bu (tBu) Tertiary butyl 
TES  Triethylsilane 
TFA  Trifluoroacetic acid 
Thr  Threonine (T) 
TIC  Total ion count 
TIRF  Total internal reflection fluorescence 
TIS  Triisopropyl silane 
TMR  Tetramethylrhodamine 
TR  Texas Red 
Trt  Trityl 
VP  Viral protein 
YFP  Yellow fluorescent protein 
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1 Introduction 
1.1 Proteases 
Proteases are enzymes that catalyse proteolysis, the hydrolysis of peptide bonds that link together 
amino acids in the polypeptide chains of proteins. [1] Proteolytic enzymes occur in all living 
organisms and are involved in the control of multiple biological processes, including the localization 
and activity of several proteins, modulation of protein-protein interactions, processing of cellular 
information, and the creation of new bioactive molecules. As a result, these enzymes play a major 
role in several physiological processes such as cell proliferation and differentiation, DNA replication, 
tissue morphogenesis, neurogenesis, immunity, inflammation and apoptosis, just to name a few. [2] 
In addition, proteolytic enzymes are also vital in many diseases and disease-causing agents. 
Examples of such proteases include the HIV-1 protease of the human immunodeficiency virus (HIV) 
[3, 4], matrix metalloproteases that contribute to pancreatic cancer [5, 6], and the picornaviral 3C 
protease in foot-and-mouth disease virus (FMDV 3Cpro) [7-9] – the enzyme of interest in this work. 
Due to their importance in health and disease, proteases have been studied extensively and several 
proteolytic enzymes have become important targets in medicinal chemistry. 
1.1.1 Peptide bond hydrolysis and substrate recognition 
Proteases catalyse the hydrolysis of polypeptide chains by the addition of a water molecule to a 
peptide bond. The bond being hydrolysed is known as the scissile bond, and Figure 1.1 shows the 
general reaction scheme for the hydrolysis of a peptide bond to yield the carboxylic acid and amine 
cleavage products. 
 
Figure 1.1. Hydrolysis of a peptide bond. 
The figure shows the general reaction scheme for the hydrolysis of an amide bond – the reaction that proteolytic enzymes 
catalyse. The amide bond, referred to as the scissile bond, is being cleaved by the addition of a water molecule to yield 
carboxylic acid and amine cleavage products. R1 and R2 represent the polypeptide chains on either side of the scissile bond. 
 
  There are several factors that contribute to the lowering of the activation barrier for peptide 
bond hydrolysis. Proteolytic enzymes provide an alternative mechanism for the scissile bond 
hydrolysis, but other factors are also involved in the reduction of activation energy. These factors 
include substrate recognition, stabilisation of various transition states, and changes in the 
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electrostatic and solvation environment of the reactants. [10] In addition, catalysis and substrate 
recognition by a protease are closely intertwined processes and involve many of the same structural 
features. [11] 
 Figure 1.2 illustrates a protease with a substrate bound in the active site and demonstrates 
the nomenclature developed by Schechter and Berger. [12] In the peptide substrate, the amino acid 
residues on the N-terminus side of the scissile bond are represented by P1 – Pn, P1 being closest to 
the scissile bond. P1’ – Pn’, on the other hand, denote the amino acid residues on the C-terminus 
side of the scissile bond. S1 – Sn and S1’ – Sn’ represent the corresponding enzyme binding sites. 
When protease specificity is investigated, the main focus is generally on the interaction between P1 
and S1, although the interactions between P2 – Pn and S2 – Sn often contribute to substrate 
recognition as well. The S1’ – Sn’ and P1’ – Pn’ sites, on the other hand, are generally less important. 
[11]  
 
Figure 1.2. Schechter and Berger notation for a protease with a bound substrate. 
P1 – Pn denote the amino acid residues on the N-terminus side of the peptide substrate, whereas P1’ – Pn’ denote the 
residues on the side of the C-terminus. S1 – Sn and S1’ – Sn’ are the corresponding enzyme binding sites. The scissile bond 
is shown in purple, and the blue line represents the enzyme active site. (Figure adapted from [12]) 
 
1.1.2? Serine proteases and their catalytic mechanism 
Proteases can be divided into five main classes based on their structure and catalytic mechanism: 
serine proteases, cysteine proteases, threonine proteases, aspartyl proteases and metalloproteases. 
The first four classes are characterised by a reactive serine (Ser), cysteine (Cys), threonine (Thr) and 
aspartic acid (Asp) in the active site, respectively, while metalloproteases contain a reactive metal 
ion. [13] FMDV 3C protease has characteristics of both serine and cysteine proteases. [7-9] 
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Nearly one third of all known proteolytic enzymes can be classified as serine proteases, and 
these can be further divided into four subclasses characterised by chymotrypsin, subtilisin, 
carboxypeptidase Y and Clp protease. [11] Chymotrypsin-like proteases are the most common serine 
protease subclass [14] and are involved in numerous physiological processes, such as hemostasis, 
digestion, signal transduction and apoptosis [11, 15]. Because of the variety of functions, there are 
significant variations in the specificities between different chymotrypsin-like serine proteases. 
Serine proteases are typically characterised by the so-called catalytic triad formed by the 
amino acid residues aspartic acid, histidine (His) and serine in the active site. [16] However, 
proteases of this class with other catalytic triads as well as dyads also exist. For example, Ser-His-Glu 
(glutamic acid), His-Ser-His, Ser-His and Ser-Cys catalytic arrangements have been observed. [17] All 
of these catalytic triads and dyads are essential for enzymatic activity and are also connected to an 
extensive hydrogen bonding network which plays an important role in peptide hydrolysis. 
Other catalytically important features of serine proteases include the oxyanion hole which 
forms a positively charged pocket that both activates the carbonyl carbon of the scissile amide bond 
and stabilises the first tetrahedral intermediate involved in the catalytic pathway which is discussed 
below. The oxyanion hole is structurally linked to the catalytic triad, and in chymotrypsin, it is 
formed by the backbone NH groups of glycine-193 (Gly193) and Ser195. Furthermore, substrate 
recognition and binding are very closely linked to substrate cleavage; a hydrogen bonding network 
links the substrate binding sites to the catalytic triad, and as the hydrolysis reaction proceeds, 
changes in charge and bonding at the scissile bond lead to more remote enzyme-substrate 
interactions. [11] 
Using chymotrypsin as an example, Figure 1.3 illustrates the widely accepted substrate 
hydrolysis mechanism of chymotrypsin-like serine proteases. After the formation of the enzyme-
substrate complex, the first step of the reaction pathway is acylation of the complex. This begins 
with the active site serine nucleophilically attacking the carbonyl carbon of the scissile bond, leading 
to the formation of a tetrahedral intermediate. This process is aided by the active site histidine 
which acts as a general base. The resulting protonated histidine is stabilised by the active site 
aspartic acid as a hydrogen bond is formed between the two residues. The tetrahedral intermediate 
formed during the acylation reaction is stabilised by the interaction with the oxyanion hole. 
Subsequently, this intermediate collapses and releases an amine leaving group. The release of the 
amine is assisted by the protonated active site histidine which protonates the leaving group. The 
acylation step finally yields the acyl-enzyme intermediate. [11] 
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Figure 1.3. The generally accepted mechanism of peptide bond hydrolysis by chymotrypsin. 
The charge relay system begins at Asp
102
 and travels through His
57
 and the peptide substrate to the oxyanion 
hole, formed by Ser
195
 and Gly
193
. This hydrogen bond network delocalises any charges during the catalytic 
cycle, facilitating stabilisation. (R and R’ represent the amino acid sequences on each side of the scissile bond.) 
[11] 
 
 The second half of the catalytic cycle is deacylation and essentially repeats the steps in the 
acylation reaction. First, a water molecule nucleophilically attacks the carbonyl carbon of the acyl-
enzyme intermediate, aided by the active site histidine which enhances the nucleophilicity of the 
water molecule by deprotonating it. The deacylation reaction yields another tetrahedral 
intermediate which then collapses releasing the catalytic serine and a carboxylic acid hydrolysis 
product. [11] Even though the key features of the catalytic mechanism of chymotrypsin-like serine 
proteases are widely agreed on, some details of the process are still disputed. [18-20] 
1.1.3 Cysteine proteases and their catalytic mechanism 
Cysteine proteases are characterised by a catalytically vital reactive cysteine residue at the active 
site. Papain is the most extensively studied cysteine protease [21] and is often thought of as the 
prototypical example of this protease class [22]. There are at least eight different cysteine protease 
super families, but the current understanding of the substrate hydrolysis mechanism of this class of 
proteases comes largely from work on the papain family of enzymes. In addition, the mechanisms of 
the related serine proteases have also helped in the understanding of cysteine proteases. 
The generally accepted catalytic mechanism of cysteine proteases similar to papain is shown 
in Figure 1.4. Typical cysteine proteases are thought to have a catalytic dyad of cysteine and 
histidine at the active site. This dyad is composed of a thiolate-imidazolium ion pair, the thiolate 
coming from the active site cysteine and the imidazolium from the histidine. [23] The high 
nucleophilicity of the active site cysteine is considered as the most important feature for the 
catalytic activity of cysteine proteases. The catalytic cycle begins with the association of the peptide 
substrate and the catalytic dyad to form the enzyme-substrate complex. This is followed by acylation 
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of the complex: the thiolate nucleophilically attacks the carbonyl carbon of the scissile bond, a 
process aided by the protonated active site histidine which donates its proton to the amide nitrogen. 
This yields a free amine peptide cleavage product and an acyl-enzyme intermediate. 
The acyl-enzyme intermediate then reacts with a molecule of water to release the carboxylic 
acid cleavage product. This deacylation process is assisted by the active site histidine which abstracts 
a proton from the water molecule, thus making it more nucleophilic. The deacylation results in the 
regeneration of the free enzyme. It is believed that several other intermediates and transition states 
also exist at various stages of the catalytic cycle [24], and even though the overall mechanism for 
cysteine proteases is well established, the details and kinetics of the catalytic cycle can vary 
significantly between different enzymes of this protease class. [25] [22] [24] 
 
Figure 1.4. The general catalytic mechanism of papain-type cysteine proteases. 
S
-
 denotes the deprotonated thiol group of the active site cysteine, whereas ImH
+
 denotes the protonated 
histidine. R(CO)NHR’ is the peptide being cleaved. The catalytic cycle begins with the association of the 
enzyme, after which acylation and release of amine take place. A water molecule then attacks the carbonyl of 
the acyl-enzyme intermediate, leading to deacylation and regeneration of the free enzyme. (Figure adapted 
from [24]) 
 
1.2 Picornaviruses 
Picornaviruses comprise a diverse family of pathogens that can cause several human and animal 
diseases. This virus family is one of the largest ones known and consists of nine genera, the 
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aphtovirus, enterovirus, erbovirus, teschovirus, cardiovirus, hepatovirus, parechovirus, kobuvirus 
and rhinovirus. [26] Although picornavirus infections are often mild, they can also cause more 
serious – and sometimes life-threatening – diseases. Foot-and-mouth disease virus [27, 28], which is 
a member of the aphtovirus genus, is one of the most clinically relevant picornaviruses and will be 
discussed in detail in Chapter 1.3. Other clinically important picornaviruses include the cardiovirus 
encephalomyocarditis virus (EMCV) [29, 30], and poliovirus, the prototypical enterovirus [31, 32]. 
Despite the diversity and severity of the diseases associated with picornaviruses, specific 
antiviral therapy for these infections has not yet been approved. However, research into developing 
antiviral drugs for picornavirus-related diseases is ongoing, and there are several steps in the 
picornaviral life cycle that have been identified as potential targets for inhibition. [26] 
1.2.1 The structure and lifecycle of picornaviruses 
Picornaviruses are small, non-enveloped RNA viruses with a diameter of approximately 30 nm. The 
viral capsid is composed of 60 protomers, each with four structural proteins, called VP1 (viral protein 
1), VP2, VP3 and VP4. Viral proteins 1, 2 and 3 form the viral shell, whereas VP4 lies on the inner 
surface and anchors the capsid to the RNA genome. [33] The picornaviral genome is composed of a 
positive-sense, single-stranded RNA, and a small protein called VPg, which takes part in the initiation 
of viral RNA replication, is attached to the 5’-end. [26] 
The coding region of the genome consists of structural and non-structural viral proteins 
which are divided into three main precursor molecules, P1, P2 and P3. The non-structural proteins, 
which are encoded by the P2 and P3 regions, include two proteases (2A and 3C), one ATPase (2C), 
one polymerase (3D) and four other proteins important for viral replication. [26] In addition, the 
genomes of aphtoviruses and cardioviruses code for the Leader (L) protein. In FMDV, the L protein is 
a protease which cleaves at its own C-terminus cotranslationally. [34, 35] 
An overview of the picornavirus replication cycle is shown in Figure 1.5. The first step is the 
binding of the virus to a cellular receptor, which leads to the uncoating of the genome and its entry 
into the host cell. The viral genome then serves as a template for viral RNA replication and protein 
translation inside the host cell. After translation, the resulting polyprotein is cleaved to produce the 
functional viral proteins. Subsequently, the newly formed RNA genomes are packaged into the new 
viral structural proteins. These then form new viral particles which are eventually released from the 
host cell by lysis. [36, 37] 
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Figure 1.5. The picornavirus replication cycle. 
The first step in the picornavirus replication cycle is the binding of the virus to a cellular receptor and its subsequent entry 
into the host cell. This is followed by the uncoating of the viral genome and its entry into the host cell cytoplasm. After this, 
the viral RNA is translated, and the translation is directed by the internal ribosome entry site (IRES). The resulting 
polyprotein is then cleaved into mature viral proteins which affect the host cell in a number of ways, e.g. they shut off host 
cell transcription. In the early stages of infection, the newly made RNA is translated into additional viral proteins. Finally, 
the new RNA genomes are packaged and the newly formed viral particles exit the host cell by lysis. [37] 
 
Several steps in the picornavirus replication cycle have been identified as potential targets in 
antiviral therapy. These include cell susceptibility, the attachment of the virus to the host cell, the 
uncoating of the virus, viral RNA replication and viral protein synthesis. [38] An attractive approach 
to preventing viral protein synthesis is to target the proteases involved in viral maturation. The most 
important picornaviral protease is the 3Cpro [26] which is discussed in the following chapter. 
1.2.2 Picornavirus 3Cpro as a drug target 
An important step in the picornavirus lifecycle is the processing of a polypeptide precursor to 
generate mature viral proteins. In all the different genera of picornaviruses, most of the cleavages 
involved in this process are carried out by the 3C protease. This is illustrated in Figure 1.6 for the 
foot-and-mouth disease virus. Due to the omnipresence of the 3C protease in the picornavirus family 
and its crucial role in viral maturation, this enzyme is the most attractive protease target for 
picornaviral inhibition. [26] In addition, it is possible to develop highly specific 3Cpro inhibitors as 
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there are no known cellular homologues of this enzyme. [39] Compounds that have been studied as 
picornavirus 3Cpro inhibitors include Michael acceptors, β-lactones, iodoacetamides, 
pseudoxazolones and ketones. [40, 41] 
 
Figure 1.6. Processing of the FMDV polyprotein precursor. 
The schematic shows the FMDV polyprotein precursor and how it is processed by the viral proteases. The black arrows 
represent junctions that are hydrolysed by the 3C protease, illustrating the important role of the 3C
pro
 in the viral 
maturation of FMDV. [42] 
 
A major challenge in the design of efficient inhibitors for picornaviral proteases is the 
development of resistance-associated mutations within the target. Due to the lack of proofreading 
by viral polymerases, picornaviruses are able to adapt to drug treatment quickly and efficiently by 
acquiring mutations that have little effect on the function of the viral target but strongly obstruct 
drug binding. This can lead to drug-resistant viral strains. One potential solution to this problem is to 
use a combination of antiviral therapies that act on different targets or via different mechanisms 
rather than only using one inhibitor. [43] 
 Another difficulty in developing inhibitors for viral proteases is that the reactions catalysed 
by these enzymes are more complex than just simple enzyme-substrate interactions. The steps 
involved in viral polyprotein processing are coordinated with other viral processes and highly 
regulated. [44] Because of the challenges involved in the development of anti-picornaviral protease 
inhibitors, it is all the more important to have a good understanding of the structure and function of 
the enzyme target, as well as its interactions with substrates and potential inhibitors. 
1.3 Foot-and-Mouth Disease 
1.3.1 Foot-and-mouth disease virus and FMDV 3Cpro 
Foot-and-mouth disease virus (FMDV) causes a serious disease that affects domesticated livestock, 
such as cattle, sheep, pigs and goats worldwide. This highly contagious aphtovirus has been the 
cause of repeated epidemics and also has severe economic consequences. [27] The importance of 
the virus is emphasized by the fact that several institutes, specifically dedicated to the study of foot-
and-mouth disease, have been founded over the past century (for instance, the Pirbright Institute in 
the UK). [37] 
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 Even though FMDV has effectively been eradicated in most countries in Europe and the 
Americas, the virus is still endemic in several areas of Africa and Asia. [37] Furthermore, the UK 
experienced two foot-and-mouth outbreaks fairly recently – in 2001 and 2007. The 2001 outbreak 
alone lead to the slaughter of more than 6.5 million animals [45] and is estimated to have cost the 
UK economy at least £8 billion (direct and indirect costs combined) [45, 46]. It is therefore important 
to continue developing control measures against FMDV. 
Vaccines have been developed against the virus but their use is restricted by the fact that 
there are seven different serotypes and several subtypes of FMDV, and this makes vaccine 
development impractical. [47] In addition, it can be difficult to distinguish vaccinated animals from 
infected ones, and this further complicates the use of vaccination. [48] A potential alternative to 
vaccination is to develop antiviral drugs against FMDV. 
An appealing target for antiviral drug design is the 3C protease that is heavily involved in the 
viral lifecycle of FMDV – FMDV 3Cpro. As is the case for all picornaviruses, this enzyme has a vital role 
in processing the polypeptide precursor into the mature viral proteins during the viral replication 
cycle. In foot-and-mouth disease virus, the 3Cpro performs 10 of the 13 cleavages involved in this 
step, as was shown in Chapter 1.2.2. This makes it an attractive target for protease inhibitor design. 
Furthermore, FMDV 3Cpro is highly conserved between the different serotypes of FMDV and no 
cellular equivalents of this enzyme have been identified in mammals. [7] This strategy of inhibiting 
viral proteases has also been shown to have potential against other viruses, hepatitis C virus [49] and 
the human immunodeficiency virus [3] being good examples. 
Successful protease inhibitor design requires detailed knowledge on the structure of the 
enzyme, its substrate specificity, and how it interacts with substrates and potential inhibitors. A 
significant amount of research has been done on FMDV 3Cpro in recent years, and some aspects of 
this work are reviewed in the following chapters. 
1.3.2 Peptide cleavage mechanism and substrate specificity of FMDV 3Cpro 
Structural [8, 9] and fluorometric [7] studies on FMDV 3C protease have shown that the enzyme has 
properties characteristic to both cysteine and serine proteases, and contains a Cys-His-Asp catalytic 
triad at the active site. It has also been demonstrated that FMDV 3Cpro is not inhibited by some 
common cysteine protease inhibitors. Furthermore, this 3Cpro has a fold similar to that in 
chymotrypsin and is inhibited by several chymotrypsin inhibitors. [7] 
It has been shown that other picornaviral chymotrypsin-like cysteine proteases also have a 
conserved catalytic triad, Cys-His-Asp or Cys-His-Glu, in their active sites. [50-52] The discovery of 
these catalytic triads led to reassessment of the catalytic dyad –based mechanism that has been 
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proposed for this enzyme class. Nevertheless, the catalytic triads of picornaviral 3C proteases – 
despite being structurally similar to those of serine proteases – have been shown to differ quite 
significantly from the characteristic Ser-His-Asp configuration of serine proteases. This suggests that 
their mechanisms are likely to be different as well. [50] 
The substrate cleavage specificity of FMDV 3Cpro has also been investigated. Comparison – 
by HPLC – of 10 peptide sequences corresponding to the polyprotein sites hydrolysed by FMDV 3C 
protease in the A1061 viral strain identified the peptide KIIAPAKQ/LLNFDLLK as the best substrate. 
(The slash indicates the cleavage site.) In the same work, alanine-scanning mutagenesis experiments 
of the sequence IAPAKQ/LLNFDL revealed P4-Pro, P2-Lys, P1-Gln, and P4´-Phe as the most important 
residues for recognition by the 3Cpro, as substituting these residues with alanine completely 
abrogated cleavage. In addition, alanine substitutions at P1’-Leu and P2’-Leu also reduced the 
cleavage rate, although to a lesser extent. Therefore, the results of the HPLC assay indicate that the 
substrate recognition site extends over at least eight amino acid residues (P4 – P4´). In addition, the 
HPLC assay showed that FMDV 3Cpro can also tolerate glutamic acid at the P1 position, as 
substituting the P1-Gln with glutamic acid only reduces the hydrolysis rate by approximately 50%. [8] 
A more recent study used a fluorescence (or Förster) resonance energy transfer (FRET) assay 
to evaluate the importance of different residues for hydrolysis by FMDV 3Cpro. The FRET assay used 
the labelled peptide DABCYL-APAKQ/LLD(EDANS)FDLLK. It was found that substitutions at all 
positions from P4 to P1’ can reduce the rate of hydrolysis by FMDV 3Cpro to between 0% and 50% of 
the hydrolysis rate observed for the control peptide. Variations at the P5 and P4’ positions, on the 
other hand, had less impact on the cleavage rate. [53] In addition, it was confirmed that the 3Cpro 
tolerates glutamic acid as well as glutamine at the P1 position. [54] 
The FRET assay results are largely consistent with the alanine-scanning analysis by HPLC, 
apart from one exception. The FRET assay results confirm the importance of the P4, P2, P1 and P1’ 
residues for substrate recognition, and also reveal that the P3 position can contribute to cleavage 
specificity. However, the FRET assay and the HPLC assay yield different results concerning the 
importance of the P4’-Phe. The fluorescence assay suggests that substituting P4’-Phe by Arg, Pro or 
Ala has little effect on peptide cleavage rate, whereas the results from the HPLC assay indicate that 
alanine substitution at P4’ completely abrogates cleavage. It is not yet known what causes this 
discrepancy. However, structural results are consistent with the finding that the P4’ residue is not 
likely to contribute significantly to substrate cleavage specificity. [53] 
The FRET assay introduced above is a convenient and continuous assay which can be used to 
compare FMDV 3Cpro substrates and inhibitors. Before using the assay to identify amino acids 
residues in the peptide substrate important for hydrolysis, FRET substrates with different lengths 
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and different dye positions were compared to identify the best FRET peptide substrate for a FMDV 
3Cpro assay. The seven peptides that were tested are shown in Table 1.1.  
As can be seen from the table, two peptides showed higher hydrolysis rates compared to the 
others – DABCYL-PAKQ/LLD(EDANS)FDLLK and DABCYL-APAKQ/LLD(EDANS)FDLLK. For both of these 
peptides, a significant change in FRET was observed when the peptide was hydrolysed. However, the 
peptide DABCYL-APAKQ/LLD(EDANS)FDLLK showed the fastest hydrolysis rate, its specificity constant 
(kcat/KM) being (57.6 ± 2.0) M
-1 s-1. This is likely to be because in DABCYL-PAKQ/LLD(EDANS)FDLLK the 
bulky DABCYL group is attached to the P4 residue which has been shown to contribute to substrate 
recognition by the 3Cpro. [7] In addition, the FRET assay results with DABCYL and EDANS showed that 
FMDV 3Cpro can recognise fluorescently labelled peptide substrates, and that the P5 and P3’ 
positions are suitable for the FRET labels. A more detailed discussion of the specificity constant can 
be found in the following section. 
 
Table 1.1. Comparison of FRET peptide substrates for FMDV 3C
pro
. 
The table shows the FRET peptides with different lengths and different inter-dye distances that have previously been 
tested for their suitability as FMDV 3C
pro
 peptide substrates. For each peptide the specificity constant (kcat/KM) was 
determined by monitoring the increase in EDANS fluorescence over time as the peptide was being hydrolysed by the 3C
pro
. 
The higher the specificity constant, the better the peptide is as a substrate. The approximately relative specificity constants 
in the table are reported relative to the peptide with the highest specificity constant (100 %). (table adapted from [7]) 
FRET peptide 
Approximate relative 
specificity constant / % 
DABCYL-PAKQLLNFD(EDANS)LLK 13 
DABCYL-PAKQLLND(EDANS)DLLK 8 
DABCYL-PAKQLLD(EDANS)FDLLK 35 
DABCYL-APAKQLLD(EDANS)FDLLK 100 
DABCYL-PAKQLD(EDANS)NFDLLK 0 
DABCYL-APAKQLD(EDANS)NFDLLK 8 
DABCYL-IPAKQLD(EDANS)NFDLLK 0 
 
1.3.2.1 Michaelis-Menten kinetics 
The specificity constant of an enzyme describes how efficient the enzyme is in converting substrates 
into products, and it can be used to compare an enzyme’s preference for different substrates. More 
specifically, the specificity constant is the quotient of the catalysis constant kcat and the Michaelis 
constant KM, i.e. kcat/KM. To understand which factors contribute to these two constants, Michaelis-
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Menten kinetics can be used. An in-depth description of Michaelis-Menten kinetics can be found in 
[55], and a derivation of the Michaelis-Menten equation is presented below. The Michaelis-Menten 
model describes an enzymatic reaction as shown in the below reaction scheme. 
 
E, S, P and ES represent the enzyme, substrate, product, and the enzyme-substrate intermediate, 
respectively. The enzyme and substrate combine to form the ES complex, with the rate constant k1. 
The ES complex has two possible routes of decay: it can either dissociate back into E and S – with a 
rate constant k-1 – or it can react to form the product P and the free enzyme, with a rate constant k2. 
E and P can also re-form the ES complex, with a rate proportional to k-2. 
 The treatment of the above reactions can be simplified by only looking at the reaction rates 
at times very close to zero, when hardly any product has been formed. In these conditions it can be 
assumed that the rate of E and P re-forming ES is approximately zero, i.e. ?????? ? ?. Therefore the 
reaction scheme can be written as shown below. 
 
The rate of catalysis can be related to the enzyme and substrate concentrations and the rates of the 
individual steps in the reaction as follows. It can first be assumed that 
 
?? ? ???????????????????? ?? 
 
where V0 is the rate of product formation at reaction times very close to zero. [ES] then needs to be 
expressed in known quantities. This can be done by considering the rates of formation and 
breakdown of the ES complex: 
Rate of formation of ES ? ?????????????????????? ?? 
Rate of breakdown of ES ? ???? ? ????????????????????? ?? 
The steady state assumption can then be used which states that, in a steady state, the 
concentrations of reaction intermediates, e.g. the ES complex, stay unchanged even if the 
concentrations of the starting materials and products are changing. A steady state occurs when the 
ES complex is being formed and broken down at the same rate. In other words, in the steady state: 
???????? ? ???? ? ????????????????????? ?? 
This can be rearranged to give: 
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This expression defines the Michaelis constant KM, and therefore 
   
      
    
                 
Rearranging the above leads to the following expression for the concentration of ES. 
     
      
  
                 
It is often the case that the substrate is present at a concentration much higher than the enzyme 
concentration, and therefore the concentration of the unbound substrate [S] is approximately equal 
to the total substrate concentration. The concentration of the unbound enzyme [E], on the other 
hand, equals the total enzyme concentration [E]T minus the concentration of the enzyme-substrate 
complex [ES]: 
                              
Substituting this into the expression of [ES] above (Equation 7) gives 
     
              
  
 
          
        
     
   
      
                 
Substituting this into the equation for V0 (Equation 1) gives: 
         
   
      
                  
The maximum rate Vmax is reached when all the catalytic sites on the enzyme are saturated with 
substrate, or in other words, when [ES] = [E]T. Therefore 
                             
The Michaelis-Menten equation can be obtained by substituting Equation 11 into Equation 10: 
       
   
      
                  
From Equation 12 it can be seen that at very low substrate concentrations, when [S] << KM, V0 equals 
approximately             , indicating a first order reaction. At relatively high substrate 
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concentrations, when [S] >> KM, the reaction rate reaches the maximum possible rate, i.e. V0 = Vmax. 
Under these conditions the reaction is zero order and independent of the substrate concentration. 
 The true meaning of KM can be seen from Equation 12. When the substrate concentration 
equals the Michaelis constant, [S] = KM, V0 = Vmax/2. Hence, KM is the substrate concentration at 
which the reaction rate is half of the maximal rate. It therefore provides a measure of the substrate 
concentration that is needed for significant catalysis to occur. Furthermore, KM is also related to the 
rate constants of the different steps in the catalytic scheme, as shown in Equation 6. It can be seen 
from the equation that when k-1 >> k2 (when the ES complex is broken down into E and S faster than 
it is converted into products), KM equals approximately k-1/k1 and describes the dissociation constant 
of the ES complex. Therefore, under these conditions KM can be seen as a measure of the strength of 
the enzyme-substrate complex; the lower the value of KM, the stronger the binding between E and S. 
In summary, when k-1 >> k2, the Michaelis constant reflects the affinity between the enzyme and the 
substrate. 
 Vmax, on the other hand, can reveal the turnover number of an enzyme. The turnover 
number can be defined as the number of substrate molecules converted into product by one 
enzyme molecule per unit time when the enzyme is fully saturated with the substrate. The turnover 
number is equal to k2, also called kcat. The turnover number can be determined from the maximum 
rate by rearranging Equation 11 and replacing k2 with kcat: 
     
    
    
                 
The turnover number therefore reflects the maximum rate of product formation for an enzyme, 
whereas the Michaelis constant describes how well the enzyme interacts with a substrate. Hence 
the specificity constant, kcat/KM, can be used to compare an enzyme’s preference for different 
substrates. 
1.3.3 The structure of FMDV 3Cpro 
FMDV 3Cpro is a chymotrypsin-like cysteine protease and has a structure similar to hepatitis A virus 
(HAV), poliovirus (PV) and human rhinovirus (HRV) 3Cpro structures [50-52]. A soluble, recombinant 
form of FMDV 3Cpro was developed in 2005 and the crystal structure of the enzyme to 1.9-Å 
resolution was determined. [8, 56] The crystallographic experiments suggested that FMDV 3Cpro 
adopts a fold similar to that of chymotrypsin with the characteristic double β-barrel structure. It was 
also shown that the 3Cpro has a Cys-His-Asp catalytic triad in the active site, and that the 
conformation of the catalytic triad is similar to the Ser-His-Asp triad of serine proteases. FMDV 3Cpro 
was the first picornaviral 3Cpro in which the catalytic triad was shown to have a truly chymotrypsin-
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like configuration. [8] Figure 1.7 shows the three dimensional structure of FMDV 3Cpro, and the 
active site with the Cys-His-Asp triad of the enzyme is illustrated in more detail in Figure 1.8. 
 
Figure 1.7. The structure of FMDV 3C
pro
. 
The figure shows the three dimensional structure of FMDV 3C protease. The three amino acid residues of the catalytic triad 
in the active site of the enzyme – Cys, His and Asp – are highlighted in pink. The atoms shown in red represent oxygen, 
whereas the blue atoms correspond to nitrogen [9] 
 
Figure 1.8. The catalytic triad in the active site of FMDV 3C
pro
. 
The figure shows the active site of FMDV 3C
pro
. The side chains of the residues forming the catalytic triad, Asp-84, His-46 
and Cys-163, are shown in pink. The atoms shown in red represent oxygen, the blue atoms correspond to nitrogen, and the 
ones shown in yellow are sulphur. Ser-182 is not part of the catalytic triad but forms a hydrogen bond with the aspartic 
acid of the catalytic triad. The serine is shown due to the importance of the corresponding serine residue in the structure 
of chymotrypsin. (*In the actual crystal structure Cys-163 is replaced with an alanine but the cysteine has been restored 
here by modelling.) [57] 
A crystal structure of FMDV 3Cpro with a peptide substrate (APAKQLLNFD) bound in the 
active site has also been solved. The structure of this enzyme-substrate complex is shown in Figure 
1.9 which has the free and substrate-bound 3Cpro structures overlaid. The crystallisation studies 
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showed that peptide binding to the 3C protease is accompanied with several conformational 
changes of the enzyme. [53] Furthermore, the structural data for the free and peptide-bound FMDV 
3Cpro can be used to explain some of the cleavage specificity results obtained from the FRET assays 
described in Chapter 1.3.2. The conformational changes associated with peptide binding to the 
enzyme lead to the formation of an extended interface of contact mainly involving the P4-P2’ 
positions of the peptide. The significant contribution of these residues might be explained by the 
fact that they occupy the deepest part of the surface groove that forms the peptide-binding cleft. 
[53] 
 
Figure 1.9. A crystal structure of a C163A mutant of FMDV 3C
pro
 and APAKQLLNFD. 
The figure shows the superposition of the free (grey) and peptide-bound (purple) forms of FDMV 3C
pro
. The 
peptide is shown in orange. The crystallisation studies revealed several conformational changes upon peptide 
binding. (The purple broken lines represent backbone-backbone hydrogen bonds, whereas other hydrogen 
bonds are shown as orange broken lines. The secondary structural features that show the greatest movement 
on peptide binding have been labelled.) [53] 
 
1.4 Fluorescence Techniques in Biological Sciences 
Over the past few decades, there has been a dramatic increase in the use of fluorescence 
methodology to study biological processes. Partly owing to the high sensitivity of fluorescence 
detection, many fluorescence techniques are now standard tools in the life sciences. [58] The rapid 
development of fluorescence microscopy methods over the last two decades was inspired by the 
Nobel Prize winning discovery of autofluorescent proteins [59-63] which allowed the investigation of 
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living cells. This also fuelled the development of more advanced and sophisticated fluorescence 
microscopy methods many of which can now be used as analytical tools that can yield quantitative 
information on biological systems. [64] Furthermore, new techniques are constantly being 
developed, and recent years have seen a rapid expansion in single-molecule detection techniques 
that allow scientists to detect individual fluorescent molecules in action and to look at biological 
processes in more detail than ever before. [65] 
1.4.1 Fluorescence anisotropy 
Fluorescence anisotropy (FA) (or fluorescence polarisation) is one of the most commonly used 
fluorescence methods in the life sciences. The degree of polarisation of light emitted from 
fluorescent molecules is an easily measurable and sensitive physical quantity and is related to 
various molecular parameters, including size, orientation, conformation, and the conditions the 
analyte is in, such as temperature and viscosity. Hence, fluorescence anisotropy is widely used to 
study biological systems. For example, it can be used to measure the folding states of nucleic acids 
and proteins, as well as the affinity constants of ligands. [66] In addition, the technique can be 
combined with single-molecule detection. [67, 68] Furthermore, anisotropy measurements can also 
be important in fluorescence resonance energy transfer (FRET) experiments, as the relative 
orientations of the FRET donor and acceptor dipoles affect FRET efficiency. [69] (FRET is discussed in 
more detail in Chapter 1.4.2) 
In fluorescence anisotropy experiments a sample of fluorescently labelled molecules is 
excited with linearly polarised light. As a result, fluorophores with their absorption transition dipole 
moment parallel to the electric field vector of the excitation light are excited. The absorption and 
emission dipoles of a fluorophore are generally collinear, and hence the fluorescence will be 
polarised in the same direction as the excitation beam, unless depolarisation occurs before 
relaxation. This depolarisation can be due to various processes, one of the main ones being 
rotational diffusion. [66] 
 Rotational diffusion, on the other hand, depends on the size and shape of the rotating 
fluorophore as well as the viscosity of the surrounding medium. It can be represented by the 
rotational diffusion coefficient, Dr. The rotational diffusion coefficient for a sphere can be 
determined using the equation below. 
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where k is the Boltzmann constant, T the absolute temperature, η the viscosity of the medium, and r 
and V the hydrodynamic radius and hydrodynamic volume of the sphere, respectively. [70] Hence, 
the smaller a fluorophore is, the more quickly it rotates in solution, leading to relatively fast 
depolarisation and low fluorescence anisotropy. 
 Steady state fluorescence anisotropy, r(t), can be determined from the parallel and 
orthogonal (compared to the polarisation of the excitation light) components of the fluorescence 
emitted from the analyte of interest: 
 
      
            
             
                  
 
where    and    are the parallel and perpendicular components of the fluorescence emission, and G 
is a correction factor accounting for the difference in sensitivities of the parallel and perpendicular 
detection modes, and for instrumental contributions to anisotropy. However, this equation is only 
valid for anisotropy measurements done with a fluorometer. If fluorescence anisotropy is measured 
with a high numerical aperture objective, some corrections to the equation must be made. [66] 
Due to the high dependence of fluorescence anisotropy on molecular size, the technique is 
useful in probing the binding of one biomolecule to another. This is especially true when the binding 
interaction significantly changes the size of the fluorescent species. Examples of biological binding 
partners that have been probed using anisotropy include glycosides and concanavalin A [71], 
warfarin or flurbiprofen and human serum albumin (HSA) [72], and the signal transducer and 
activator of transcription 3 (Stat3) protein and its binding partner [73]. The last example is illustrated 
in Figure 1.10. As can be seen from the figure, when the fluorescent peptide binding partner of the 
Stat3 protein is bound to the protein, fluorescence anisotropy is relatively high. As the fluorescent 
peptide is released from the protein, fluorescence anisotropy decreases because the fluorescent 
species in the solution is now smaller. 
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Figure 1.10. A fluorescence anisotropy competition assay for a Stat3 protein inhibitor. 
The figure shows fluorescence anisotropy plotted against inhibitor (green) concentration. The decrease in anisotropy is 
caused by the inhibitor – an organometallic drug – disrupting the binding of a fluorescent peptide (blue and red) to the 
Stat3 protein (yellow). As the peptide is released from the Stat3 protein by the inhibitor, the size of the fluorescent species 
decreases, and this leads to lower fluorescence anisotropy. [66] 
 
1.4.2 Fluorescence resonance energy transfer (FRET) 
Fluorescence (or Förster) resonance energy transfer (FRET) is one of the most commonly used 
fluorescence methods in biology and biochemistry. Since the FRET phenomenon was first described 
by Förster over half a decade ago [74, 75], the technique has found numerous applications in the 
biological sciences. FRET is very useful for probing molecular interactions and distances in the 10-75 
Å range [76, 77], and on the ensemble level it has been applied to study proteases such as kallikreins 
[78], cathepsin G [79], as well as FMDV 3C protease [7]. FRET on the single-molecule level will be 
discussed in Chapter 1.5. 
 FRET can be described as the non-radiative transfer of energy from a donor fluorophore to 
an acceptor fluorophore through a dipole-dipole coupling. For FRET to occur, several criteria must be 
met. Firstly, the fluorescence lifetime of the donor dye must be sufficiently long to allow energy 
transfer. In addition, the emission spectrum of the donor must overlap the absorption spectrum of 
the acceptor. [80] The spectral overlap for a commonly used FRET pair Cy3 and Cy5 is shown in 
Figure 1.11. 
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Figure 1.11. Spectral overlap of FRET donor emission and FRET acceptor absorption. 
The figure shows the absorption and emission spectra of Cy3 and Cy5, a commonly used FRET pair. For FRET to occur 
between the two fluorophores, the donor (Cy3) emission spectrum must overlap the acceptor (Cy5) absorption spectrum, 
as indicated by the overlap integral     . As a result of energy transfer, the donor emission Dem decreases whereas the 
acceptor emission Aem increases, as shown in the figure. [81] 
 
Furthermore, the donor and acceptor fluorophores must be close enough to each other for 
FRET to occur, typically within a distance of 10-100 Å. The energy transfer efficiency EFRET falls off 
with the sixth power of the distance R between the two dyes: 
 
       
 
         
                  
 
where R0 is the so-called Förster distance at which 50% of the donor fluorescence is transferred to 
the acceptor. [80] The value of R0 depends on the properties of the two dyes and the relative 
orientations of the dyes’ dipole moments and, in an aqueous solution, can be expressed as 
 
           
             
     
                                   
 
where      is the overlap integral of the donor emission spectrum and the acceptor absorption 
spectrum,    the quantum yield of the donor,  
  a geometrical factor accounting for the relative 
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orientations of the dipole moments of the donor emission and the acceptor absorption, and     the 
maximum extinction coefficient of the acceptor (in dm3 mol-1 cm-1) . [81] A typical value of R0 for a 
FRET pair is approximately 20-60 Å. [80] As shown in Figure 1.12, parallel orientation of the donor 
and the acceptor is ideal for maximal FRET to occur. Without any prior knowledge of the orientations 
of the two fluorophores, it is assumed that 0 <    < 4. However, the dipole moments of the dyes are 
often assumed to be freely rotating in all directions, on a time scale that is much faster than their 
fluorescence lifetimes. If this is the case,    = 2/3.  Although it should be noted that if attached to 
large biomolecules, the rotation of the dyes might be restricted, introducing uncertainties in the 
value of   . [69] 
If all the above criteria are satisfied and the donor fluorophore is excited, fluorescence from 
the donor can be transferred to the acceptor, which can lead to fluorescence emission from the 
acceptor (unless the acceptor is non-fluorescent). In other words, FRET results in the donor returning 
to its ground state and the acceptor being promoted to an excited state. Relaxation of the acceptor 
from the excited state can then result in acceptor fluorescence. Therefore, ensemble EFRET can be 
calculated experimentally in several ways, using the fluorescence intensity (I), fluorescence lifetime 
(τ), or the relative quantum yield (Φ) of the FRET donor (D) in the presence and absence of the 
acceptor (A) [82]: 
        
  
 
  
   
  
 
  
   
  
 
  
                  
 
If R0 is known, the distance R between the donor and the acceptor can be calculated by rearranging 
equation 16. However, due to the uncertainty in   , FRET is generally more useful for determining 
relative rather than absolute distances. [83] 
The highly distance-dependent nature of FRET makes it a useful technique for the study of 
biomolecular interactions. The relationship between FRET efficiency and the inter-dye distance is 
shown in Figure 1.12. As can be seen from the figure, FRET efficiency is most sensitive to inter-dye 
distance changes around R = R0. Common examples of FRET pairs used in ensemble FRET work 
include variants of the green fluorescent protein (GFP) [84, 85], and fluorescein and 
tetramethylrhodamine (TMR) [86, 87]. Single-molecule FRET dyes are discussed in Chapters 1.6.1 
and 1.6.2. 
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Figure 1.12. Dependence of FRET on the inter-dye distance and dye orientation. 
A) Fluorescence resonance energy transfer between two fluorophores is highly distance-dependent. If the two dyes are 
more than approximately 10 nm apart, there is only fluorescence emission from the FRET donor (green) but no FRET. [88] 
At shorter inter-dye distances FRET from the donor to the acceptor (red) can occur, leading to fluorescence emission from 
the acceptor. As can be seen from the FRET efficiency vs. Distance graph, FRET efficiency is most sensitive to inter-dye 
distance changes around R = R0. B) The extent of FRET depends on the angle between the donor and the acceptor. Parallel 
orientation of the two dyes is ideal and results in maximal FRET, whereas virtually no energy is transferred if the dyes are 
perpendicular to each other, as illustrated in the figure. The relative alignment of the two fluorophores determines the 
value of   . [81] 
 
1.5 Single-Molecule Fluorescence Techniques 
Single-molecule fluorescence microscopy is one of the most commonly used single-molecule 
techniques. [65] Since the first optical detection of an individual molecule in a solid at liquid helium 
temperatures in the late 1980’s [89, 90], the field of single-molecule fluorescence has been 
expanding rapidly. The first detection of single molecules in solution at room temperature was 
achieved in 1990 [91], and the first biological application of single-molecule fluorescence in aqueous 
conditions was demonstrated a few years later [92]. 
Since the late 1980’s, there has been an exponential increase in the published single-
molecule fluorescence work, as shown in Figure 1.13 [93]. The expansion of the field has also 
brought along several technical advances, and hence the instrumentation used to probe single 
fluorophores has become more sophisticated and more complex, enabling the probing of ever more 
complex biological systems on the single-molecule level. Recent advances include the use of super-
resolution microscopy imaging [94, 95], multi-colour [96, 97] and multi-laser [98, 99] fluorescence 
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imaging techniques, and combining fluorescence detection with single-molecule force spectroscopy 
[100, 101]. 
Single-molecule fluorescence detection offers much improved sensitivity and resolution 
compared to bulk level measurements. Furthermore, by looking at individual molecules rather than 
whole populations of molecules, it is possible to measure the distribution of a molecular property in 
a heterogeneous sample without ensemble averaging. This allows the observation of subpopulations 
and intermediates that would not be measurable in ensemble level experiments. In addition, 
temporal changes in the behaviour of single molecules can be probed without sample 
synchronisation, meaning that rare intermediates and pathways that would not be detectable in 
bulk experiments can be probed at equilibrium. Hence, detecting and analysing biomolecules on the 
single-molecule level can yield very detailed information that would not be possible to obtain from 
ensemble level measurements. [82] In addition, the area of single-molecule fluorescence is very 
diverse and new techniques for different applications are constantly being developed. 
 
Figure 1.13. Exponential growth in single-molecule fluorescence publications. 
The figure shows the number of publications each year from 1989 to 2008 containing the words ‘single-molecule 
fluorescence’, as searched in PUBMED. Since 1989, the number of publications related to single-molecule fluorescence has 
grown exponentially. Major technical contributions are shown in red. Furthermore, since the publication of the figure 
above in 2008, the growth of the single-molecule fluorescence field has continued growing; the search words ‘single-
molecule fluorescence’ now give over 3000 hits in PUBMED. (Figure adapted from [93]) 
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 One of the most important parameters in single-molecule fluorescence detection is the 
signal-to-noise (S/N) ratio. A key method for achieving a high S/N ratio is the reduction of the 
excitation/detection volume, so that the background signal from the numerous solvent molecules 
and any fluorescent impurities in the sample can be minimised. [102] Another important 
consideration for successful single-molecule measurements is the choice of the fluorescence dye as 
well as the dye conjugation chemistry. [103, 104] Common ways to reduce the detection volume in 
single-molecule experiments are described in the following chapters, and single-molecule 
fluorescence dyes are discussed in Chapter 1.6. 
1.5.1 Single-molecule fluorescence on freely diffusing molecules 
There are two main configurations for single-molecule fluorescence detection: the analytes can be 
either freely diffusing in solution or immobilised on a surface. Various methods have been used to 
achieve single-molecule sensitivity in solution [105, 106], and one of the most commonly used 
detection techniques is confocal microscopy [82]. A major advantage of studying freely diffusing 
single molecules in solution is the simplicity of the approach. There is no need to consider 
perturbations caused by surface attachment or interactions between molecules and surfaces, and 
biomolecules can often be probed in near-physiological conditions. However, confocal detection 
only allows the probing of fast to intermediate dynamics of biomolecules (up to approximately 1 
ms), whereas surface attachment allows the analysis of longer-lasting processes. 
The basic principle of a confocal microscope is illustrated in Figure 1.14. The sample is 
excited with a laser beam that is directed towards the sample by a dichroic mirror and then focused 
onto a small area of the sample by a high numerical aperture objective. The fluorescence emitted 
from the sample is collected by the same objective, passed through the dichroic mirror, and focused 
onto a pinhole of approximately 50 µm in diameter. Light that is transmitted through the pinhole is 
then imaged onto a photon-counting detector, commonly an avalanche photodiode (APD), although 
a photomultiplier tube can also be used [82, 107]. Any fluorescence emission from the sample that is 
out of focus is effectively rejected by the pinhole. Hence, the high numerical aperture objective and 
the spatial pinhole help achieve single-molecule resolution by reducing the probe volume to typically 
approximately 1 fL. [105, 108]  In the case of smFRET, additional mirrors and filters can be used to 
split the emitted fluorescence into separate donor and acceptor detector channels. 
When a fluorescent analyte diffuses through the small confocal volume, bursts of photons 
are generated upon excitation. These photon bursts are detected by the detector and can be 
analysed in terms of their brightness, spectrum, duration, and fluorescence lifetime, and hence yield 
information on the size, identity, concentration, and diffusion coefficient of the analyte. As a fairly 
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large number of photon bursts can be easily collected in a relatively short time, statistical analysis of 
the data is possible. [105, 109]  
 
Figure 1.14. The basic principle of a confocal microscope. 
The figure shows a schematic of a confocal microscope that can be used for solution-based single-molecule fluorescence 
experiments. The excitation beam (blue) is directed towards the sample (at the bottom of the figure) with a dichroic mirror 
and focused onto a small area of the sample with a high numerical aperture objective (denoted as ‘Lens’ in the figure). The 
fluorescence emission (red) from the analytes is collected by the same objective lens and then passes through the dichroic 
mirror as well as a spatial filter with a pinhole. Any out-of-focus light is effectively blocked by the spatial pinhole. Finally, 
the emission is collected by a photon-counting detector. [108] 
 
Methods for analysing data generated in solution-based single-molecule experiments 
include burst analysis [110, 111], photon counting histogram (PCH) analysis [112], and fluorescence 
correlation spectroscopy (FCS) [113, 114]. However, one of the most commonly used single-
molecule fluorescence techniques, both in solution and for immobilised molecules, is FRET (Chapter 
1.5.4). A major advantage of FRET over PCH and FCS is the ratiometric nature of the technique. In 
fluorescence resonance energy transfer experiments the ratio of two signals, the donor and the 
acceptor fluorescence, is determined, which removes a number of complicating factors, and hence 
complex statistical analysis of the data is not required. [69, 115] 
1.5.2 Single-molecule fluorescence on immobilised molecules 
Although solution-based single-molecule fluorescence techniques have many advantages, one 
disadvantage of probing freely diffusing molecules is the relatively short diffusion time through the 
detection volume. This means that investigating relatively slow (> 10 ms) biological processes is not 
possible. [116] Immobilisation of the biomolecules of interest, on the other hand, allows the 
monitoring of their fluorescence as a function of time for up to several minutes [115] and hence 
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enables the construction of fluorescence time trajectories for individual molecules. This can be 
especially useful when looking at kinetic processes such as enzyme catalysis. [117, 118] However, 
the success of single-molecule fluorescence experiments on stationary molecules is largely 
dependent on the immobilisation process; the biomolecules must be immobilised in a way that does 
not perturb their structure or biological function. 
 Common techniques for single-molecule fluorescence detection of immobilised molecules 
include laser scanning confocal fluorescence microscopy (LSCFM) [119, 120], near-field scanning 
optical microscopy (NSOM) [102, 121], and total internal reflection fluorescence (TIRF) microscopy 
[122, 123]. In LSCFM the object or surface of interest is scanned with a laser beam, and confocal 
optics enable single-molecule resolution. However, the scanning rate is generally quite slow, and 
hence images are not usually recorded. Instead, the sample is scanned until a fluorescent molecule is 
detected, and the confocal volume is then centred on the molecule, allowing the recording of the 
fluorescence time trajectory of the molecule with very high time resolution. 
In NSOM, near-field optics is used to create a laser spot that is smaller than the diffraction 
limit. This is done by using an aperture with a diameter significantly smaller than the wavelength of 
light which is placed very near the sample surface and used to detect the emitted fluorescence. Even 
though the technique has its advantages, the relative complexity of NSOM [124] as well as 
perturbation of the sample due to the closeness of the probe tip [102] limit its use. 
TIRF, on the other hand, allows large amounts of data to be collected relatively quickly as 
several single molecules can be monitored simultaneously. [124] The use of single-molecule TIRF in 
aqueous conditions was first demonstrated in the mid-1990’s [92], and since then the technique has 
been extensively used for several biological applications. Examples include RNA enzyme dynamics 
[125], enzymatic cleavage rates of the ApaI-DNA complex [126], and the kinetics of binding of 
nuclear receptors and their ligands [127]. In addition, in recent years novel TIRF techniques and 
applications have been introduced. Key improvements to the technique include enhanced depth 
resolution, miniaturisation, reduction of the detection volume, and the combination of TIRF with 
other techniques. [122] 
1.5.2.1 Theory of total internal reflection fluorescence 
The basic principle of total internal reflection is demonstrated in Figure 1.15. When a light beam that 
is propagating through a medium with a refractive index n1 (for example, glass) meets an interface 
with another medium of refractive index n2 (for example, water), where n2 < n1, total internal 
reflection of the light beam occurs at all incident angles that are greater than the so called critical 
angle   . The critical angle is defined as 
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In spite of being totally internally reflected, the incident light beam creates an evanescent 
electromagnetic wave that enters into the second medium and decays exponentially with distance 
from the interface. According to the equation 
? ? ? ????????????????? ? ???????????????????????? ??? 
where d is the penetration depth of the evanescent wave, ? is the wavelength of light used, and ? is 
the incident angle, d can be adjusted between approximately 70 and 300 nm. Hence, only the 
fluorophores that are located within this distance of the surface are excited and detected, and there 
is no fluorescence detection from the rest of the sample; this essentially minimises the detection 
volume. [122] Furthermore, by varying the incident angle of the excitation beam surface 
topography, for example, the topography of cell-substrate contacts, can be determined [128]. 
TIRF experiments can be implemented using two different configurations – prism-type TIRF 
and objective-type TIRF.  In recent years, new techniques have been introduced for both 
configurations. For example, a prism that allows sample excitation by two orthogonal beams has 
been used to overcome the problem that incident light of different polarisations can excite different 
patterns of fluorophores in a sample [129] – a difficulty commonly encountered in TIRF experiments. 
Furthermore, objective-type TIRF has been combined with two-photon excitation, allowing further 
localisation of the excited sample volume as well as the reduction of background emission. [130] 
 
Figure 1.15. Total internal reflection of light. 
When a light beam propagates in a medium with a refractive index n1 (e.g. glass) and meets an interface with another 
medium of refractive index n2 (e.g. water), where n2 < n1, total internal reflection of the light beam (blue) occurs at all 
incident angles that are greater than the so called critical angle Ɵc (red). At incident angles smaller than the critical angle, 
light is both reflected and refracted (green). (Adapted from [82]) 
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 In TIRF experiments the fluorescence signal from the analytes can be detected by either an 
APD or a charge-coupled device (CCD) camera. The CCD camera has the advantage of being able to 
observe multiple single molecules simultaneously, whereas the APD can only detect one molecule at 
a time. On the other hand, the APD has a higher signal-to-noise ratio and a better time resolution. 
[131] 
1.5.2.2 Prism-type and objective-type TIRF 
A prism-based TIRF system (Figure 1.16a,b) is relatively cheap to set up. A prism – either cubic, 
hemispherical or hemicylindrical in shape – is used to couple the excitation light into the system and 
also to collect the reflected excitation beam.  An advantage of the prism-type TIRF system is that it 
can produce lower background fluorescence compared to the objective-type setup, as the excitation 
beam does not enter the objective that is used to collect the fluorescence emission form the 
analytes of interest. In addition, with this type of TIRF system, it is possible to vary the penetration 
depth of the evanescent wave. [122] 
A disadvantage of the prism-type setup is that often the objective that is used to collect the 
emitted fluorescence is placed above the sample, thus restricting access to the sample. This problem 
can be overcome by using the objective-type setup, shown in Figure 1.16c. This approach is based on 
sample illumination with an objective of high numerical aperture. The excitation beam is directed to 
the sample using the objective, and the totally reflected beam is collected by the same objective. 
The objective-type setup is commonly used in biological applications of TIRF and has also been 
commercialised. [122] Single-molecule detection in combination with objective-type TIRF has been 
used, for instance, to measure the oligomeric forms of the  H/K-ATPase [132] and the binding 
kinetics of pleckstrin homology domains in living cells [133]. Furthermore, a good example of the use 
of the technique is the visualisation of individual Cy3-labelled ATP molecules as they bind to and are 
hydrolysed by surface-immobilised ATPase. The authors of the study were able to demonstrate that 
the surface immobilisation and labelling procedures did not affect he biological function of the 
ATPase. [123]  
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Figure 1.16. Prism-type and objective-type TIRF. 
There are two different configurations for TIRF experiments – prism-type TIRF (a and b) and objective-type TIRF (c). In 
prism-type TIRF, a prism is used to couple the excitation light into the system of interest, and an objective above the 
sample (not shown in the figure) collects the emitted fluorescence. In an objective-type TIRF system a high numerical 
aperture objective is used to illuminate the fluorescent sample and also to collect the fluorescence emission from the 
sample. [122] 
 
1.5.3 Immobilisation of proteins for TIRF 
A vital aspect of TIRF experiments is the immobilisation of the analytes in a way that does not 
perturb their structure or biological function. In the case of proteins, this is not a trivial matter, as 
the function of a protein is closely related to its structure, and the structure can often be easily 
disrupted by even minor sequence changes. [82] 
 When proteins of interest are attached onto a surface, it is important that they bind 
specifically, with minimal non-specific binding of other proteins. In addition, the conformation and 
orientation of the protein is an important consideration. The immobilised biomolecules must retain 
their native state and biological activity after modification and surface attachment, and also be in 
the right orientation to carry out their biological function. [134] In fact, it has been shown that 
immobilised protein molecules with uniform and controlled orientation possess higher activity 
compared to those with random orientation. [135] 
 Common strategies for immobilisation of proteins onto surfaces include passive adsorption, 
tethering to a functionalised surface with a site-specific tag, confinement inside polyacrylamide 
[136], silica [137] or agarose [138] gel matrices, and encapsulation inside liposomes [139]. (Figure 
1.17) The advantage of site-specific tethering is the ability to control the orientation of the analytes 
on the surface. Methods of specific tethering include the use of mRNA-protein hybrids [140], fusion 
proteins [141], binding of immobilised protein A or G to the Fc part of antibodies [142], biotin-
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streptavidin interaction [135], Staudinger ligation [143], and the interaction between a poly-histidine 
tag (His-tag) and a metal ion [134, 144]. The His-tag immobilisation approach is discussed in the 
following chapter. 
 
 
Figure 1.17. Surface-immobilisation strategies for biomolecules. 
Various techniques exist for immobilising biomolecules onto a surface, including passive adsorption (A), tethering to a 
functionalised surface with a site-specific tag (B), confinement inside a gel matrix (C), and trapping inside a liposome (D). 
[145] 
 
1.5.3.1 Protein immobilisation using NTA-Ni-His-tag interaction 
Protein immobilisation via His-tag binding is based on the well-known protein purification technique 
immobilised metal affinity chromatography (IMAC) [146] which relies on the interaction between 
His-tag, a metal ion, and a chelate group – commonly nitrilotriacetic acid (NTA), although 
iminodiacetic acid (IDA) can be used as well [147]. This method allows the specific and reversible 
binding of proteins with a sequence of histidine residues – normally six of them – on their N- or C-
terminus, while preserving their biological function. NTA is a tetradentate ligand and can form a 
complex with a divalent metal ion, such as Ni2+, Cu2+, Co2+ and Zn2+. After binding to the metal ion, 
two binding sites remain free for binding to a His6 sequence. [134, 148] This is illustrated in Figure 
1.18. The usefulness of the NTA-Ni-His-tag approach has been demonstrated using the green 
fluorescent protein (GFP) [149], and the techniques has been successfully used for biological 
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applications such as investigation of the rotation of F1-ATPase [150] and flexibility of the PEVK 
domain of titin [151].  
 
Figure 1.18. Surface attachment of a protein via His-tag. 
His-tagged protein can be immobilised onto a surface that has been functionalised with NTA and nickel. The His-tagged 
protein can specifically bind to the functionalised surface via a complex formation between the imidazole of the histidine 
(black) and the nickel and NTA (purple), as shown in the figure. The surface is shown in light blue, and the wavy line 
represents the linker between the surface and NTA. 
 
One advantage of the NTA/metal ion/His-tag immobilisation is the simplicity of the approach 
– His-tag is often incorporated into a protein for purification purposes, so no additional 
functionalization step is needed. Furthermore, the anchoring complex is highly stable as well as 
reversible, and unbinding of the His-tagged protein from the surface only occurs in the presence of 
large excess of a competing ligand, such as histidine or imidazole, or if the whole chelate complex is 
released by adding EDTA. [134, 144, 148] Further advantages include high specificity [146], control 
over protein orientation [134], and the fact that there is no need for pre-purification of the protein 
sample.  
To further minimise the non-specific binding of unwanted proteins on functionalised 
surfaces, the surface can be passivated with another compound. Polyethylene glycol (PEG) is often 
used for this purpose. [152, 153] It has been shown that combining the His-tag approach with a PEG-
coated surface creates an inert surface that minimises non-specific binding, and contains a uniform 
layer of functional groups for His-tag attachment. [147] However, PEGylation adds another 
component to the system being studied, which might be a disadvantage in some cases. 
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1.5.4 Single-molecule FRET 
Single-molecule FRET is one of the most adaptable and most commonly used single-molecule 
fluorescence methods. Since FRET was first demonstrated on single-molecule level in 1996 [154], the 
technique has been rapidly developing and can now be used to answer many fundamental biological 
questions about, for instance, protein folding and conformational changes [155], RNA folding and 
catalysis [156, 157], enzyme mechanisms [131], and DNA dynamics [158]. 
As was discussed in chapter 1.4.2, FRET provides a powerful molecular ruler in the 
nanometre scale. Furthermore, FRET efficiency can be calculated from various properties of the FRET 
donor fluorophore in the presence and absence of the acceptor. However, especially in diffusion 
single-molecule FRET experiments it is rarely possible to measure the donor fluorophore intensity or 
lifetime from the same molecule with and without the presence of the acceptor. Hence, FRET 
efficiencies are often expressed as a ratio of the acceptor fluorescence intensity over the total 
intensity from both donor and acceptor: 
 
       
  
      
                   
 
In this equation, IA and ID are the acceptor and donor fluorescence intensities, respectively, and γ is a 
correction factor that accounts for different detection efficiencies and quantum yields of the donor 
and acceptor [109, 159], and is generally assumed to have a value of 1. [82] If γ = 1, EFRET is referred 
to as the proximity ratio P [82, 160, 161]: 
 
   
  
     
                  
 
Thus, true FRET efficiencies or distances between the donor and acceptor are generally not 
calculated in solution-based smFRET experiments. Although real distances can be obtained with 
careful analysis and control experiments, if required. [139, 162] 
As mentioned in chapter 1.5.1, one of the main advantages of smFRET compared to other 
single-molecule fluorescence methods is the ratiometric nature of FRET. In particular, the 
ratiometric approach enables the normalisation of single-molecule fluorescence data with respect to 
intensity fluctuations that are characteristic to single-molecule fluorescence measurements. These 
fluctuations can be especially amplified in solution-based single-molecule experiments due to the 
variation in excitation intensity in different regions of the confocal volume. [109] 
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A major advantage of smFRET over ensemble FRET is the ability to study reaction kinetics in 
detail without having to synchronise the reacting molecules. This means that rare conformational 
transitions as well as short-lived reaction intermediates can be detected in real time by monitoring 
FRET efficiency over time (Figure 1.19B), as is often done for surface-attached molecules. In addition, 
smFRET can be used to obtain information on a distribution of a molecular property by determining 
FRET values for individual biomolecules and showing the FRET efficiency distribution in a histogram. 
This approach can reveal subpopulations that would not be detectable in ensemble steady state 
FRET. (Figure 1.19A) [69] 
 
 
Figure 1.19. Advantages of smFRET. 
A A smFRET efficiency histogram can reveal the distribution of subpopulations in a sample, whereas ensemble steady-state 
FRET would only give the average value. B FRET efficiency fluctuations for individual molecules can be monitored in real 
time using smFRET. The FRET efficiency fluctuations for three single molecules are shown in the diagram. This dynamic 
information would be lost in ensemble FRET measurements unless all the molecules in the sample were synchronised. [69] 
 
 Single-molecule FRET can be carried out either in solution for freely diffusing molecules or 
on a surface for immobilised molecules. The advantages and disadvantages of the two approaches 
were discussed in chapters 1.5.1 and 1.5.2. Solution-based smFRET is simpler to implement [115] 
and has been used to measure, for example, protein folding [163, 164]. Figure 1.20 shows smFRET 
histogram data from folding studies of protein L and a cold-shock protein CspTm. The histograms 
reveal the distributions of folded and unfolded proteins at different denaturant (guanidinium 
chloride) concentrations, the folded proteins having a higher FRET efficiency compared to the 
unfolded ones. The FRET data, together with molecular dynamics simulations, were used to obtain 
information on the size and dynamics of the two proteins, in both their folded and unfolded states. 
[164] 
Single-molecule FRET experiments on surface-immobilised molecules, on the other hand, 
enable the monitoring of individual molecules for longer periods of time, and dynamic information 
from milliseconds to minutes can be gained. An example of smFRET applied to probe conformational 
dynamics of a mutant hairpin ribozyme [165] is shown in Figure 1.21. The figure shows how three 
different FRET states of the biomolecule could be detected by monitoring the FRET efficiency over 
51 
 
time. The FRET efficiency was determined from the donor and acceptor fluorescence signals. The 
anti-correlated relationship between the donor and acceptor intensities means that fluorescence 
fluctuations due to photophysical phenomena, such as photobleaching or photoblinking, can be 
distinguished from fluctuations caused by energy transfer due to biological processes, such as 
conformational changes. This is also illustrated in the figure. 
 
Figure 1.20. Single-molecule FRET efficiency histograms for protein L and CspTm. 
The histograms show the distributions of folded and unfolded protein L (left) and CspTm (right) at different denaturant 
(guanidinium chloride, GdmCl) concentrations. The intermediate and high measured FRET efficiency (Em) peaks correspond 
to the unfolded and folded state populations, respectively, whereas the zero peak at approximately Em = 0 is due to protein 
molecules only containing the donor fluorophore. The blue and green lines represent the Gaussian fits to the unfolded and 
folded protein subpopulations, respectively. The black dashed lines at 0 and 6 M GdmCl show the contribution of shot 
noise to the unfolded and folded FRET peak widths. [164] 
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Figure 1.21. Single-molecule FRET data for surface-immobilised ribozyme molecules. 
The figure shows smFRET data for a hairpin ribozyme labelled with a FRET donor and a FRET acceptor on different parts of 
the molecule. The top diagram shows the donor (green) and acceptor (red) fluorescence emission over time, and the 
bottom diagram displays the apparent FRET efficiency over time, calculated using the donor and acceptor intensities. The 
ribozyme undergoes transitions between three different FRET states (E1, E2 and E3). The zero intensities of the acceptor are 
believed to be caused by photoblinking (at approximately 9 s) and photobleaching (at approximately 19 s). [115] 
 
 
 Another good example of smFRET on surface-immobilised molecules is the direct 
observation of the reaction kinetics of the restriction enzyme ApaI when it cuts DNA. Using 
AlexaFluor 532 and YOYO as a FRET pair, the authors carried out smTIRF experiments that revealed 
anomalous reactions kinetics of the ApaI-DNA complex. [126]  
 Single-molecule FRET has also recently been used to study peptide hydrolysis by the enzyme 
HIV-1 protease. Substrates of the protease were tagged with a FRET pair of dyes and immobilised 
onto a glass slide to monitor substrate binding and cleavage using TIRF. Single-molecule fluorescence 
time traces for the FRET-labelled substrates in the presence of the HIV-1 protease were recorded 
that showed distinct binding and cleavage events, as illustrated in Figure 1.22. It was shown that the 
unbound peptide substrate adopts a random coil conformation in which the two dyes are very close 
to each other, resulting in high FRET efficiency. Upon binding to the protease, there is a decrease in 
FRET as the bound peptide adopts an extended β-strand conformation. This is followed by a near-
zero FRET efficiency as the peptide is hydrolysed. These experiments illustrate well the level of detail 
that can be obtained from smFRET experiments; similar insights into the mechanism of the HIV-1 
protease would not be possible with ensemble fluorescence methods. [118] 
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Figure 1.22. Single-molecule FRET data for peptide hydrolysis by HIV-1 protease. 
a) FRET donor (green) and acceptor (red) fluorescence intensities of a FRET-labelled peptide substrate of HIV-1 protease 
were monitored over time in the presence of the enzyme. b) FRET efficiencies were calculated using the donor and 
acceptor intensities. The stepwise decrease in FRET may be attributed to separate binding and hydrolysis events. The 
unbound peptide is suggested to adopt a random coil conformation in which the two dyes are very close to each other, 
resulting in high FRET efficiency. When the peptide binds to the enzyme, there is a decrease in FRET as the peptide adopts 
an extended conformation, and after peptide hydrolysis FRET drops to almost zero as the donor and acceptor dyes are 
separated. [118] 
 
1.6 Single-Molecule Fluorescence Dyes and Labelling Techniques 
One of the most important factors contributing to successful single-molecule fluorescence 
experiments is the choice of the fluorescence dyes and their attachment to the biomolecule of 
interest. Requirements for a good single-molecule fluorophore include high brightness, steady 
emission intensity, and low photobleaching rate. [93] In addition, the dye should have a relatively 
short excited state lifetime (in the order of a few nanoseconds), so that the ground state is quickly 
replenished, and a large Stokes shift to minimise background signal from scattered excitation light in 
the detector. [106] It is also desirable that the dye molecule is small and water-soluble, and that it 
does not perturb the biological function of the biomolecule it is attached to. Furthermore, the 
fluorescence properties of the dye should be insensitive to pH and the local environment of the dye. 
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1.6.1 Requirements for single-molecule fluorescence dyes 
1.6.1.1 Brightness 
In single-molecule fluorescence experiments a weak fluorescence emission must be discriminated 
from background noise. Hence, the rate and number of photons emitted from the fluorescent 
molecule of interest must be maximised. This can be achieved by either increasing the extinction 
coefficient (ε) or the fluorescence quantum yield of the dye. [103] The extinction coefficient is a 
measure of how strongly a fluorophore absorbs light at a given wavelength, while the fluorescence 
quantum yield is the ratio of the number of emitted photons to the number of absorbed photons. 
The brightness of a dye is described by the product of these two parameters. [104] 
For an ideal single-molecule fluorophore the fluorescence quantum yield should be more 
than 10% and the extinction coefficient higher than 50 000 M-1 cm-1. [106]. For many synthetic dyes 
it is now possible to approach the theoretical limit for the maximum photon emission rate. [166] 
Consequently, much recent effort has focused on attempting to enhance dye photostability. [103] 
1.6.1.2 Photostability 
Photostability can be divided into two different categories – photobleaching and photoblinking. 
Photobleaching means the irreversible loss of fluorescence due to changes in the structure of the 
fluorophore following a chemical reaction induced by light. Photobleaching of the Cyanine 3b 
fluorophore (Cy3b) is illustrated in Figure 1.23. Photoblinking, on the other hand, can be described 
as intermittent changes in the fluorescence emitted from a dye because of triplet state population. 
[103] Sometimes it can be difficult to distinguish between photoblinking and fluorescence changes 
that are due to other phenomena, for example, biological changes in the system of interest. 
Fluorescent semiconductor nanocrystals called quantum dots (QDs), for example, are known to 
show fluorescence intermittency [167], complicating their use in single-molecule applications.  
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Figure 1.23. Photobleaching of a biomolecule labelled with Cy3. 
The top diagram shows the single-step photobleaching event of a Cy3b-labelled biomolecule. The bottom images show the 
spot intensity of the molecule observed with a total internal reflection fluorescence (TIRF) microscope. [103] 
 
Photostability of single-molecule fluorescence dyes can have major impact on single-
molecule measurements. For example, it can be difficult to distinguish bleaching and blinking effects 
from fluorescence fluctuations due to biological changes in the system of interest. It should be 
noted, however, that changes in fluorescence intensity due to photobleaching are not always 
unwelcome; sometimes counting photobleaching steps is used to determine the stoichiometry of 
biomolecular complexes. [168, 169] 
The main mechanism of photobleaching is photo-oxidation of a fluorescent molecule by 
molecular oxygen. Reducing the effect of dissolved oxygen can be achieved by simply degassing the 
buffer used or by adding oxygen scavengers. [103] The most commonly used enzymatic oxygen 
scavenger system is a mixture of glucose oxidase, catalase and β-D-glucose [170]. [115] Other 
options include the combination of protocatechuic acid and protocatechuate-3,4-dioxygenase. [171] 
However, as well as causing photobleaching, molecular oxygen can also efficiently quench a 
fluorophore’s unfavourable triplet state. [172] Hence, removing oxygen may prolong the dye’s triplet 
dark state, which can cause early signal saturation or blinking. [115] To prevent this, triplet state 
quenchers such as Trolox can be used in combination with enzymatic oxygen scavengers when 
working with cyanine dyes. [173] Several alternatives to Trolox exist for non-cyanine dyes. [174] 
In addition to the methods described above, improved photostability in single-molecule 
fluorescence experiments can also be achieved by simply lowering the laser power used or by using 
pulsed laser excitation instead of continuous excitation. Furthermore, other attempts to improve the 
photostability of fluorophores include encapsulation of dyes within supramolecular hosts such as 
cucurbituril [175] or within rotaxanes [176], rigidification of cyanine dyes [177], and the use of large 
near-IR terrylene dimide dyes [178]. 
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1.6.1.3 Requirements for smFRET dyes 
As well as the properties mentioned above, there are some additional requirements for 
fluorophores used as a smFRET pair. The donor and acceptor dyes should have large enough spectral 
separation between donor emission and acceptor emission to minimise donor emission leakage into 
the acceptor detector channel and vice versa. In addition, the two fluorophores need to have similar 
detection efficiencies and quantum yields. [115] Furthermore, the donor and acceptor should 
typically be placed within approximately 100 nm from each other, and to maximise the distance 
sensitivity of FRET measurements, the detected distances should be somewhere between 0.5R0 and 
2R0 [106]. Typical values for R0 are of the order of 50 Å for smFRET pairs. [82] Some common FRET 
pairs used in single-molecule experiments are given in Table 1.2. 
 
Table 1.2. Dye pairs used in smFRET experiments. 
The table shows some FRET donor and acceptor fluorophores that have been used in smFRET experiments. Also the Förster 
distance for each dye pair is shown. (Abbreviations: TMR = tetramethylrhodamine, Cy5 = Cyanine 5, AF488 = AlexaFluor 
488, TR = Texas Red, Cy3 = Cyanine 3, AF594 = AlexaFluor 594, R6G = Rhodamine 6G, Flu = Fluorescein) (Table adapted 
from [82]) 
FRET donor FRET acceptor Biological system R0 / Å Reference
 
TMR Cy5 Protein chymotrypsin 
inhibitor 2 
53 [179] 
AF488 TR Protein adenylate 
kinase 
49 [139] 
Cy3 Cy5 Helicase binding to a 
DNA duplex 
~60 [180] 
AF488 AF594 Protein CspTm 54 [181] 
R6G TR Coiled-coil peptide 
GCN4 
37-51 [182] 
Flu Cy3 RNA ribozyme 53 [183] 
 
1.6.2 Different classes of single-molecule fluorophores 
Examples of fluorophores that have been used in single-molecule studies include auto-fluorescent 
proteins, small organic dye molecules, quantum dots, gold nanoparticles, and fluorescent 
microspheres. [106] Fluorescent proteins, such as the green fluorescent protein (GFP) and its 
derivatives, are advantageous from the point of view of protein labelling (Chapter 1.6.3), and have 
found use especially in live cell experiments. [93] However, their large size and low brightness 
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compared to some other fluorophores are a disadvantage, as illustrated in Figure 1.24 which shows 
a comparison of enhanced GFP (eGFP) with a small organic dye AlexaFluor 488. In addition, 
significant fluctuation has been observed in the fluorescence of GFP and yellow fluorescent protein 
(YFP). [136, 184] Nevertheless, newer generations of fluorescent proteins with high quantum yields 
and reasonable photostability have also been developed. [185] 
Like fluorescent proteins, quantum dots also suffer from their relatively large size – 
commercial QDs are commonly more than 20 nm in diameter. [115] In addition, QDs cannot be 
attached to biomolecules monovalently [115] and often suffer from photoblinking [167]; both 
factors limit the use of these fluorophores in single-molecule applications. 
The most popular class of single-molecule fluorophores are small (< 1nm in diameter) 
organic dyes. [104, 115] The majority of in vitro single-molecule fluorescence studies have recently 
relied on two major fluorophore families – the cyanine and the rhodamine dyes. [93] Dyes from the 
cyanine family include Cy3 and Cy5 [186], both of which have a high absorption coefficient (over 105 
M-1 cm-1) [187] and a modest quantum yield [69]. Other popular cyanine dyes include Cy5.5, Cy7, 
and DiI, as well as AlexaFluor 647. Popular rhodamine dyes are tetramethylrhodamine, Texas Red, 
Rhodamine 6G, AlexaFluor 488, AlexaFluor 546, and AlexaFluor 555. Many of these dyes show high 
quantum yield and high photostability. [93] However, a comparison of the AlexaFluor and Cy dyes 
has shown that AlexaFluor 555 and AlexaFluor 647 are brighter and more resistant to 
photobleaching and self-quenching that their Cy counterparts Cy3 and Cy5. [187] 
 
 
Figure 1.24. Comparison of the brightness of eGFP and AlexaFluor 488. 
The TIRF image shows a mixture of eGFP and AlexaFluor 488. The brighter spots (A) are assumed to correspond to 
AlexaFluor 488 molecules, and the less intense spots (B) to eGFP, illustrating the relatively low brightness of the 
fluorescent protein compared to the small organic fluorophore. [103] 
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 Despite the suitability of small organic fluorophores for single-molecule fluorescence work, 
there are some disadvantages associated with them. For example, conjugation to biomolecules can 
alter the fluorescence properties of the dyes. [187] In addition, care must be taken when attaching 
two dyes on the same biomolecule: it has been shown that too short a distance between the two 
dyes can lead to quenching of their fluorescence. [118] 
 However, in any single-molecule fluorescence experiment, the exact properties of a certain 
dye molecule in a specific molecular environment are difficult to predict, as the fluorescence 
properties of a dye can be complex and highly situation-specific. It is therefore important to carefully 
test for and eliminate any factors that might influence the fluorescence signal due to a real biological 
change in the system being analysed. In addition, photobleaching still remains a problem even with 
newer dyes with enhanced photophysical properties, and new fluorophores are constantly being 
developed. 
1.6.3 Protein and peptide labelling for single-molecule fluorescence work 
A well-established and commonly used in vitro labelling technique for proteins and peptides is direct 
chemical labelling of a specific amino acid side chain in a purified biomolecule. Due to their relatively 
low occurrence in proteins, cysteine residues are commonly exploited in the labelling reaction. The 
thiol group in cysteine can be reacted with a fluorophore containing a thiol-reactive group, most 
often a maleimide, although iodoacetamide can also be used. [103, 104, 188] The reaction of the 
thiol-reactive maleimide with cysteine is illustrated in Figure 1.25. 
 Both the maleimide reaction and the iodoacetamide reaction occur rapidly in protein-
friendly conditions, i.e. buffers of moderate pH and temperature, to form a stable thioether bond. At 
the optimal pH for cysteine modification, around pH 7.0, most aliphatic amines are unreactive, 
enabling selective thiol modification in the presence of amines. However, a potential problem with 
iodoacetamides is their instability to light, particularly in solution. [188] On the other hand, 
iodoacetamide dyes are less sensitive than maleimides to reducing agents such as TCEP and DTT 
which may be required in labelling reactions to ensure that cysteines are in their reduced form. [189] 
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Figure 1.25. Cysteine labelling with a maleimide-functionalised fluorophore. 
The cysteine thiol in a protein or a peptide can be selectively reacted with a maleimide dye at near-physiological pH. Even 
in the presence of an amine, the maleimide reacts selectively with the cysteine. The green star represents the fluorescent 
part of the dye molecule. (Figure adapted from [188]) 
 
 Another commonly modified functional group in proteins and peptides is aliphatic amine, 
either the ε-amine in a lysine residue or the N-terminal α-amine. The most commonly used amine-
reactive conjugate is N-hydroxysuccinimidyl ester (NHS ester). [103] The reaction between an amine 
and an NHS ester to form a stable amide product is shown in Figure 1.26. This reaction can be 
carried out under non-aqueous or aqueous conditions, the optimal pH for the reaction being 8.0-9.0. 
[188] A disadvantage of amine labelling is that lysine residues are relatively abundant in proteins, 
making specific labelling with a single fluorophore difficult. However, due to the different pKa values 
of the lysine ε-amine and the N-terminal α-amine, it can be possible to achieve moderately selective 
labelling of the N-terminus in the presence of lysines. For example, this approach has been used to 
label the N-terminus of the bacterial RecA protein for fluorescence studies of the assembly and 
disassembly of RecA protein filaments on DNA. [190] 
 
Figure 1.26. Amine labelling with an NHS ester -functionalised fluorophore. 
Aliphatic amines (the ε-amine in lysine or the N-terminal α-amine) in a peptide or a protein can be labelled with an NHS 
ester dye at pH 8.0-9.0. The green star represents the fluorescent part of the dye molecule. (Figure adapted from [188]) 
 
A potential drawback of the direct chemical labelling approach is that highly purified peptide or 
protein samples are needed, and hence the technique is not suitable for in vivo labelling. Alternative 
protein labelling methods include auto-labelling of fusion proteins, protein ligation techniques, 
fusion to intrinsically fluorescent proteins, and fluorescent ligand binding. [103] In addition, chemical 
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synthesis can be used to produce fluorescent peptides and proteins. An example of this approach is 
the chemical synthesis of the labelled GCN4 protein for smFRET studies. [191] However, for peptide 
modification the chemical labelling approach is ideal. 
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2 Results 
2.1 Design and Synthesis of Peptide Substrates for FMDV 3Cpro 
2.1.1 Introduction to FMDV 3Cpro peptide substrates 
Peptide substrates for FMDV 3Cpro were synthesised for experiments probing the binding specificity 
of the enzyme on ensemble level and its hydrolysis mechanism on single-molecule level. Both 
unlabelled and fluorescently labelled substrates were made, following the synthetic procedures 
described in detail in Chapter 4.1 of Materials and Methods. All the peptides that were made were 
based on a naturally occurring hydrolysis site in the FMDV polyprotein precursor, 
KIIAPAKQ/LLNFDLLK, where the slash represents the scissile bond. This sequence corresponds to the 
VP1/2A junction that is cleaved by the 3Cpro (Figure 2.1). In a previous study, ten peptide sequences 
based on the natural FMDV 3Cpro cleavage sites were compared in an HPLC hydrolysis assay, and the 
peptide corresponding to the VP1/2A junction was shown to have the highest hydrolysis rate out of 
the ten peptides. [8] 
 
Figure 2.1. FMDV polyprotein precursor. 
The schematic shows the FMDV polyprotein precursor and how it is processed. The black and purple arrows represent 
junctions that are hydrolysed by the 3C protease. [42] A peptide based on the VP1/2A junction (purple) has been identified 
as a good substrate for the enzyme and used in previous hydrolysis assays of FMDV 3C
pro
. [8] (Figure adapted from [42]) 
 
 Table 2.1 shows all the unlabelled and fluorescently labelled peptides that were synthesised 
for either fluorescence anisotropy assays or FRET experiments, or for testing peptide labelling 
protocols. The synthetic procedures are described in the following chapters, and all peptides were 
purified to a minimum of 90% purity following the purification protocols described in chapter 
2.1.3.3. Characterisation data for the fluorescent peptides can be found in the Appendix (6.1). 
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Table 2.1. Unlabelled and labelled peptides synthesised. 
The table shows all the unlabelled and fluorescently labelled FMDV 3C
pro
 peptide substrates that were synthesised for 
either fluorescence anisotropy assays or FRET experiments, or for testing the labelling protocols. H2N and Bz denote a free 
and benzoylated N-terminus, respectively. Flu, TMR, HL488, HL647 and AF647 represent fluorescein, 
tetramethylrhodamine, HiLyte 488, HiLyte 647 and AlexaFluor 647, respectively. Amino acid residues written in bold and 
underlined indicate how each peptide sequence differs from APAKQLLNFDLLKK. 
Unlabelled peptides  
H2N-APAKQLLNFDLLKK H2N-APAKELLNFDLLKK 
H2N-AAAKQLLNFDLLKK H2N-APAKQLLNFDCLKK 
H2N-APAAQLLNFDLLKK Bz-APAKALLNFDLLKK 
H2N-APAKALLNFDLLKK  
Ensemble fluorescence peptides  
Flu-APAKQLLNFDLLKK Flu-APAKQLLNADLLKK 
Flu-AAAKQLLNFDLLKK Flu-APAKQLLCFDLLKK 
Flu-APAAQLLNFDLLKK APAKQLLC(TMR)FDLLKK 
Flu-APAKALLNFDLLKK Flu-APAKQLLC(TMR)FDLLKK 
Flu-APAKQALNFDLLKK  
Single-molecule peptides  
HL488-APAKQLLCFDLLKK HL488-APAKQLLNFDLC(HL647)KK 
HL488-APAKQLLC(HL647)FDLLKK HL488-APAKQLLC(AF647)FDLLKK 
 
2.1.2 FMDV 3Cpro substrate design 
2.1.2.1 The peptide sequence 
Peptides based on the VP1/2A junction sequence KIIAPAKQ/LLNFDLLK have also been used in 
previous FMDV 3Cpro assays. [7, 8] However, some of these peptides showed limited solubility in the 
buffer that was used in these assays. [7] To enhance the water-solubility of the peptides synthesised 
and used in the present study, an additional lysine residue was added to the C-terminal end of each 
peptide. It was thought that a lysine at this position (P9) would not affect binding to or hydrolysis by 
FMDV 3Cpro, since residues beyond P4 and P4’ do not seem to contribute to substrate recognition by 
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the enzyme [8, 53]. In addition, to keep the FRET distance between the donor and acceptor 
fluorophores optimal, residues P6-P8 were not included in the peptides that were synthesised in the 
current project. The positions of the dyes will be discussed in more detail in Chapter 2.1.2.2. 
Furthermore, shorter peptides are often easier to synthesise compared to longer ones. Hence, the 
peptides made here were all based on the sequence APAKQLLNFDLLKK. The full chemical structure 
of this peptide is shown in Figure 2.2. 
 
Figure 2.2. The structure of the APAKQLLNFDLLKK peptide. 
The peptides used in the binding and cleavage assays were all based on the sequence APAKQLLNFDLLKK. The figure shows 
the full chemical structure of the peptide. 
 
2.1.2.2 Positions of the fluorescence labels 
As well as unlabelled peptides, peptide substrates with a single fluorescent tag were made for the 
fluorescence anisotropy binding assays, and doubly labelled peptides were synthesised for the FRET 
studies. The FRET donor and acceptor were placed on different sides of the scissile bond, so that 
there would be a change in FRET upon peptide hydrolysis by FMDV 3Cpro. In the unhydrolysed 
peptide the two dyes are sufficiently close to each other for energy transfer to occur from the donor 
to the acceptor. As the peptide is hydrolysed, the two dyes are separated, leading to loss of FRET. 
Hence peptide hydrolysis by the 3C protease can be detected as an increase in donor fluorescence or 
a decrease in acceptor fluorescence. This is shown schematically in Figure 2.3, using one of the FRET 
peptides that was synthesised as an example.  
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Figure 2.3. FRET substrate for FMDV 3Cpro. 
In the intact peptide the donor (green star) and acceptor (pink star) dyes are sufficiently close to each other for FRET to 
occur after the donor is excited. As the two dyes are placed on different sides of the scissile bond (the dashed line), after 
hydrolysis by the 3C protease the dyes are separated, which leads to loss of FRET. This can be observed as an increase in 
donor fluorescence and a decrease in acceptor fluorescence. 
 
 As discussed in Chapter 1.4.2, FRET between a donor and an acceptor is highly dependent 
on the distance between the two fluorophores. Hence, the inter-dye distance has to be short 
enough for FRET to occur. However, introducing a tag too near the scissile bond might result in a 
peptide that is not recognised or cleaved by FMDV 3Cpro. In addition, it is not advisable to attach tags 
– which can be quite bulky molecules – on or sometimes even near residues that are important for 
recognition by the enzyme. Therefore, the FRET donor and acceptor need to be close enough to 
each other for FRET to occur but far enough from the scissile bond and from residues important for 
recognition by the enzyme, so that binding and hydrolysis are not compromised. Hence, the 
positioning of the two dyes is not a trivial matter. 
In previous work on the substrate specificity of FMDV 3Cpro it has been shown that the 
residues P4, P3, P2, P1, P1’, and P2’ all contribute to cleavage specificity of the protease, some to a 
greater extent than others. The results concerning the importance of P4’ are somewhat inconclusive. 
[8, 53] Dye attachment to the P4, P3, P2, P1, P1’, P2’ and P4’ is therefore not advisable. 
Furthermore, a FRET assay for the 3Cpro which uses EDANS as the FRET donor and DABCYL as 
the FRET acceptor has previously been used to compare 3Cpro peptide substrates with different 
lengths and different dye positions, as was discussed in Chapter 1.3.2. Two peptides were identified 
that showed higher turnover rates compared to the rest – DABCYL-PAKQ/LLD(EDANS)FDLLK and 
DABCYL-APAKQ/LLD(EDANS)FDLLK. A significant change in FRET upon hydrolysis was observed for 
both peptides. However, the latter peptide showed a faster hydrolysis rate, possibly because in the 
former one the bulky DABCYL group is attached to the P4 residue which has been shown to 
contribute to substrate recognition by the 3Cpro. [7] 
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The results with DABCYL and EDANS showed that FMDV 3Cpro can tolerate tags on its peptide 
substrates, and that the P5 and P3’ positions are suitable for the FRET labels. Although it should be 
noted that in the present work different fluorophores were used, and the extent of FRET between a 
donor and an acceptor is highly dependent on the spectral characteristics of the dyes in question. 
However, as the 3Cpro can tolerate tags on the P5 and the P3’ residues [7], these positions were 
chosen for the FRET donor and acceptor dyes. In addition, the P7’ position was also tested as the 
acceptor labelling site to compare two different inter-dye distances. In summary, for the singly 
labelled peptides a fluorescent dye was introduced in the P5 position, whereas the FRET-peptides 
were labelled at P5 and either P3’ or P7’, as shown in Figure 2.4. 
 
Figure 2.4. Fluorophore positions for the singly and doubly labelled FMDV 3Cpro substrates. 
(a) For the singly labelled peptides, a fluorophore was introduced onto the N-terminal P5 alanine. (b) The FRET-peptides 
were labelled at two positions: the P5 alanine and either the P3’ position or the P7’ position, to compare two different 
inter-dye distances. A cysteine was incorporated into the peptide for the P3’ and P7’ labelling reactions. The dashed line 
indicates the scissile bond. 
 
2.1.3? Solid phase peptide synthesis 
2.1.3.1? Peptide synthesis based on Fmoc/tBu chemistry 
Automated solid phase peptide synthesis (SPPS) based on Fmoc/tBu chemistry was employed in 
making the peptide substrates for FMDV 3Cpro. This well established and commonly used method for 
synthesising peptides [192] builds peptide sequences on a solid support residue by residue from the 
C-terminus to the N-terminus. The technique relies on an orthogonal protecting strategy in which 
the amino acids are protected with the base-labile 9-fluorenylmethoxycarbonyl (Fmoc) group on 
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their N-terminus, whereas reactive amino acid side chains are protected with acid-labile protecting 
groups based on tertiary butyl (tBu). This approach enables the addition of amino acids to the 
peptide backbone without unwanted side reactions. The shorter peptides that are mentioned in 
Chapter 2.1.5.2 were made manually but also using Fmoc/ tBu chemistry. 
Figure 2.5 shows the general reaction sequence for Fmoc/tBu SPPS that was used. Starting 
with the C-terminal amino acid protected with Fmoc and attached to the resin via its C-terminal 
carboxyl group, the first step of the synthesis is the removal of the Fmoc protecting group from the 
α-amine. To couple the next amino acid in the sequence, activation of the C-terminal carboxylic acid 
of the incoming amino acid is required. This is achieved by using HBTU to aid the formation of a 
reactive ester in the C-terminus of the incoming amino acid. This cycle of α-amine deprotection and 
amino acid activation and coupling is then repeated for all the amino acid residues in the peptide. 
Since the reactive side chains are protected with acid-labile groups, they remain unreactive during 
the peptide backbone elongation and therefore unwanted side reactions are avoided. The details of 
the SPPS procedures can be found in Chapters 4.1.2 and 4.1.3 of Materials and Methods. 
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Figure 2.5. Solid phase peptide synthesis based on Fmoc/tBu chemistry. 
All the peptides in the current project were made using automated SPPS based on Fmoc/tBu chemistry. Starting with a pre-
loaded Wang resin, the first step of the synthesis is to remove the N-terminal Fmoc protecting group with a base. After 
this, the next amino acid – which has been activated in its C-terminus – is coupled to the peptide. The Fmoc removal and 
activated amino acid coupling steps are then repeated until all the amino acids in the peptide have been added. The final 
step is Fmoc removal from the N-terminal amino acid. (Rx = amino acid side chain, PG = acid-labile amino acid side chain 
protecting group, A = activating group, the grey sphere = the solid support) (Figure adapted from [192]) 
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2.1.3.2 The resin for SPPS 
When peptides with a free carboxylic acid at the C-terminus are synthesised, it can often be difficult 
to couple the C-terminal amino acid to the solid support [192]. Hence, a resin pre-loaded with the C-
terminal residue lysine was used for all the peptides that were synthesised. The structure of the 
resin of choice, a p-alkoxybenzyl alcohol resin – more commonly known as the Wang resin – is 
shown in Figure 2.6. In this solid support, Fmoc-Lys(Boc) is attached to the resin via a p-alkoxybenzyl 
alcohol linker. 
 
Figure 2.6. Fmoc-Lys(Boc) Wang resin. 
A pre-loaded Fmoc-Lys(Boc) Wang resin was used in the solid phase peptide synthesis of the FMDV 3C
pro
 substrates. In this 
p-alkoxybenzyl alcohol (green) resin, the α-amine of lysine is protected with the base-labile Fmoc group (pink), whereas the 
lysine side chain amine is protected with Boc (blue) which is stable to base and can be removed with an acid. The grey 
sphere represents the solid support. 
2.1.3.3 Peptide purification 
After SPPS, some of the peptides were labelled with one or two fluorescence dyes as will be 
described in Chapter 2.1.5. All labelled and unlabelled peptides were cleaved off the solid support 
with 95% TFA to yield a peptide with a free acid at the C-terminus. Treatment with concentrated TFA 
also removed the acid-labile amino acid side chain protecting groups. Purification of the final 
products was done by first precipitating the peptide in cold tert-butyl methyl ether (TBME), after 
which LC/MS was used for the final purification. For the single-molecule FRET peptides, also a Sep-
Pak C18 cartridge was used in the purification process. More details on the peptide purification 
protocols can be found in Chapter 4.1.12 of Materials and Methods. 
2.1.4 Benzoylation of APAKALLNFDLLKK 
The peptide APAKALLNFDLLKK was benzoylated on the N-terminal α-amine and the benzoylated 
peptide was used in the fluorescence anisotropy binding experiments, as will be discussed in 
Chapter 2.2. The benzoylation reaction was done before amino acid side chain deprotection and 
cleavage off the resin, and the reaction scheme is shown in  
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Figure 2.7. After the reaction, the peptide was deprotected, cleaved from the resin and purified 
following the procedures described in Chapter 2.1.3.3. More details on the benzoylation reaction 
can be found in Chapter 4.1.4 of Materials and Methods. 
 
Figure 2.7. Benzoylation of APAKALLNFDLLKK. 
The peptide APAKALLNFDLLKK was benzoylated on its N-terminus with benzoic anhydride (10 eq) and N,N-
diisopropylethylamine (DIPEA) (10 eq) as shown in the reaction scheme. The reaction was carried out when the peptide 
was still attached to the solid support (the grey sphere). (PG = amino acid side chain protecting group) 
 
2.1.5 Fluorescence labelling of  peptides 
2.1.5.1 Labelling of the N-terminal α-amine 
As mentioned in Chapter 1.6.3, one of the most common peptide and protein labelling techniques is 
the attachment of an amine-reactive dye to either the N-terminal α-amine or the ε-amine of a lysine 
residue. One of the most commonly used amine-reactive functionalities on the dye is an NHS ester. 
[103, 188] In the present study, NHS ester -functionalised fluorophores – fluorescein (Flu) and HiLyte 
488 (HL488) – were used to label the N-terminal α-amine of FMDV 3Cpro peptide substrates while 
each peptide was still attached to the solid support. The reaction scheme is shown in Figure 2.8. 
The labelling conditions were optimised using fluorescein NHS ester and the highest labelling 
efficiency was achieved with four equivalents of the dye and approximately 30 equivalents of N,N-
diisopropylethylamine (DIPEA). The DIPEA, a weak non-nucleophilic base, was added to the reaction 
to ensure the N-terminal α-amine remained deprotonated and could hence react with the NHS 
ester. The reaction was carried out in DMF for approximately 17 hours to form a stable amide bond 
between the amine and the NHS ester. After the N-terminal labelling reaction, the peptides were 
either taken forward for another on-resin labelling (Chapter 2.1.5.2) or fully deprotected and 
cleaved off the resin using 95% TFA. The details of the N-terminus labelling reaction can be found in 
Chapter 4.1.5 of Materials and Methods. 
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Figure 2.8. Fluorescence labelling of the N-terminal α-amine with an NHS ester dye. 
Labelling of the N-terminal α-amine with an amine-reactive NHS ester -functionalised fluorophore was used in the 
synthesis of both singly and doubly labelled peptides. The reactions were done in DMF with 4 equivalents of the dye and 
approximately 30 equivalents of DIPEA, while the peptide was still attached to the solid support. After labelling, most of 
the peptides were cleaved off the resin and fully deprotected with 95% TFA. For some of the FRET peptides, another on-
resin labelling reaction was done before cleavage and deprotection. (The green star and the grey sphere represent the 
fluorescent part of the NHS ester dye and the resin, respectively. PG denotes an amino acid side chain protecting group, 
whereas TIS stands for triisopropylsilane.) 
 
The N-terminal α-amine was chosen as a labelling position for several reasons. Firstly, this 
approach enabled completely selective labelling of the amine. After making the peptide sequence by 
SPPS, the reactive amino acid side chains were still fully protected and the peptide was attached to 
the solid support. The only reactive group on the peptide chain at this stage was the N-terminal α-
amine from which the Fmoc protecting group had been removed in the peptide synthesiser. Hence, 
none of the other NHS ester -reactive groups in the peptide were able to react with the NHS ester -
derivatised fluorophore. This allowed the reaction to be carried on until maximal labelling efficiency 
was achieved, as there were no unwanted side reactions to be concerned about. 
Furthermore, labelling of the N-terminal amine allowed the reaction to be carried out on 
resin. Doing the labelling on solid support rather than in solution made the removal of the unreacted 
dye significantly easier – the peptidyl resin was simply washed with copious amounts of DMF. 
Removing most of the unreacted dye in this manner made the final peptide purification by LC/MS 
considerably easier. Hence the on-resin labelling of the N-terminal α-amine with an NHS ester -
derivatised fluorophore allowed completely selective and highly efficient labelling, and also 
simplified the purification of the final product. All the N-terminal labelled peptides that were 
synthesised are shown in Table 2.2. In addition, the N-terminal labelling method was also used in the 
synthesis of the FRET peptides in Table 2.3 (Chapter 2.1.5.2). 
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Table 2.2. Peptides labelled on the N-terminus. 
The table shows all the peptides that were labelled with an NHS ester dye on the N-terminal α-amine. Flu and HL488 
denote fluorescein and HiLyte488, respectively, and the residues written in bold and underlined signify changes in the 
peptide sequences compared to the unmutated fluorescein peptide. 
Name of the peptide The peptide sequence 
Unmutated fluorescein peptide Flu-APAKQ/LLNFDLLKK 
P4-Ala fluorescein-peptide Flu-AAAKQ/LLNFDLLKK 
P2-Ala fluorescein-peptide Flu-APAAQ/LLNFDLLKK 
P1-Ala fluorescein-peptide Flu-APAKA/LLNFDLLKK 
P1’-Ala fluorescein-peptide Flu-APAKQ/ALNFDLLKK 
P4’-Ala fluorescein-peptide Flu-APAKQ/LLNADLLKK 
P3’-Cys fluorescein-peptide Flu-APAKQ/LLCFDLLKK 
P3’-Cys HiLyte488-peptide HL488-APAKQ/LLCFDLLKK 
 
The labelling efficiency of the α-amine was evaluated by analysing the crude reaction 
mixture by LC/MS. The LC/MS trace for the crude HL488-peptide is shown in Figure 2.9 and 
demonstrates the high labelling efficiency achievable with the on-resin N-terminal labelling method. 
No unlabelled peptide is detected by UV. However, both labelled and unlabelled peptide can be seen 
in the total ion count (TIC). Even though it is not possible to determine the labelling efficiency 
accurately (because the labelled and unlabelled peptides might ionise to different extents), the 
LC/MS results suggest that most of the peptide has been labelled. It should be noted that the LC/MS 
trace shown in Figure 2.9 is for the crude HiLyte 488 peptide, and that the peptide was purified by 
LC/MS, as described in Chapter 2.1.3.3, before it was used in any further experiments. The pure 
peptide was characterised from its matrix-assisted laser desorption ionisation (MALDI) mass 
spectrum as well as UV/Vis absorption and fluorescence emission spectra. The fluorescein-labelled 
peptides, on the other hand, were characterised by LC/MS. The characterisation data can be found 
in the Appendix (6.1).  
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(a) 
 
(b) 
 
Figure 2.9. LC/MS trace for the crude HL488-peptide. 
The figure shows the LC/MS trace for the crude HL488-peptide. In (a), the peaks at 6.0 and 6.5/6.6 minutes in the diode 
array (top) and total ion count (TIC) (bottom) correspond to HL488-APAKQLLCFDLLKK. There are two peaks for the labelled 
peptide due to two isomers of the HiLyte 488 NHS ester dye that was used in the labelling. The smaller peak at 2.9 minutes 
in the TIC is due to the unlabelled peptide APAKQLLCFDLLKK. The mass spectra of the three peaks seen in the TIC (at 2.9, 
6.0 and 6.6 min) are shown in (b). Mass/charge ratios (m/z) 1030, 687 and 515 correspond to the twice, three times and 
four times protonated HL488-APAKQLLCFDLLKK, respectively. The m/z values of 795 and 530 correspond to the twice and 
three times protonated unlabelled peptide APAKQLLCFDLLKK. As can be seen, the amount of labelled peptide is 
significantly higher than the amount of unlabelled peptide, illustrating the high labelling efficiency that can be achieved 
with the on-resin N-terminal labelling method used. It should be noted that the figure shows the LC/MS data for the crude 
HL488-peptide, and that the crude peptide was purified using LC/MS before any further experiments. (Molecular weight of 
the unlabelled peptide = 1588; molecular weight of the labelled peptide = 2058) 
2.1.5.2 Labelling of the cysteine thiol 
For the FRET peptides, two fluorescence labels were introduced, the FRET donor and the FRET 
acceptor. The donor was placed on the N-terminus and the acceptor – tetramethylrhodamine (TMR), 
HiLyte 647 (HL647) or AlexaFluor 647 (AF647) – on a cysteine which was incorporated into the 
sequence of each FRET peptide. Because the peptides used contained several lysine residues, 
cysteine was chosen as the labelling site for the acceptor. This enabled selective labelling with the 
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FRET acceptor dye. Table 2.3 shows all the peptides that were labelled at a cysteine residue. For the 
FRET peptides, the N-terminal labelling with the donor dye was done as described in Chapter 2.1.5.1. 
Table 2.3. Peptides with a fluorescence tag on a cysteine. 
The table shows all the peptides that were labelled with a cysteine-reactive dye. In addition to the singly labelled TMR 
peptide, doubly labelled FRET peptides were also synthesised. One FRET peptide was made for ensemble FRET experiments 
– the eFRET (ensemble FRET) peptide. Three FRET peptides were made for single-molecule FRET experiments – the smFRET 
(single-molecule FRET) peptides 1-3. (Flu = fluorescein, TMR = tetramethylrhodamine, HL488 = HiLyte 488, HL647 = HiLyte 
647, and AF647 = AlexaFluor 647) 
Name of the peptide The peptide sequences 
TMR peptide APAKQ/LLC(TMR)FDLLKK 
eFRET peptide Flu-APAKQ/LLC(TMR)FDLLKK 
smFRET peptide 1 HL488-APAKQ/LLC(HL647)FDLLKK 
smFRET peptide 2 HL488-APAKQ/LLNFDLC(HL647)KK 
smFRET peptide 3 HL488-APAKQ/LLC(AF647)FDLLKK 
 
The introduction of the cysteine-reactive dye was more challenging than the N-terminus 
labelling. After careful optimisation of the reaction conditions, successful labelling was achieved with 
two different labelling methods that will be discussed here. The first method was based on an on-
resin reaction that involved the use of cysteine in which the side chain thiol is protected with 
monomethoxytrityl (Mmt). The second approach, on the other hand, employed trityl (Trt) as the 
cysteine protecting group and was based on labelling in solution. Mmt is significantly more acid-
labile compared to the Trt group which is more commonly used as a cysteine protecting group in 
Fmoc/tBu SPPS. [193] It has been shown that Mmt removal from cysteine can occur selectively in the 
presence of Trt-protected cysteine with a TFA concentration of 0.5-1.0%. [194] The removal of Trt, 
on the other hand, is done with 95% TFA. [193] The structures of the two cysteine side chain 
protecting groups are shown in Figure 2.10.  
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Figure 2.10. Trityl and monomethoxytrityl protecting groups for cysteine side chain protection.  
Two different thiol protecting groups were tested for the cysteine labelling reactions, trityl (Trt) (a) and monomethoxytrityl 
(Mmt) (b). Mmt can be removed with 0.5-1.0% TFA, whereas Trt removal is done with 95% TFA. [193, 194] 
2.1.5.2.1 The on-resin cysteine labelling strategy using Mmt 
The labelling strategy involving the Mmt protecting group was used to synthesise two peptides – the 
singly labelled APAKQLLC(TMR)FDLLKK (referred to as the TMR peptide)  and the FRET peptide Flu-
APAKQLLC(TMR)FDLLKK (referred to as the ensemble FRET or eFRET peptide) in which TMR 
represents tetramethylrhodamine. The synthetic strategy is summarised in Figure 2.11 using the 
eFRET peptide as an example. 
In short, after peptide synthesis by automated SPPS and the on-resin labelling of the N-
terminal α-amine (Chapter 2.1.5.1), Mmt removal was done using a slightly modified pre-existing 
method [194]. This involved treating the peptide with 0.5% TFA in DCM/triisopropylsilane (TIS) (95:5) 
for 30 minutes while the peptide was still attached to the solid support. Before the addition of 
maleimide-derivatised TMR, the extent of Mmt removal was tested by reacting a small amount of 
the peptidyl resin with N-ethylmaleimide (NEM) as discussed below.  
To label the cysteine from which Mmt had been removed, maleimide-derivatised TMR (8 
eq), along with DIPEA (40 eq), was added to the peptidyl resin from which Mmt had been removed. 
After approximately 17 hours, the peptide was fully deprotected and cleaved off the solid support 
with 95% TFA. LC/MS analysis of the crude FRET peptide showed the presence of the doubly labelled 
peptide but also the singly labelled fluorescein peptide, as illustrated in Figure 2.12. The labelling 
efficiency is difficult to determine because the fluorescein-peptide and the FRET-peptide have very 
similar retention times and, therefore, their peaks in the diode array cannot be resolved. However, 
the mass spectrum of the peptide peak shows only a relatively small amount of the singly labelled 
fluorescein-peptide compared to the FRET peptide, indicating high labelling efficiency. Finally, the 
doubly labelled FRET peptide was purified using LC/MS. The full experimental procedures for the 
cysteine labelling employing the Mmt strategy are given in Chapters 4.1.6-4.1.9 of Materials and 
Methods. 
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Figure 2.11. The on-resin cysteine labelling strategy using Mmt. 
The reaction scheme shows the on-resin cysteine labelling reaction for the fluorescein- and TMR-labelled peptide. After 
SPPS and the N-terminal labelling, Mmt is selectively removed from the cysteine with 0.5% TFA. The free cysteine is then 
labelled with TMR maleimide, after which the peptide is fully deprotected and cleaved off the resin with 95% TFA. The 
labelling protocol was the same for the singly labelled TMR peptide. (PG denotes an amino acid protecting group 
removable by 95% TFA, and the grey sphere represents the resin.)  
76 
 
(a) 
 
(b) 
 
Figure 2.12. LC/MS trace for the crude Flu-APAKQLLC(TMR)FDLLKK peptide. 
The figure shows the LC/MS trace for the crude Flu-APAKQLLC(TMR)FDLLKK peptide after on-resin labelling of the cysteine. 
The unreacted starting material, Flu-APAKQLLCFDLLKK, and the FRET peptide product both come off the column at 
approximately 7.8 minutes, as shown in the diode array (top trace) and TIC (bottom trace) in (a). The mass spectrum in (b) 
is for the TIC peak at 7.8 minutes and shows that both the unreacted fluorescein peptide and the FRET peptide are 
contained in the same peak. By comparing the heights of the peaks in the mass spectrum, it can be seen that the amount 
of FRET peptide is significantly higher than the amount of unlabelled fluorescein peptide. The mass/charge (m/z) ratios 
1250, 834, 626 and 501 correspond to the twice, three times, four times and five times protonated FRET peptide, 
respectively, and the m/z values of 974, 650 and 488 are due to the twice, three times and four times protonated Flu-
APAKQLLCFDLLKK, respectively. It should be pointed out that before using the eFRET peptide in any further experiments 
the crude peptide product illustrated in the figure was purified by LC/MS. (Molecular weight of the FRET peptide = 2499, 
molecular weight of the fluorescein-peptide = 1946) 
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2.1.5.2.2? Testing the extent of the Mmt removal reaction 
As mentioned above, to test the extent of Mmt removal before cysteine labelling, a small amount of 
the peptidyl resin was reacted with NEM. The reaction scheme for the reaction between NEM and 
Flu-APAKQLLCFDLLKK is shown in Figure 2.13. After full deprotection of the NEM peptide and 
cleavage off the resin, LC/MS analysis of the crude NEM reaction product showed the presence of 
the NEM peptide and the unreacted peptide, as illustrated in Figure 2.14. According the mass 
spectrum shown in the figure, not much of the unreacted peptide is present, indicating that at least 
most of the Mmt has been removed. It is also possible that the Mmt removal was 100% complete 
but not all of the peptide reacted with the NEM. In addition, no multiple NEM adducts were present, 
suggesting that at least one of the two reactions – the Mmt removal or the NEM addition reaction – 
was selective. 
 
Figure 2.13. N-ethylmaleimide reaction to test for Mmt removal. 
After removing the Mmt protecting group from cysteine, the extent of Mmt removal was tested by reacting a small amount 
of the resin with approximately 40 equivalents of NEM. The figure shows the reaction between Flu-APAKQLLCFDLLKK and 
NEM. After the reaction, the peptide was deprotected and cleaved off the resin, and the products were analysed by LC/MS. 
(The green star and the grey sphere represent fluorescein and the resin, respectively.) 
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(a) 
 
(b) 
 
Figure 2.14. LC/MS trace for an NEM-peptide. 
The figure shows the LC/MS trace for the peptide Flu-APAKQLLCFDLLKK after Mmt removal and a reaction with NEM. In (a), 
the peak at 7.2 minutes in the diode array (top) – or 7.1 minutes in the total ion count (TIC) (bottom) – corresponds to the 
peptide. Both the NEM-peptide and the unreacted peptide are present and are contained in the same peak. This is shown 
in the mass spectrum of the 7.1 min TIC peak in (b). The mass/charge ratios (m/z) of 1037, 692 and 519 correspond to the 
twice, three times and four times protonated NEM peptide, respectively. The m/z values of 974, 650 and 488 correspond 
to the twice, three times and four times protonated unreacted fluorescein peptide, respectively. Hence, according to the 
mass spectrum, most of the peptide has reacted with NEM. (Molecular weight of unreacted peptide = 1946, molecular 
weight of the NEM peptide = 2073) 
 
2.1.5.2.3 Optimising the conditions for Mmt removal 
It has previously been shown that full deprotection of Mmt-protected cysteine can be achieved with 
0.5% TFA in 95:5 DCM/triethylsilane (TES) [194] over 30 minutes. Due to availability, 
triisopropylsilane (TIS) was used instead of TES in the current project. The Mmt removal conditions 
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were tested on the peptides Cys(Mmt)-Leu-Cys(Trt) and Gln(Trt)-Cys(Mmt)-Leu-Cys(Trt). The extent 
of the deprotection reaction was established by reacting a small amount of the peptidyl-resin with 
iodoacetamide after removing the cysteine side chain protecting group. Iodoacetamide readily 
reacts with the deprotected cysteine thiol as shown in Figure 2.15. After the iodoacetamide reaction, 
the peptide was fully deprotected and cleaved off the resin, and the reaction product was analysed 
by LC/MS. Presence of the iodoacetamide peptide adduct indicated successful removal of Mmt. 
 
Figure 2.15. Reaction of iodoacetamide with the cysteine side chain thiol. 
The reaction conditions for removing Mmt were tested on short peptides that contained both Cys(Mmt) and Cys(Trt). The 
extent of deprotection was tested by reacting a small amount of the deprotected peptidyl resin with either 3 or 10 
equivalents of iodoacetamide for 17 (for 3 eq) or 5 hours (for 10 eq), as shown in the reaction scheme above.  
 
Different TFA concentrations (0.5-1.5%) were tested on Cys(Mmt)-Leu-Cys(Trt) and different 
reaction times (30 min - 2 h) on Gln(Trt)-Cys(Mmt)-Leu-Cys(Trt). It was shown that increasing the TFA 
concentration above 0.5% did not improve Mmt removal efficiency. Likewise, increasing the reaction 
time beyond 30 minutes did not make a difference to the extent of deprotection. Therefore, 0.5% 
TFA over 30 minutes was used in the Mmt removal reactions. 
2.1.5.2.4? Cysteine labelling in solution 
The second methodology that was used for the cysteine labelling reaction involved carrying out the 
labelling in solution and using trityl as the cysteine protecting group. This strategy was used to make 
the single-molecule FRET peptides HL488-APAKQLLC(HL647)FDLLKK (smFRET peptide 1), HL488-
APAKQLLNFDLC(HL647)KK (smFRET peptide 2) and HL488-APAKQLLC(AF647)FDLLKK (smFRET peptide 
3) in which HL488, HL647 and AF647 denote HiLyte 488, HiLyte 647 and AlexaFluor 647 
fluorophores, respectively. 
 The solution-based cysteine labelling approach is summarised in Figure 2.16 using the 
synthesis of smFRET peptide 1 as an example. In short, after SPPS and the labelling of the N-terminal 
α-amine, the peptide was fully deprotected and cleaved off the resin, and precipitated with cold 
TBME. The peptide was then dried and re-dissolved in HEPES buffer (100 mM, pH 7.5). After this, the 
maleimide-derivatised dye (2-3 eq) was added to the peptide solution and the solution was left 
shaking for two hours. The reaction was then stopped with glutathione to inactivate the remaining 
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excess maleimide dye. Leaving the cysteine labelling reaction on for longer was shown to results in 
multiple additions of the maleimide dye, probably due to reactions with the lysines in the peptide. 
After the labelling, the reaction mixture was desalted using a Sep-Pak C18 cartridge attached to a 
syringe – the desalting step also removed most of the excess dye. Final purification of the peptide 
was done using LC/MS. 
 
Figure 2.16. Cysteine labelling in solution. 
The synthesis of the smFRET peptides involved labelling the cysteine with the acceptor dye in solution. After the N-terminal 
labelled peptide had been cleaved off the resin and deprotected, the peptide was dissolved in HEPES (100 mM, pH 7.5) and 
2-3 equivalents of the maleimide dye (HiLyte 647 or AlexaFluor 647) were added. After two hours, the reaction was 
stopped by adding 30 equivalents of glutathione (GSH). (The green star represents HiLyte 488, and the pink star represents 
HiLyte 647 or AlexaFluor 647. The grey sphere denotes the resin, whereas PG denotes an amino acid side chain protecting 
group.) 
 
The labelling efficiency using the solution-based cysteine labelling methodology was 
evaluated by analysing the crude reaction mixture using LC/MS. Figure 2.17 shows the CL/MS trace 
for the crude smFRET peptide 1. No unreacted peptide is seen in the trace, which suggests 100% 
labelling efficiency. As mentioned above, the crude peptide was then purified using LC/MS. An 
analytical LC/MS trace of the purified HL488-APAKQLLC(HL647)FDLLKK is shown in Figure 2.18. 
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(a) 
 
(b) 
 
Figure 2.17. LC/MS trace for the crude HL488-APAKQLLC(HL647)FDLLKK peptide. 
The figure shows the LC/MS trace for the crude HL488-APAKQLLC(HL647)FDLLKK peptide after cysteine labelling in 
solution. The top trace in (a) shows the diode array at 651 nm (HiLyte 647 absorption wavelength), whereas the bottom 
trace in (a) is the total ion count (TIC). The peaks at 5.4 and 6.2 minutes correspond to the FRET peptide; there are two 
peaks due to the two isomers of the HiLyte 488 dye. The mass spectra for the two peaks (at 5.4 and 6.2 min) are shown in 
(b). The mass/charge ratios (m/z) 1086 and 820/821 correspond to the three times and four times protonated FRET 
peptide, respectively. No unreacted HL488-APAKQLLCFDLLKK is detected. Even so, the crude peptide illustrated in the 
figure was purified by LC/MS before it was used in any further experiments. (Molecular weight of smFRET peptide 1 = 
3266) 
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(a) 
 
 
(b) 
 
Figure 2.18. LC/MS trace for the pure HL488-APAKQLLC(HL647)FDLLKK peptide. 
The figure shows the LC/MS trace for the purified HL488-APAKQLLC(HL647)FDLLKK peptide (smFRET peptide 1). The top 
trace in (a) shows the diode array, whereas the bottom trace in (a) is the total ion count (TIC). The peak at 3.6 minutes 
corresponds to the FRET peptide. The mass spectrum for the peak is shown in (b). The mass/charge ratios (m/z) 1086 and 
820 correspond to the three times and four times protonated FRET peptide, respectively. (Molecular weight of the FRET 
peptide = 3266) 
 
 Due to the relatively high cost of the HiLyte and AlexaFluor dyes, only a fairly small amount 
of each smFRET peptide was made (less than 0.5 µmol). Hence there was not enough pure final 
product for LC/MS analysis for all of the single-molecule fluorescence peptides. Consequently, the 
crude smFRET peptides were analysed by LC/MS to confirm the presence of the desired products 
before the final purification step, while the purified labelled peptides were mainly characterised 
from their MALDI mass spectra and absorption and fluorescence emission spectra. The desired peaks 
for all the FRET peptides were detected in the MALDI spectra. The absorption and fluorescence 
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spectra also showed peaks at the correct wavelengths and are described in Chapter 2.3.2. 
Characterisation data for smFRET peptides 2 and 3 can be found in the Appendix (6.1). 
2.1.5.2.5 Comparison of the two cysteine labelling strategies 
Advantages and disadvantages of the two cysteine labelling reactions are listed in Table 2.4. In the 
on-resin labelling methodology that uses Mmt as the cysteine protection group the purification of 
the final peptide product is easier compared to the other approach. This is because the excess 
unreacted dye can simply be washed off after the labelling reaction, as the peptide is still attached 
to the resin, and no de-salting step is required because the labelling is done in DMF and not in a 
buffer. In addition, there are no concerns about the maleimide dye reacting with the other amino 
acid side chains in the peptide – for instance, the lysine ε-amine – as all the other amino acids still 
have their side chain protecting groups on. 
On the other hand, acid-labile dyes cannot be used when the on-resin labelling strategy is 
employed. This is because the final labelled peptide product is treated with 95% TFA to cleave it off 
from the solid support and to deprotect the remaining amino acid side chains. In addition, the 
amount of peptide being labelled can only be estimated because the peptide is still on the resin and 
hence difficult to quantify. But when the cysteine labelling is done in solution, the concentration of 
the peptide being labelled can easily be determined by absorbance measurements, provided that 
the peptide is already labelled with another dye, as was the case with the FRET peptides. This helps 
determine the amount of dye needed for the labelling reaction. This aspect of the solution-based 
cysteine labelling method was particularly important for the single-molecule FRET peptides: due to 
the relatively high cost of the single-molecule dyes, only small amounts of these dyes were used, and 
therefore carefully optimising the reaction conditions, including the ratios of the reactants, was 
crucial. 
Another advantage of the solution-based method is that acid-lability of a fluorophore does 
not prevent its use because the peptide is deprotected and cleaved off the resin (with TFA) before 
the cysteine labelling reaction. However, labelling the cysteine in solution has some disadvantages 
as well. First of all, the purification of the final product is somewhat more complicated and more 
time-consuming compared to on-resin labelling method. Furthermore, the reaction time for the 
labelling reaction had to be carefully optimised in order to prevent non-specific labelling of the other 
amino acid side chains in the peptide. All in all, the solution based labelling method seems to be 
better for making smFRET peptides because the relative amounts of the reactants can be better 
controlled. For larger scale cysteine labelling reactions, both methods can be used. 
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Table 2.4. Advantages and disadvantages of the two cysteine labelling strategies. 
The table shows the advantages and disadvantages of the two cysteine labelling methodologies that were employed in the 
present work, the on-resin approach that uses Mmt and the solution-based labelling method. Labelling in solution is the 
method of choice when very small amounts of peptide are labelled. For larger scale reactions, either method can be used. 
Cys labelling strategy Advantages Disadvantages 
On-resin labelling employing 
Mmt 
Excess dye easily removed; 
guaranteed selectivity 
Acid-labile dyes cannot be 
used; 
amount of peptide not known 
accurately 
Labelling in solution 
Amount of peptide more 
controllable; 
acid-lability of the dye not an 
issue 
Purification more complex; 
reaction time must be 
optimised for specific labelling 
 
2.1.6 The fluorescence dyes 
The dyes that were used in the fluorescence measurements of FMDV 3Cpro in the present project can 
be divided into two categories: ensemble fluorophores (fluorescein and tetramethylrhodamine) and 
single-molecule fluorophores (HiLyte 488, HiLyte 647 and AlexaFluor 647). Being more affordable 
than the single-molecule dyes, fluorescein and TMR were used in optimising the labelling conditions 
for the N-terminal and cysteine labelling reactions, respectively. In addition, the two dyes were also 
used to make labelled peptides for bulk level fluorescence experiments. The bulk level experiments 
included the fluorescence anisotropy binding assays (Chapter 2.2) as well as proof-of-principle FRET 
experiments to confirm that fluorescence labels at the P5 and P3’ positions do not prevent the 
binding of FMDV 3Cpro peptide substrates to the enzyme or their hydrolysis by the enzyme (Chapter 
2.3.2.2). The single-molecule fluorophores were used to label the peptides for single-molecule 
fluorescence work (Chapters 2.4 and 2.5). Selected properties of the five fluorophores are shown in 
Table 2.5.  
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Table 2.5. Spectral and photophysical properties of the ensemble and single-molecule fluorophores. 
The table shows selected spectral and photophysical properties of the fluorophores used – the maximum absorption and 
emission wavelengths when attached to a FRET peptide (AbsMax and EmMax, respectively), and the extinction coefficients as 
reported by the suppliers. (The spectra were recorded in a phosphate buffer with pH 7.4.) 
Fluorophore AbsMax / nm EmMax / nm Extinction coefficient / 
M-1 cm-1 
Fluorescein NHS ester 496 519 70,000 
TMR C2 maleimide 544 574 85,810 
HiLyte 488 NHS ester 502 527 77,940 
HiLyte 647 C2 maleimide 657 669 255,900 
AlexaFluor 647 C2 
maleimide 
655 667 263,000 
 
2.1.7 Ensemble fluorescence dyes 
Fluorescein NHS ester and tetramethylrhodamine maleimide were used as the ensemble 
fluorescence labels. The structures of the dyes are shown in Figure 2.19 and Figure 2.20. Fluorescein 
was the dye of choice for the fluorescence anisotropy (FA) binding assays because it is an affordable, 
well characterised and commonly used fluorophore and its use in several ensemble level 
fluorescence anisotropy binding assays has demonstrated its suitability in anisotropy experiments 
[195-197]. TMR can be used as a FRET acceptor with fluorescein as the donor, and was therefore 
used in the cysteine labelling reactions. 
 
Figure 2.19. Structure of fluorescein NHS ester. 
Fluorescein (green) NHS ester was used in peptide N-terminus labelling reactions. The figure shows the structure of 
fluorescein-6 NHS ester. The dye used in the labelling reactions was a mixture of the fluorescein-5 and -6 NHS ester 
isomers and was obtained from Pierce Biotechnology, Inc. (Rockford, USA). 
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Figure 2.20. Structure of tetramethylrhodamine C2 maleimide. 
Tetramethylrhodamine (pink) maleimide was used in cysteine labelling reactions. The figure shows the structure of TMR-5-
C2 maleimide. A mixture of TMR-5- and TMR-6-C2 maleimides was used in the labelling reactions and was obtained from 
AnaSpec (Seraing, Belgium). 
 
The eFRET peptide Flu-APAKQLLC(TMR)FDLLKK was tested under single-molecule conditions 
using a confocal microscope to see if a good single-molecule fluorescence signal can be observed. 
(The confocal setup and the experimental conditions for the solution-based single-molecule 
fluorescence experiments are described in Chapter 2.4, and also Chapter 4.5.1 of Materials and 
Methods) As expected, no single-molecule sensitivity could be obtained with the eFRET peptide. A 
possible explanation for this is that fluorescein and TMR are not photostable enough and are 
therefore photobleached under laser excitation. In addition, the two dyes might not be bright 
enough for single-molecule detection. Therefore, fluorophores with better photophysical properties 
were used to make the single-molecule fluorescence peptides. 
2.1.7.1 Single-molecule fluorescence dyes 
Choosing the correct fluorophores for single-molecule level fluorescence measurements is not a 
trivial matter. It is, in fact, one of the main factors contributing to the success of single-molecule 
fluorescence experiments. The demands for single-molecule dyes were discussed in Chapter 1.6.1. In 
short, to be able to detect a fluorophore under single-molecule conditions, it needs to be bright, 
have high photostability, and show stable fluorescence emission intensity. It is also important that 
the dye molecule does not perturb the biological function of the biomolecule it is attached to. 
Furthermore, the fluorescence properties of the dye should be insensitive to pH and the local 
environment of the dye. 
As mentioned above, fluorescein and TMR were found to be unsuitable for single-molecule 
fluorescence experiments, and therefore alternative dyes with better photophysical properties had 
to be found. AlexaFluor dyes are commonly used in single-molecule fluorescence experiments [117, 
198, 199], and the HiLyte range of dyes is also suitable for high-resolution fluorescence detection 
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[200-202]. Hence, in the single-molecule FRET peptides, HiLyte 488 was used as the FRET donor. 
Both HiLyte 647 and AlexaFluor 647 were tested as the FRET acceptor. It was shown that single-
molecule resolution could be achieved with all three dyes, although HiLyte 647 gave better results as 
a FRET acceptor compared to AlexaFluor 647. The single-molecule fluorescence experiments with 
the three smFRET peptides are discussed in detail in Chapters 2.4 and 2.5. 
According to the supplier of the HiLyte dyes (AnaSpec), HiLyte 488 can be used as a brighter 
and more photostable alternative to fluorescein. In addition, unlike fluorescein, HiLyte 488 
fluorescence intensity is insensitive to changes in pH within the pH range 4-10. [203] HiLyte 647 can 
be used as a FRET acceptor to HiLyte 488. Unfortunately, the structures of the AlexaFluor and HiLyte 
dyes are proprietary information. 
2.1.8 Summary of FMDV 3Cpro peptide substrate synthesis and labelling 
Unlabelled and fluorescently labelled peptide substrates for FMDV 3Cpro were synthesised for studies 
into the binding specificity of the enzyme on the ensemble level and its hydrolysis mechanism on the 
single-molecule level. All the peptides were based on the sequence APAKQ/LLNFDLLKK in which the 
slash indicates the hydrolysis position, and the peptides were made using automated solid phase 
peptide synthesis, after which some of them were fluorescently labelled. Singly labelled peptides 
with a fluorophore attached to the N-terminal α-amine were synthesised mainly for fluorescence 
anisotropy binding assays, and FRET peptides with the donor fluorophore on the N-terminus and the 
acceptor fluorophore on either the P3’ or the P7’ position were made for FRET experiments. 
 The N-terminal labelling of the peptides with NHS ester –derivatised dyes was done when 
the peptides were still attached to the solid support and the amino acid side chains were still 
protected. This on-resin methodology enabled selective and efficient peptide labelling and yielded 
products that were easy to purify. Conditions for the second labelling reaction, on the other hand, 
required more careful optimisation. In addition, the high cost of the single-molecule fluorophores 
that were used meant that some of the labelling reactions had to be done on a relatively small scale 
(less than 0.5 µmol of peptide), which made the optimisation of the reactions even more crucial and 
the analysis of the reaction products somewhat more complicated. 
For the second labelling reaction (with a FRET acceptor dye), a cysteine was introduced into 
the peptides and the peptides were labelled with a maleimide-derivatised fluorophore. Two 
different cysteine labelling methodologies were used, one based on an on-resin reaction and the 
other one based on a reaction in solution. The first strategy involved using the Mmt protecting group 
on the cysteine side chain thiol. This protecting group could be selectively removed with 0.5% TFA 
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without removing the less acid labile protecting groups on the other amino acid side chains. Hence, 
the cysteine could be labelled selectively in the presence of the lysines in the peptide.  
The second cysteine labelling methodology used the more common trityl protecting group 
on the cysteine thiol, and the peptide was fully deprotected before the labelling reaction, and also 
cleaved from the solid support. The labelling selectivity was controlled by carrying out the reaction 
in a pH 7.5 buffer and carefully optimising the reaction time to ensure the maleimide dye would not 
react with the lysine residues of the peptide. 
The solution-based cysteine labelling method enabled more control over the amount of 
peptide being labelled. This method was therefore used in the synthesis of the smFRET peptides 
which were made in relatively small quantities. The ensemble FRET peptide, on the other hand, was 
synthesised using the on-resin labelling strategy. The main advantage of the on-resin cysteine 
labelling method was that the purification process for the labelled peptide product was relatively 
simple compared to the solution-based approach. 
One of the most important aspects of single-molecule fluorescence experiments is choosing 
the right fluorophores. The dyes must be bright and photostable and also insensitive to changes in 
pH or other conditions of the environment the dyes are in. Furthermore, it is important that the 
fluorescent labels do not perturb the biological function of the biomolecules they are attached to. 
Fluorescein NHS ester and tetramethylrhodamine maleimide were used in the synthesis of the 
ensemble fluorescence peptides, both singly labelled ones (tagged with fluorescein) and a FRET 
peptide (labelled with both fluorescein and TMR). However, fluorescein and TMR were found to be 
unsuitable for single-molecule fluorescence detection, most likely due to the relatively low 
brightness and poor photostability of the dyes.  
Fluorophores with better photophysical properties were therefore used to synthesise the 
single-molecule fluorescence peptides. HiLyte 488 NHS ester was used in the N-terminal amine 
labelling reactions and as the FRET donor in the smFRET peptides. Both HiLyte 647 and AlexaFluor 
647 were tested as the FRET acceptor and attached to the peptide using the solution-based cysteine 
labelling reaction. All three dyes were shown to be suitable for single-molecule detection. However, 
HiLyte 647 was shown to yield better smFRET peptides than AlexaFluor 647 (see Chapter 2.4). 
2.2 Fluorescence Anisotropy Binding Assays 
2.2.1 Introduction to fluorescence anisotropy binding assays 
Steady-state fluorescence anisotropy (FA) binding assays were carried out to investigate the 
substrate binding specificity of FMDV 3Cpro. Previous studies have probed the substrate cleavage 
specificity of the enzyme [8, 53] but there are limited data on its binding specificity. Two different 
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fluorescence anisotropy assays were developed and their suitability for probing the substrate 
binding specificity of the 3Cpro was investigated. A direct anisotropy binding assay compared the 
binding of fluorescein-labelled peptide substrates to the enzyme, whereas an indirect anisotropy 
competition assay used unlabelled peptide substrates. 
The aim of the binding experiments was to find out which residues in the FMDV 3Cpro 
peptide substrate APAKQLLNFDLLKK are important for binding to the enzyme, and to compare the 
binding specificity results with the existing cleavage specificity data. The binding specificity results 
can give valuable information on how the 3Cpro interacts with its substrates, and this information can 
be used in FMDV 3Cpro inhibitor design. 
2.2.2? Development of fluorescence anisotropy binding assays 
Fluorescence anisotropy is commonly used in ligand binding studies [195, 204, 205], and the use of 
anisotropy in high-throughput assays has also been demonstrated [196, 206]. FA is a convenient 
technique that allows the probing of biomolecular interactions in a simple and non-radiative fashion. 
Two FA assays were developed – a direct binding assay to compare the binding of fluorescein-
labelled peptide substrates to FMDV 3Cpro and an indirect competition assay to investigate the 
binding of unlabelled substrates to the enzyme. A comparison of the two assays is presented in 
Chapter 2.2.4. 
 A catalytically inactive mutant of FMDV 3Cpro in which the active site cysteine (Cys163) had 
been replaced with an alanine was used in the fluorescence anisotropy work. Assuming that catalysis 
by the 3Cpro follows Michaelis-Menten kinetics, the peptide substrates bind to this mutant enzyme to 
form the enzyme-substrate complex, but hydrolysis of the substrates does not occur, as shown in 
Figure 2.21. Hence, the C163A FMDV 3Cpro mutant can be used to probe the binding interaction 
between the enzyme and its substrates. Investigating the binding step is important for thorough 
understanding of the catalytic mechanism of the enzyme. 
 
 
Figure 2.21. Binding of a substrate to a catalytically inactive mutant of FMDV 3Cpro. 
An inactive C163A mutant of FMDV 3Cpro was used in the fluorescence anisotropy binding assays. A peptide substrate (S) 
binds the active site of the enzyme (E) to form the enzyme-substrate complex (ES), but hydrolysis of the peptide to release 
the cleavage products (P) and the free enzyme does not occur. kon, koff and kcat represent the rate constants of the 
association, dissociation and hydrolysis steps, respectively. 
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The FA binding assays are based on the difference in size and hence difference in 
fluorescence anisotropy of the free fluorescein-labelled peptide substrate and the enzyme-bound 
fluorescein peptide. When free in solution, the labelled peptide tumbles around quite rapidly due to 
its small size, leading to relatively low fluorescence anisotropy. On the other hand, when the peptide 
is bound to the 3Cpro, the rotational diffusion of the fluorescent peptide-enzyme complex is slower 
than that of the free peptide, leading to increased fluorescence anisotropy. Therefore, fluorescence 
anisotropy can be used to determine the extent of binding between FMDV 3Cpro and its peptide 
substrates, and so the binding affinities of different substrates can be compared with FA assays. A 
more detailed description of the theory behind fluorescence anisotropy was given in Chapter 1.4.1. 
2.2.2.1 The dissociation constant 
To compare the strength of binding of different unlabelled and fluorescein-labelled peptides to 
FMDV 3Cpro, the two fluorescence anisotropy assays were used to determine the dissociation 
constants for the peptides. The dissociation constant, Kd, is a good measure of the affinity between 
two binding partners, such as the 3C protease and its substrate. It can be defined as the enzyme 
concentration that gives half of the maximum binding between the enzyme and its ligand, and 
therefore the lower the value of Kd, the stronger the binding. 
A bimolecular binding reaction between two molecules A and B – such as the binding of a 
peptide substrate to FMDV 3Cpro – can be described by the equilibrium 
 
in which kon and koff represent the rate constants for association and dissociation, respectively. The 
association constant, Ka, can be defined in terms of the two rate constants or the concentrations of 
A, B and the AB complex ([A], [B] and [AB], respectively): 
 
    
   
    
  
    
      
                  
 
The dissociation constant, Kd, is the reciprocal of Ka: 
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Even though both of these affinity constants can be used to describe the strength of binding 
between two molecules, it is more common to use the dissociation constant when discussing 
enzyme kinetics. As can be seen from Equation 24, Kd has the units of molar concentration, mol dm
-3. 
[207] 
2.2.2.2 Direct fluorescence anisotropy binding assay 
A direct fluorescence anisotropy binding assay was developed to investigate the substrate binding 
specificity of FMDV 3Cpro using peptide substrates labelled with fluorescein on their N-terminus. In 
this assay a solution of fluorescein-labelled peptide was titrated with the catalytically inactive C163A 
mutant of the 3Cpro while keeping the peptide concentration constant throughout the assay. As the 
3Cpro concentration increased, more of the fluorescent peptide bound to the protease, causing an 
increase in fluorescence anisotropy. Hence, the fluorescence anisotropy of the assay solution 
increased with increasing enzyme concentration, and the binding of the peptide substrate to the 
protease could therefore be detected as an increase in anisotropy. 
 An equation for determining the dissociation constant using the direct binding assay can be 
derived from Equation 24. If the total concentration of A is assumed to be the sum of free A and 
bound A ([A]tot = [A]+[AB]), the fraction of bound A at equilibrium, [AB]/[A]tot, can be defined as 
 
    
      
  
   
      
                  
 
where [B] is the concentration of unbound B. Determining the Kd using Equation 25 involves keeping 
the concentration of A constant while varying the concentration of B, and determining the 
concentration of the AB complex or the fraction of bound A. The curve defined by Equation 25 is 
shown in Figure 2.22 in which the faction of A bound ([AB]/[A]tot) is plotted against [B]. As can be 
seen from the figure, the fraction of bound A increases from zero and approaches the value of 1.0 
asymptotically when [B] is increased. The dissociation constant is equal to the concentration of 
unbound B at which half of total A is bound to B – i.e. when [B] = Kd, [AB]/[A]tot = 0.5. [208] 
For simplicity, the concentration of A in the reaction should be significantly below the Kd – 
ideally, at least 100-fold lower. If this is the case, it can be assumed that at any time, only a very 
small fraction of B is in the bound state in the AB complex. The total concentration of B can be 
expressed as [B]tot = [B] + [AB]. If [A] << Kd, free [B] is significantly greater than [AB], and 
consequently, [B]tot ≈ *B+. Hence, *B+ does not need to be measured experimentally, but *B+tot (the 
concentration of added B) can be used in place of [B] when plotting the graph in Figure 2.22. In 
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summary, the Kd for two binding partners, A and B, can be determined by setting [A]tot << Kd, plotting 
[AB]/[A]tot against [B]tot, and then fitting the data with Equation 25. [208] 
 
 
Figure 2.22. A binding curve for two binding partners A and B. 
The figure shows a binding curve for two molecules, A and B, defined by Equation 25. The fraction of A bound to B is 
plotted against the concentration of free B. Kd is the concentration of free B at which the fraction of bound A equals 0.5. If 
the concentration of A is significantly below the Kd, [B]tot can be plotted on the x-axis instead of [B], which simplifies the 
binding experiments. (Figure adapted from [208]) 
 
 However, in many binding experiments [AB]/[A]tot approaches a value less than 1.0. When 
this is the case, an additional term fmax must be added to Equation 25 to give 
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This equation can be used to derive a fitting equation for the direct anisotropy binding assay for 
FMDV 3Cpro. If A and B are the fluorescent peptide substrate and the inactive FMDV 3Cpro, 
respectively, the fraction of bound peptide, [AB]/[A]tot can be measured in terms of the anisotropy of 
the assay solution – the fluorescence anisotropy is proportional to the fraction of enzyme-bound 
fluorescein peptide. Because the free fluorescein peptide has a fluorescence anisotropy value higher 
than zero, an additional term accounting for this ‘background’ anisotropy also has to be added to the 
equation. 
  Hence, the Kd values for fluorescein-labelled peptide substrates of FMDV 3Cpro can be 
determined by plotting fluorescence anisotropy against the inactive 3Cpro concentration and fitting 
the data with the equation 
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in which Af and Ab are the fluorescence anisotropies of the free fluorescein peptide and the enzyme-
bound fluorescein-peptide, respectively, and [E] is the enzyme concentration. The terms Af and Ab 
are needed to account for the fact that the anisotropy of the free peptide (when      ) is above 
zero and that the measured anisotropy does not approach 1.0. Af accounts for ‘background’ 
fluorescence anisotropy due to free labelled peptide, whereas Ab represents the maximum 
anisotropy measured. Data fitting can then yield the values of Af, Ab and Kd for each fluorescein-
peptide. It should be noted, however, that for Equation 27 to be valid, the fluorescein peptide 
concentration must be significantly below the Kd. Details of how the dissociation constants for the 
fluorescein-labelled peptides were obtained from the fluorescence anisotropy data can be found in 
Chapter 4.3.2 of Materials and Methods. 
2.2.2.3 Indirect fluorescence anisotropy competition assay 
To avoid the need to use labelled FMDV 3Cpro peptide substrates, an indirect fluorescence anisotropy 
competition assay was developed. The competition assay was used to compare the binding affinities 
of unlabelled peptides to FMDV 3Cpro. In the assay, a solution containing fluorescein-labelled 
APAKQLLNFDLLKK (Flu-APAKQLLNFDLLKK) and the C163A mutant of the 3Cpro was titrated with 
various non-fluorescent peptide substrates while keeping the fluorescein peptide and the 3Cpro 
concentrations constant. The 3Cpro concentration was high enough for essentially all of the 
fluorescein peptide to be enzyme-bound at the start of the assay. Initially, the anisotropy of the 
solution was relatively high due to the presence of enzyme-bound fluorescein-peptide. As unlabelled 
peptide was added, the binding of the unlabelled peptide to the enzyme could be detected as a 
decrease in fluorescence anisotropy, as the unlabelled peptide replaced the fluorescein peptide on 
the 3Cpro binding site. 
The fitting equation for the competition assay data is slightly different to Equation 27 (as the 
anisotropy starts from the maximum value and decreases as more unlabelled peptide is added) and 
is shown below. 
                        
   
      
                    
 
Again, Af and Ab are the fluorescence anisotropies of the free fluorescein peptide and the enzyme-
bound fluorescein-peptide, respectively, [U] is the unlabelled peptide concentration, and Kd is the 
dissociation constant for the unlabelled peptide. The term Ab accounts for the maximum anisotropy 
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not being 1.0, whereas Af accounts for ‘background’ fluorescence anisotropy due to free labelled 
peptide. Since the concentration of the labelled peptide is significantly lower than the KD for the 
labelled peptide, the observed KD of the unlabelled peptide can be assumed not to be affected by 
the presence of the fluorescein-peptide. 
Data fitting using Equation 28 can yield the values of Af, Ab and Kd for each unlabelled 
peptide. Experimental details of how the dissociation constants for the unlabelled peptides were 
obtained using the competition assay can be found in Chapter 4.3.3 of Materials and Methods. 
2.2.2.4 The FMDV 3Cpro mutants 
As mentioned earlier, a catalytically inactive mutant of FMDV 3Cpro was used in the fluorescence 
anisotropy binding assays. This protein contains three mutations to the wild type FMDV 3Cpro – C95K, 
C142L and C163A. The first two mutations enhance the solubility of the enzyme, whereas replacing 
the active site Cys163 with an alanine eliminates the catalytic activity of the protease. In addition, a 
catalytically active mutant of FMDV 3Cpro – containing the C95K and C142L mutations – was used in 
the hydrolysis assay discussed in Chapter 2.2.6. Both the active and inactive 3Cpro mutants were 
expressed and purified following previously established procedures [53, 54, 56], and the active 
enzyme was prepared with the help of Nicholas Milton. Details of the protein expression and 
purification protocols can be found in Chapter 4.2 of Materials and Methods. 
In short, the FMDV 3Cpro mutants (A1061 viral strain) with an N-terminal His-tag were 
expressed in Escherichia coli and then purified using TALON metal affinity resin. The inactive 3Cpro 
was further purified using gel filtration. After purification the pure inactive and active proteins were 
concentrated to approximately 10 mg ml-1 in a buffer containing HEPES (50 mM, pH 7.1), NaCl (400 
mM), β-mercaptoethanol (1 mM) and sodium azide (0.01 %). 
2.2.2.5 Assay conditions 
The fluorescence anisotropy assays were carried out in a quartz ultra-micro fluorescence cell (100 µl) 
using a bench top fluorometer equipped with polarisers. All assays were done at room temperature. 
More details on the assay conditions can be found in Chapter 4.3 of Materials and Methods. To be 
consistent throughout all the fluorescence experiments, the same buffers were used in all the 
ensemble and single-molecule fluorescence work. As the demands for single-molecule fluorescence 
buffers are fairly stringent, the choice of buffer components was based on their suitability for single-
molecule fluorescence work.  
Due to its low fluorescence background and pH range suitable for FMDV 3Cpro, phosphate-
buffered saline (PBS) was chosen as the assay buffer with the pH adjusted to 7.4. A detergent was 
added to the buffer to prevent the attachment of the peptide and the 3Cpro onto the cuvette walls. 
95 
 
Bovine serum albumin (BSA) (0.3 mg mL-1) together with Tween 20 (0.05 % v/v) were used in the 
earlier assays. However, in later assays Block Ace (AbD Serotec) (0.4 mg mL-1) was used instead of 
BSA and Tween 20, as Block Ace was found to give a lower fluorescence background signal under the 
single-molecule conditions. A reducing agent, either dithiothreitol (DTT) (1.3 mM) or tris(2-
carboxyethyl)phosphine (TCEP) (0.1 mM), was added to the fluorescence anisotropy assay buffer for 
peptides containing a cysteine residue to ensure the cysteines remained in their reduced form. 
 In the direct FA binding assay the concentration of fluorescein-labelled peptide was 110 nM 
which was high enough to give an easily detectable fluorescence signal. Furthermore, this 
concentration is significantly below the Kd values obtained for all the fluorescein-peptides (which 
were in the µM range), allowing the approximation that [3Cpro]tot ≈ *3C
pro]. The values of [3Cpro] 
ranged from 0 to approximately 200 µM. 
 In the indirect FA competition assays, the initial assay solution contained the peptide Flu-
APAKQLLNFDLLKK at 110 nM and the catalytically inactive 3Cpro at 50 µM. This enzyme concentration 
ensured that essentially all of the labelled peptide was bound to the enzyme, as the Kd for Flu-
APAKQLLNFDLLKK was determined to be 22 µM (see Chapter 2.2.5.1). Each unlabelled peptide was 
then titrated into the assay solution, the unlabelled peptide concentrations ranging from 0 to 4-8 
mM. In addition, the anisotropy of the free unbound Flu-APAKQLLNFDLLKK was determined in a 
separate experiment before each competition assay. This measurement provided the fluorescence 
anisotropy value that, in the competition assay, would indicate that all the fluorescein-peptide had 
been replaced by the unlabelled peptide in the 3Cpro binding site. 
2.2.3 FMDV 3Cpro peptide substrates for the FA binding assays 
Peptides based on the sequence APAKQ/LLNFDLLKK were used in the fluorescence anisotropy 
binding assays. The importance of selected amino acid residues to binding to FMDV 3Cpro was 
investigated by replacing them with an alanine. This was done for both fluorescein-labelled peptides 
and unlabelled peptides. Also P1-Glu fluorescein-peptide was tested, as it has been shown that 
FMDV 3Cpro tolerates glutamic acid as well as glutamine at the P1 position [8]. In addition, the effect 
of replacing certain residues with a cysteine was investigated, as cysteine was required for attaching 
the FRET acceptor to the FRET peptides (Chapter 2.1.5.2). Finally, a peptide with a benzoyl group on 
the N-terminus was synthesised and tested to investigate the effect of the positively charged free N-
terminus on binding to the 3Cpro. All the peptides used in the FA assays are shown in Table 2.6 and 
Table 2.7, and Figure 2.23 illustrates the different peptide N-termini that were compared. 
 
  
96 
 
Table 2.6. Fluorescein peptides used in the binding specificity studies of FMDV 3Cpro. 
The table show the different fluorescein-labelled peptides based on APAKQ/LLNFDLLKK that were used in the FA binding 
assays. Residues written in bold and underlined indicate how each of the mutant peptides differs from the unmutated 
fluorescein peptide. (Flu = fluorescein on the N-terminal α-amine) 
Name of the peptide The peptide sequence 
Unmutated fluorescein peptide Flu-APAKQLLNFDLLKK 
P4-Ala fluorescein peptide Flu-AAAKQLLNFDLLKK 
P2-Ala fluorescein peptide Flu-APAAQLLNFDLLKK 
P1-Ala fluorescein peptide Flu-APAKALLNFDLLKK 
P1’-Ala fluorescein peptide Flu-APAKQALNFDLLKK 
P4’-Ala fluorescein peptide Flu-APAKQLLNADLLKK 
P3’-Cys fluorescein peptide Flu-APAKQLLCFDLLKK 
 
Table 2.7. Unlabelled peptides used in the binding specificity studies of FMDV 3C
pro
. 
The table show the different unlabelled peptides based on APAKQ/LLNFDLLKK that were used in the FA competition assays. 
Residues written in bold and underlined indicate how each of the mutant peptides differs from the unmutated peptide 
APAKQLLNFDLLKK. (H2N = free N-terminus, Bz = benzoylated N-terminus) 
 
Name of the peptide The peptide sequence 
Unmutated peptide H2N-APAKQLLNFDLLKK 
P4-Ala peptide H2N-AAAKQLLNFDLLKK 
P2-Ala peptide H2N-APAAQLLNFDLLKK 
P1-Ala peptide H2N-APAKALLNFDLLKK 
P1-Glu peptide H2N-APAKELLNFDLLKK 
P6’-Cys peptide H2N-APAKQLLNFDCLKK 
P1-Ala benzoylated peptide Bz-APAKALLNFDLLKK 
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Figure 2.23. The different N-termini in the peptides used in the FA binding assays. 
The peptides tested with the direct FA binding assay were labelled with fluorescein on their N-terminus (a), and most of 
the peptides tested with the indirect FA competition assay had a free N-terminus (b). In addition, to investigate the effect 
of the charged free N-terminal amine to binding, a peptide benzoylated on the N-terminus (c) was made and tested. 
 
For the direct binding assay, peptides with fluorescein on the N-terminus α-amine were 
synthesised. In addition to the unmutated fluorescein-peptide APAKQLLNFDLLKK, peptides with an 
alanine at the P4, P2, P1, P1’ or P4’ position were made. These positions were chosen because they 
have been shown to be important for hydrolysis by FMDV 3Cpro in previous alanine scan experiments 
[8, 53]. In addition, a P3’-Cys fluorescein-peptide was made. It has been shown that the P3’ residue 
is not important for cleavage by the 3Cpro [8, 53] and was therefore chosen as one of the labelling 
sites in the FRET peptide substrates. The P3’-Cys peptide was run on the direct anisotropy binding 
assay to ensure cysteine at this position does not hinder binding. 
 To find out if the fluorescein-label on the N-terminus of the 3Cpro peptide substrates affects 
binding to the enzyme, unlabelled peptides were synthesised and tested using the indirect FA 
competition assay. In addition to the unmutated peptide APAKQLLNFDLLKK, P4-Ala, P2-Ala and P1-
Ala peptides were made to see if the binding of these peptides differs from the corresponding 
fluorescein-labelled peptides. A peptide with a glutamic acid instead of glutamine at the P1 position 
was also made to compare the two residues at this position. Furthermore, a peptide benzoylated at 
the N-terminus, Bz-APAKALLNFDLLKK, was made and its binding was tested to investigate the role of 
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the free N-terminus of the peptide substrates in binding to the 3Cpro. Finally, the P6’ residue was 
considered as a labelling site in the FRET peptide substrates, and therefore a P6’-Cys peptide was 
synthesised and tested on the competition binding assay to investigate the effect of P6’-Cys on 
binding to the protease. 
2.2.4 Comparison of the direct and indirect FA binding assays 
The direct fluorescence anisotropy binding assay was carried out at least twice for each fluorescein 
peptide and proved to be quick, simple, sensitive and reproducible. Figure 2.24 shows the FA binding 
curve for Flu-APAKQLLNFDLLKK. It can be seen that the data fit to the binding equation is excellent. 
In addition, a significant difference in fluorescence anisotropy is observed between the unbound 
fluorescein peptide and the enzyme-bound fluorescein peptide, the values being 0.036 and 0.134, 
respectively. This demonstrates the high sensitivity of the assay. Binding curves similar to that in 
Figure 2.24 were obtained for the other fluorescein peptides shown in Table 2.6 as well, with 
excellent fitting to the binding equation – the R2 values for all the peptides exceeded 0.98, most of 
them being above 0.99. The binding specificity results for fluorescein peptides obtained with the 
direct FA binding assay will be discussed in more detail in Chapter 2.2.5.1. 
 
Figure 2.24. Fluorescence anisotropy binding curve for Flu-APAKQLLNFDLLKK. 
The figure shows fluorescence anisotropy plotted against inactive 3C
pro
 concentration for Flu-APAKQLLNFDLLKK. Fitting the 
data using Equation 27 allows the values of Kd, Af and Ab to be determined. 
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 Despite its advantages, a limitation of the direct fluorescence anisotropy binding assay was 
the requirement of a fluorescent tag on the peptide substrates that were compared with the assay. 
The effect of the fluorophore on binding was not known and it was not possible to look at label-free 
FMDV 3Cpro substrates using the direct binding assay. The indirect fluorescence anisotropy 
competition assay was used to overcome these limitations. 
Figure 2.25 shows the competition binding curve for APAKQLLNFDLLKK. As can be seen from 
the figure, anisotropy plateaus at approximately 0.03 at high unlabelled peptide concentrations. 
When the fluorescence anisotropy of a solution only containing Flu-APAKQLLNFDLLKK was 
measured, the same value (0.03) was obtained. This indicates that in the competition assay, the 
unlabelled peptide APAKQLLNFDLLKK has completely replaced the fluorescein-labelled peptide from 
the enzyme binding site, and hence Kd for the peptide can be reliably determined. 
 
Figure 2.25.. Fluorescence anisotropy competition curve for APAKQLLNFDLLKK. 
The graph shows the indirect FA binding assay results for the unlabelled peptide APAKQLLNFDLLKK. Plotting fluorescence 
anisotropy against the unlabelled peptide concentration shows that anisotropy approaches 0.03 – the value for the free 
unbound fluorescein peptide – as the unlabelled peptide concentration is increased. This indicates that the unlabelled 
peptide has completely replaced the labelled peptide in the enzyme binding site. 
 
 
However, similar results were not obtained with the other unlabelled peptides. Figure 2.26 
shows the competition binding curve for the unlabelled P1-Glu peptide. As can be seen from the 
figure, fluorescence anisotropy seems to level off at approximately 0.06 which is considerably higher 
than the anisotropy of the free unbound Flu-APAKQLLNFDLLKK (approximately 0.03). This suggests 
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that the unlabelled peptide is unable to completely compete off the labelled peptide from the 
enzyme binding site at these concentrations. It may also indicate solubility problems at such high 
peptide concentrations – which might, at least partly, explain why the curve levels off at such a high 
FA value. Unfortunately, the rest of the unlabelled peptides shown in Table 2.7 show a similar trend, 
all of them displaying competition binding curves that plateau at anisotropy values above the 
anisotropy of the free unbound Flu-APAKQLLNFDLLKK. Consequently, the dissociation constants for 
the unlabelled peptides determined using the indirect FA competition assay are likely to be 
somewhat inaccurate. 
 
Figure 2.26. Fluorescence anisotropy competition curve for APAKELLNFDLLKK. 
The graph shows the indirect FA binding assay results for APAKELLNFDLLKK. When fluorescence anisotropy is plotted 
against the unlabelled peptide concentration, it can be seen that even at high unlabelled peptide concentrations the 
anisotropy of the solution does not approach the value expected for the free unbound fluorescein peptide (approximately 
0.03) but seems to plateau around approximately 0.06. This indicates either weak binding of the unlabelled peptide to the 
enzyme or a problem with the assay conditions. 
 
2.2.5 FMDV 3Cpro binding specificity results 
2.2.5.1 Binding specificity results for labelled peptides 
Table 2.8 shows the dissociation constants that were determined for the fluorescein-labelled 
peptides using the direct FA binding assay, and the values are shown graphically in Figure 2.27. 
According to the direct binding assay, the residue in the fluorescein peptide Flu-APAKQ/LLNFDLLKK 
101 
 
that is the most important for binding to FMDV 3Cpro is the P2 lysine. Replacing the lysine with an 
alanine causes a larger than 7-fold increase in the dissociation constant. This finding is supported by 
structural data, as shown in the crystal structure of the 3Cpro in a complex with a peptide substrate 
[53] in Figure 2.28. It can be seen that the P2-Lys interacts with an aspartic acid (Asp146) on the 
enzyme. Disrupting this binding interaction by replacing the lysine with an alanine is detrimental to 
binding. 
Table 2.8. Dissociation constants for the fluorescein-labelled peptides. 
The table shows the dissociation constants (Kd) for the fluorescein-labelled peptides determined using the 
direct fluorescence anisotropy binding assay. Each peptide was run on the assay two or three times, and the R
2
 
values for the data fitting for each peptide are also displayed. 
Labelled peptide Kd / µM R
2 
Flu-APAKQ/LLNFDLLKK 22 ± 2 0.996, 0.997, 0.993 
P4-Ala fluorescein peptide 16 ± 1 0.996, 0.996, 0.994 
P2-Ala fluorescein peptide 166 ± 30 0.993, 0.988 
P1-Ala fluorescein peptide 11 ± 1 0.997, 0.996 
P1’-Ala fluorescein peptide 106 ± 22 0.981, 0.981 
P4’-Ala fluorescein peptide 77 ± 10 0.997, 0.987 
P3’-Cys fluorescein peptide 49 ± 5 0.996, 0.994 
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Figure 2.27. Dissociation constants for the fluorescein-labelled peptides. 
The figure shows the dissociation constants that were determined for the fluorescein-labelled peptides using the direct FA 
binding assay. The x-axis shows which residue in the peptide Flu-APAKQLLNFDLLKK has been replaced by alanine or 
cysteine. 
?
Figure 2.28. Crystal structure of the C163A mutant of FMDV 3Cpro with a peptide substrate bound in the active site. 
The figure above shows the superposition of the free FMDV 3Cpro (grey) and the peptide-bound 3Cpro (purple). The peptide 
(APAKQLLNFD) is shown in amber. It can be seen that the P2 lysine (P2-K) of the peptide interacts with an aspartic acid 
residue (D146) of the peptide (circled in blue). The FA binding assay confirms the importance of this interaction to binding. 
(Figure adapted from [53]) 
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 The P1’-Leu also appears to be important for binding of the fluorescein peptide to the 3Cpro. 
Replacing the P1’ residue with an alanine causes an approximately 5-fold increase in dissociation 
constant. Substituting the P4’ phenylalanine also increases KD, although to a lesser extent. 
Conversely, replacing the P4-Pro or the P1-Gln with an alanine leads to increased binding affinity, 
the binding of the P1-Ala peptide being stronger than that of the P4-Ala peptide. Finally, replacing 
the P3’ asparagine of the fluorescein peptide with a cysteine does affect the binding affinity of the 
peptide to FMDV 3Cpro but the impact of this substitution is not as significant as that of some of the 
other substitutions. This result is encouraging from the point of view of FRET substrate design. 
Although it should be noted that even though cysteine at this position is not detrimental to binding, 
it does not necessarily mean that a fluorescent label at P3’ will be tolerated by the enzyme. The 
binding of a doubly labelled FRET peptide to the 3C protease is discussed in Chapter 2.3.5. 
 The binding specificity results for the fluorescein peptides are partly in correlation with the 
existing cleavage specificity data. For the fluorescein peptide Flu-APAKQ/LLNFDLLKK, the P2, P1’ and 
to some extent the P4’ residues seem to contribute to binding, whereas P4 and P1 are not important 
for binding to the 3Cpro. Replacing the P3’ asparagine with a cysteine weakens binding but not as 
much as some of the other substitutions. According to previous work done on FMDV 3Cpro, the 
residues in the peptide substrate DABCYL-APAKQLLD(EDANS)FDLLK that contribute to the cleavage 
specificity of the enzyme are P4, P3, P2, P1 and P1’, whereas the P4’-Phe was shown to have little 
importance. The effect of P2’ was not investigated. [53] With a different assay using the peptide 
IAPAKQ/LLNFDL the residues P4, P2, P1 and P4’and were identified as important for hydrolysis and 
also the P1’-Leu and the P2’-Leu were shown to contribute to substrate recognition. As the assay 
was based on an alanine scan, contribution by P3-Ala to binding could not be determined. [8] 
Hence, P2-Lys and P1’-Leu are important for both binding and hydrolysis, whereas P3’ does 
not significantly contribute to hydrolysis and does not seem to affect binding as much as some other 
residues in the peptide. Due to its relatively insignificant contribution to recognition by the enzyme, 
the P3’ position can potentially be used as the second labelling site in the FMDV 3Cpro FRET 
substrates. Interestingly, P4-Pro and P1-Gln are important for hydrolysis by FMDV 3Cpro but do not 
seem to contribute to binding. The P4’-Phe contributes to binding to some extent, but it is not clear 
how significant this residue is for hydrolysis by the 3Cpro. 
 However, it is important to note that the peptide substrates used in the binding specificity 
and the cleavage specificity studies are slightly different, and therefore comparison across different 
assays should be made with care. It is possible that the different labels used in the different assays 
could affect the substrate binding and cleavage specificity results. 
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2.2.5.2 Binding specificity results for unlabelled peptides 
As mentioned in Chapter 2.2.4, there were some issues with the indirect FA competition assay. 
Because fluorescence anisotropy levelled off at a value higher than that expected for the 
fluorescein-labelled peptide Flu-APAKQLLNFDLLKK for most of the unlabelled peptides, analysing the 
competition assay data was somewhat challenging. A plausible cause for the high final anisotropy 
was solubility problems – such high concentrations of unlabelled peptide (several mM, in most 
cases) were needed to displace the fluorescein peptide from the 3Cpro binding site that it is possible 
the peptides were no longer fully dissolving in the assay buffer.  
Therefore, when the competition assay data were analysed, only data points with less than 1 
mM unlabelled peptide concentration were included in the data fitting. An exception was the 
unmutated APAKQLLNFDLLKK which did not display any solubility problems (as discussed in Chapter 
2.2.4), and hence the same value of Kd was obtained for this peptide regardless of how many data 
points were included in the data analysis. 
 The dissociation constants obtained for the unlabelled FMDV 3Cpro peptide substrates using 
the indirect FA competition assay are shown in Table 2.9 and Figure 2.29. Looking at the results, it is 
obvious that the unmutated peptide APAKQLLNFDLLKK binds considerably more tightly than any of 
the mutant peptides, indicating that replacing any of the residues P4, P2, P1 and P6’ with an alanine 
– or in the case of P6’, a cysteine – is detrimental to binding. In addition, substituting the P1 
glutamine with a glutamic acid also increases the dissociation constant. The residue with the largest 
impact on binding is the P2 lysine, whereas the P1 glutamine seems to contribute less than the other 
residues that were looked at. 
Table 2.9. Dissociation constants for the unlabelled peptides. 
The table shows the dissociation constants (Kd) for the unlabelled peptides determined using the indirect FA 
competition assay. Also the R
2
 value for the data fitting for each peptide is displayed. 
Unlabelled peptide Kd / µM R
2 
H2N-APAKQ/LLNFDLLKK 278 ± 23 0.988 
P4-Ala peptide 1652 ± 141 0.976 
P2-Ala peptide 4839 ± 914 0.869 
P1-Ala peptide 868 ± 91 0.970 
P1-Glu peptide 1301 ± 94 0.980 
P6’-Cys peptide 1947 ± 426 0.840 
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These results are, to some extent, in agreement with the binding specificity results of the 
direct FA binding assay which also showed that the residue that is the most important for binding is 
the P2 lysine. Nevertheless, a more detailed analysis of the indirect FA competition assay results is 
not feasible due to the rather poor quality of the data. The problems with the data analysis are also 
reflected in the relatively low R2 values of data fitting that were observed for some of the unlabelled 
peptides (Table 2.9). 
However, overall comparison of the dissociation constants of the fluorescein-labelled 
peptides and the unlabelled peptides shows that the labelled peptides bind the 3Cpro much more 
tightly than the unlabelled peptides do. This could be an indication that either the free (positively 
charged) N-terminus of the unlabelled peptides hinders binding, or that the fluorescein tag interacts 
strongly with the enzyme, enhancing the binding of the fluorescein-labelled peptides. A possible 
explanation for this enhanced interaction could be the bulky nature of the dye: as the natural 
substrates of FMDV 3Cpro are large polypeptides which are significantly bigger than the peptides 
used in the fluorescence anisotropy assays, the enzyme might show preference towards bulkier 
substrates. 
 
Figure 2.29. Dissociation constants for the unlabelled peptides. 
The figure shows the dissociation constants that were determined for the unlabelled peptides using the indirect FA 
competition assay. The x-axis shows which residue in the peptide APAKQLLNFDLLKK has been replaced by another residue 
– either alanine, glutamic acid or cysteine. 
 
 To determine whether the free N-terminus of the unlabelled peptides was detrimental to 
binding to the 3Cpro, the benzoylated peptide Bz-APAKALLNFDLLKK was used in a fluorescence 
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anisotropy competition experiment with Flu-APAKQLLNFDLLKK. A full competition assay was not 
done, but it was shown that even at a large excess of Bz-APAKALLNFDLLKK (approximately 4 mM), 
the benzoylated peptide could not displace the peptide with a free N-terminus from the FMDV 3Cpro 
binding site. This result suggests that the free N-terminus is not the reason for the poor binding of 
the unlabelled peptides compared to the fluorescein-labelled ones, but rather the fluorescein label 
enhances peptide substrate binding to the enzyme, possibly because of the bulky nature of the dye. 
Finally, to ensure that the peptides based on the sequence APAKQLLNFDLLKK bind FMDV 
3Cpro active site rather than binding to the enzyme non-specifically, a competition experiment was 
carried out with a peptide unrelated to FMDV 3Cpro substrates. It was shown that the peptide 
SLLRVQAHIRKKHVAQ (approximately 4 mM) could not displace Flu-APAKQLLNFDLLKK from the 
enzyme binding site, suggesting that the fluorescein peptide based on a natural FMDV 3Cpro 
substrate was bound specifically to the enzyme binding site. 
 
2.2.6 An LC/MS cleavage assay for the fluorescein-labelled peptides 
2.2.6.1 Introduction to the LC/MS cleavage assays 
To confirm that the fluorescein label on the FMDV 3Cpro peptide substrates does not prevent 
hydrolysis by the enzyme and to compare the hydrolysis rates of the fluorescein-labelled peptides, 
LC/MS cleavage assays were carried out for six of the fluorescein-labelled peptides. The P1-Ala 
fluorescein peptide, which showed relatively tight binding to the enzyme in the anisotropy binding 
assay, was of particular interest – the cleavage assay was used to find out whether the peptide only 
binds to the 3Cpro or whether it is hydrolysed as well. 
 The LC/MS assay was based on an existing HPLC cleavage assay that has previously been 
developed for monitoring peptide hydrolysis by FMDV 3Cpro [8]. Each fluorescein-peptide (12 µM) 
was incubated with the catalytically active (C95K, C142L) mutant of the 3Cpro (2 µM) at 37 °C, and 
samples for LC/MS analysis were taken out after 1 h, 3 h, 5h and 23 h of incubation. Disappearance 
of the intact peptide and appearance of the P1’-P9’ cleavage product in the LC/MS trace indicated 
hydrolysis by the 3Cpro. 
2.2.6.2 LC/MS cleavage assay results 
The cleavage assay results are summarised in Table 2.10. It can be seen that the presence of 
fluorescein on the N-terminus of the peptides does not prevent hydrolysis. Furthermore, as 
expected, the unmutated fluorescein peptide is cleaved more rapidly than any of the alanine mutant 
peptides, and no unhydrolysed peptide is detected after 1 hour of incubation. The LC/MS trace for 
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the hydrolysed Flu-APAKQLLNFDLLKK (after 1 hour of incubation with the 3Cpro) is shown in Figure 
2.30. The cleavage product LLNFDLLKK can clearly be seen, but no intact peptide Flu-
APAKQLLNFDLLKK is detected. When the peptide was incubated without the 3Cpro only the intact 
peptide was detected but no hydrolysis products were seen. An LC/MS trace for the unhydrolysed 
peptide Flu-APAKQLLNFDLLKK can be found in the Appendix (6.2). 
The fluorescein-labelled P4-Ala, P2-Ala, P1-Ala, P1’-Ala and P4’-Ala peptides, on the other 
hand, take longer to get processed by the 3Cpro. After 3 hours, the unhydrolysed peptide can still be 
detected, but 5 hours of incubation results in essentially complete hydrolysis of all the alanine 
mutant peptides apart from the P1-Ala peptide which is discussed below. These results indicate that 
P4-Pro, P2-Lys, P1-Gln, P1’-Leu and P4’-Phe are important for hydrolysis by FMDV 3Cpro and are 
consistent with existing cleavage specificity data obtained using an HPLC assay [8]. 
The same fluorescein-labelled peptides were used in both the direct FA binding assay and 
the LC/MS cleavage assay, and the residues important for binding were to some extent different to 
the residues important for cleavage. Therefore, it seems that either the binding specificity of the 
3Cpro differs from its cleavage specificity, or the inactive and active FMDV 3Cpro mutants have 
different specificities. Further LC/MS assays – with a lower enzyme concentration and more time 
points – could be done to obtain more detailed cleavage specificity results with the fluorescein-
labelled peptides. 
Table 2.10. FMDV 3Cpro cleavage specificity results obtained from with the LC/MS cleavage assay. 
The table shows the cleavage specificity results that were obtained with the LC/MS cleavage assay. The unmutated 
fluorescein peptide was hydrolysed faster than any of the alanine mutant peptides, whereas the P1-Ala peptide was not 
hydrolysed even after 23 hours of incubation with the 3C
pro
. The second column in the table indicates whether the 
cleavage of each peptide has proceeded to at least 95% completion. Residues written in bold and underlined indicate how 
each of the mutant peptides differs from the unmutated Flu-APAKQLLNFDLLKK. 
Peptide substrate Result of cleavage assay 
Flu-APAKQ/LLNFDLLKK Cleaved within 1 h 
Flu-AAAKQ/LLNFDLLKK Cleaved within 5 h 
Flu-APAAQ/LLNFDLLKK Cleaved within 5 h 
Flu-APAKA/LLNFDLLKK Not cleaved after 23 h 
Flu-APAKQ/ALNFDLLKK Cleaved within 5 h 
Flu-APAKQ/LLNADLLKK Cleaved within 5 h 
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(a) 
 
(b) 
 
Figure 2.30. The LC/MS trace for hydrolysed Flu-APAKQLLNFDLLKK. 
The figure shows the LC/MS trace for the peptide Flu-APAKQLLNFDLLKK after 1 hour of incubation with FMDV 3C
pro
. The 
top figure (a) shows the total ion count (TIC), the peak at 7.3 minutes corresponding to the cleavage product LLNFDLLKK. 
The mass spectrum for the peak is shown in (b), the m/z ratio of 552 corresponding to the doubly protonated peptide 
fragment LLNFDLLKK. None of the intact peptide Flu-APAKQLLNFDLLKK is seen in the LC/MS trace, indicating that the 
peptide has essentially been completely hydrolysed by the enzyme within 1 hour. (Molecular weight of LLNFDLLKK = 1103) 
 
 Interestingly, no hydrolysis of the P1-Ala fluorescein peptide by the 3Cpro is detected even 
after 23 hours, suggesting that replacing the P1-Gln with an alanine completely abrogates hydrolysis 
by the enzyme – a result consistent with previous cleavage specificity data [8]. This finding together 
with the fluorescence anisotropy binding assay results suggests that the labelled P1-Ala peptide 
binds tightly to the enzyme but is not hydrolysed. The Flu-APAKALLNFDLLKK peptide could, 
therefore, potentially be useful in FMDV 3Cpro inhibitor design. 
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2.2.7 Summary of the fluorescence anisotropy results 
Two different fluorescence anisotropy assays were developed to investigate the substrate binding 
specificity of FMDV 3C protease. A direct FA binding assay was used to compare the binding of 
fluorescein-labelled peptide substrates to the enzyme, whereas an indirect anisotropy competition 
assay was developed for comparing label-free peptide substrates. All the labelled and unlabelled 
peptides used in the assay were derived from the peptide APAKQLLNFDLLKK which is based on a 
naturally occurring FMDV 3Cpro hydrolysis site. The labelled peptides were tagged with fluorescein on 
their N-terminal α-amine. 
 The direct FA binding assay for comparing fluorescein-labelled FMDV 3Cpro substrates proved 
to be quick, simple, sensitive and reproducible. In addition, this assay yielded data that were very 
well described by the fitting equation. Reliable values for the dissociation constants of the labelled 
peptides were therefore obtained using the direct binding assay. However, the main disadvantage of 
the direct FA binding assay is the requirement for tagged substrates. The indirect FA competition 
assay, on the other hand, has the advantage of using label-free peptide substrates. Nevertheless, the 
competition assay suffered from poor data quality, possibly due to limited peptide solubility in the 
assay buffer. Consequently, the dissociation constants obtained for the unlabelled peptides using 
the indirect FA competition assay may be somewhat inaccurate. The direct binding assay is therefore 
more suitable than the indirect competition assay for investigating the substrate binding specificity 
of FMDV 3Cpro. 
 According to the direct FA binding assay results, the residue in the peptide Flu-
APAKQ/LLNFDLLKK that is the most important for binding to FMDV 3Cpro is the P2 lysine. This finding 
is supported by a previously published crystal structure of the 3C protease in a complex with its 
substrate [53] showing the close interaction between the P2-Lys of the peptide substrate and an 
aspartic acid residue on the enzyme. The direct FA binding assay results also indicate that the P1’-
Leu and the P4’-Phe contribute to binding to the protease. P4-Pro and the P1-Gln, on the other 
hand, do not seem to be important for binding, the labelled P1-Ala peptide binding to the 3Cpro more 
tightly than any of the other fluorescein peptides. 
 The binding specificity results from the direct binding assay and the competition assay are to 
some extent in correlation.  Both assays suggest that the residue that is the most important for 
binding is the P2 lysine. According to the indirect competition assay also the P4, P2, P1 and P6’ 
residues contribute to binding, whereas the direct binding assay results suggest that the P4-Pro and 
the P1-Gln are not important for binding. Comparison of the results from the two assays also shows 
that the fluorescein-labelled peptide substrates bind to FMDV 3Cpro considerably better than the 
unlabelled substrates. A likely explanation for this is the bulky nature of the fluorescein tag – the 
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natural substrates of FMDV 3Cpro are large polypeptides that are significantly bigger than the 
peptides used in the FA assays, and the enzyme might therefore prefer bulkier substrates. 
 To compare the binding specificity and the hydrolysis specificity of the fluorescein-labelled 
peptides, the hydrolysis of six of the peptides was analysed using an LC/MS assay. According to the 
results from the LC/MS assay, the residues in the peptide Flu-APAKQLLNFDLLKK that are important 
for hydrolysis are P4-Pro, P2-Lys, P1-Gln, P1’-Leu and P4’-Phe. These results are consistent with 
existing cleavage specificity data obtained using an HPLC assay. [8] However, the cleavage specificity 
results differ from the binding specificity results – the P4-Pro and P1-Gln were shown not to 
contribute to binding even though they are important for hydrolysis. The labelled P1-Ala peptide is 
especially interesting, as no hydrolysis of the peptide was detected with the LC/MS assay even after 
23 hours of incubation with the 3Cpro. Therefore it seems that this peptide binds to the enzyme 
relatively tightly but is not hydrolysed. 
 The inconsistency between the substrate binding specificity results from the direct FA 
binding assay and the cleavage specificity results from the LC/MS hydrolysis has two plausible 
explanations. Firstly, it is possible that the amino acid residues in the FMDV 3Cpro peptide substrates 
that are important for binding are different from residues important for hydrolysis. Another 
possibility is that the catalytically inactive 3Cpro and the active 3Cpro have different substrate 
specificities due to the different amino acid residues in the active site – Cys163 in the active site of the 
catalytically active FMDV 3Cpro has been mutated into an alanine in the inactive mutant of the 
enzyme. 
 The fluorescence anisotropy work carried out here yields novel information on the substrate 
binding specificity of FMDV 3Cpro, as previous work on the enzyme has mainly concentrated on its 
hydrolysis specificity. The FA binding specificity results, together with the existing cleavage 
specificity data, can come in very useful when designing inhibitors for FMDV 3Cpro. 
2.3 Properties of Fluorescent FMDV 3Cpro Peptide Substrates 
2.3.1 Introduction to properties of FMDV 3Cpro substrates 
Before moving onto the single-molecule fluorescence studies of FMDV 3Cpro, various ensemble 
experiments were done with the labelled peptides. First of all, the spectral properties of the 
fluorescent peptides were examined. This was particularly important for the single-molecule 
fluorescence peptides, as only relatively small amounts of these peptides were synthesised due to 
the high cost of fluorophores that are suitable for single-molecule work. Therefore, these peptides 
were characterised by LC/MS before purification, and the purified single-molecule fluorescence 
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peptides were characterised mainly from their MALDI mass spectra as well as their UV/Vis 
absorption and fluorescence properties which are discussed below. 
Furthermore, before testing the smFRET peptides with FMDV 3Cpro, the ensemble FRET 
peptide Flu-APAKQLLC(TMR)FDLLKK was used to show that there can be FRET between a donor dye 
and an acceptor dye at the P5 and P3’ positions, and that the enzyme can recognise and hydrolyse a 
FRET peptide with tags at these two positions. In addition, the ensemble spectral properties of the 
single-molecule fluorescence peptides were examined. In particular, FRET efficiency and the 
brightness of the FRET acceptor dye in the three smFRET peptides were important factors that 
proved to be central for the single-molecule level experiments. 
Finally, changes in the fluorescence properties of the single-molecule FRET peptides upon 
interaction with FMDV 3Cpro were investigated on the ensemble level.  The ensemble properties of 
the smFRET peptides were then compared with their single-molecule fluorescence properties which 
will be discussed in the following chapters (Chapters 2.4 and 2.5). 
 
2.3.2 Spectral properties of the fluorescently labelled peptides 
2.3.2.1 UV/Vis absorption spectra of the single-molecule fluorescence peptides 
UV/Vis absorption experiments on the single-molecule fluorescence peptides were done for 
characterisation purposes, following procedures described in Chapter 4.4.1 of Materials and 
Methods. The spectra were recorded in PBS buffer (pH 7.4) containing BSA (0.3 mg mL-1) and Tween 
20 (0.05 % v/v), and absorption peaks at the correct wavelengths were observed for all the single-
molecule fluorescence peptides. The UV/Vis absorption spectrum for smFRET peptide 1 (HL488-
APAKQLLC(HL647)FDLLKK) is shown below (Figure 2.31), whereas the spectra for the other single-
molecule fluorescence peptides (the singly labelled HL488-peptide and smFRET peptides 2 and 3) 
can be found in the Appendix (6.1). The singly labelled HL488-APAKQLLCFDLLKK and the three 
smFRET peptides were all shown to absorb light at approximately 500 nm (due to HiLyte 488), and 
the FRET peptide spectra also displayed a peak at approximately 655 nm (due to HiLyte/Alexa 647). 
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Figure 2.31. Absorption spectrum for HL488-APAKQLLC(HL647)FDLLKK. 
The figure shows the absorption spectrum for the smFRET peptide HL488-APAKQLLC(HL647)FDLLKK. The peak on the left 
(at 502 nm) is due to HiLyte 488 absorption, whereas the peak on the right (at 658 nm) corresponds to HiLyte 647 
absorption. The two peaks indicate the presence of the two fluorophores. The peptide (approximately 3 µM) was dissolved 
in PBS buffer (pH 7.4) containing BSA (0.3 mg mL
-1
) and Tween 20 (0.05 % v/v).   
 
 To determine whether there is any singly labelled HL488-peptide present in the smFRET 
peptide stock solutions, the concentrations of the donor and acceptor dyes were calculated using 
the Beer-Lambert law 
 
                        
 
where   is absorbance (or optical density),   is the extinction coefficient of the fluorophore,   is the 
thickness of the sample (or the path length), and   is the concentration of the fluorophore. [58] 
According to the calculations, the proportion of the singly labelled peptide of the total peptide 
content in each smFRET peptide stock was at least 40%. This result is in contradiction with the 
results obtained from the fluorescence spectra, as will be discussed in Chapter 2.3.3. It is therefore 
unlikely that the amounts of singly labelled donor-only peptide in the smFRET peptide stocks are as 
high as the absorption measurements suggest – although small amounts of the HL488-peptide might 
well be present. It is more likely that the close proximity of the donor and acceptor dyes affects their 
extinction coefficients, resulting in uncertainties in the concentration calculations when Equation 29 
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is used. This can be caused, for example, by the formation of excimers, dimers with associated 
excited electronic state, leading to shifts in energy levels compared to the monomers. [58, 209] As 
well as affecting absorbance, interactions between the FRET donor and the FRET acceptor can also 
cause other adverse effects, as will be discussed in Chapter 2.3.4. 
2.3.2.2 Fluorescence spectra of the FRET peptides before and after hydrolysis 
The fluorescence spectra of the single-molecule fluorescence peptides were recorded for 
characterisation purposes, and the spectra for smFRET peptides 2 and 3 can be found in the 
Appendix (6.1). The emission spectrum for smFRET peptide 1 is shown in Figure 2.35 and will be 
discussed later on in this chapter. 
In addition, the fluorescence spectra of the FRET peptides were able to show whether there 
was any FRET between the donor and the acceptor dyes and also whether the peptides were 
hydrolysed by FMDV 3Cpro. For the eFRET peptide Flu-APAKQLLC(TMR)FDLLKK, hydrolysis by the 3Cpro 
was also monitored using LC/MS. Details of the eFRET peptide hydrolysis experiments by LC/MS and 
fluorescence can be found in Chapters 4.4.2 and 4.4.3 of Materials and Methods, respectively. In 
short, the peptide (12 µM) was incubated without the 3Cpro and with the 3Cpro (2 µM) in a PBS buffer 
(pH 7.4) at 37 °C for 45 minutes, after which both solutions were analysed by LC/MS. The LC/MS 
analysis showed that in the absence of FMDV 3Cpro the peptide remained intact (Figure 2.32), 
whereas incubation with the 3Cpro resulted in peptide hydrolysis (Figure 2.33). This proved that the 
labels at the P5 and P3’ positions of the peptide substrate do not prevent recognition by the 
enzyme. 
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(a) 
 
(b) 
 
Figure 2.32. LC/MS trace for the eFRET peptide after incubation without FMDV 3C
pro
. 
The figure shows the LC/MS trace for Flu-APAKQLLC(TMR)FDLLKK after incubation in the absence of FMDV 3C
pro
. The peak 
at approximately 12.9 minutes in the diode array (top trace) and total ion count (TIC) (bottom trace) in (a) corresponds to 
the unhydrolysed peptide. The mass spectrum of the TIC peak at 12.9 minutes is shown in (b). The mass/charge (m/z) 
ratios 834, 626 and 501 correspond to the three times, four times and five times protonated eFRET peptide, respectively. 
The mass spectrum of the TIC peak at 11.3 minutes (not shown) does not contain any of the masses that correspond to the 
eFRET peptide cleavage products. This peak is likely to be due to an impurity in the sample. (Molecular weight of the FRET 
peptide = 2499) 
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(a) 
 
(b) 
 
Figure 2.33. LC/MS trace for the eFRET peptide after incubation with FMDV 3C
pro
. 
The figure shows the LC/MS trace for the eFRET peptide after incubation with FMDV 3C
pro
. The peak at approximately 12.6 
minutes in the diode array (top trace) and total ion count (TIC) (bottom trace) in (a) corresponds to the hydrolysis product 
LLC(TMR)FDLLKK. The mass spectrum of the peak is shown in (b). The mass/charge (m/z) ratios 824 and 550 correspond to 
the twice and three times protonated LLC(TMR)FDLLKK, respectively. The presence of the cleaved peptide fragment 
indicates that the 3C
pro
 has hydrolysed the eFRET peptide. (Molecular weight of LLC(TMR)FDLLKK = 1645) 
 
After the LC/MS experiments, the two peptide solutions were diluted to give a peptide 
concentration of 1 µM and a 3Cpro concentration of 0.2 µM. The fluorescence spectra of the two 
solutions were recorded to see if fluorescence emission from the eFRET peptide had changed as a 
result of hydrolysis by the 3Cpro. The fluorescence spectra in the presence and absence of the 
enzyme, when excited at 480 nm, are shown in Figure 2.34. As can be seen from the spectra, there is 
a large increase in fluorescence from the FRET donor (fluorescein) after the peptide has been 
hydrolysed. This suggests that in the intact peptide there is FRET from fluorescein to TMR, but when 
the peptide is cleaved and the two dyes are separated, FRET disappears. 
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Figure 2.34. Fluorescence spectra of the eFRET peptide upon donor excitation before and after hydrolysis. 
The figure shows the fluorescence emission spectra for the eFRET peptide Flu-APAKQLLC(TMR)FDLLKK after incubation 
without (blue) and with (green) FMDV 3C
pro
 upon excitation of the FRET donor (fluorescein) (at 480 nm). The increase in 
donor fluorescence (at approximately 520 nm) in the presence of the enzyme indicates that the enzyme has hydrolysed the 
peptide. The spectral changes also confirm that there is FRET from the donor to the acceptor (TMR) and that FRET 
disappears when the peptide is hydrolysed. The spectra were recorded in a PBS buffer (pH 7.4) and the peptide 
concentration in both samples was the same, 1 µM. In the solution containing the 3C
pro
, the enzyme concentration was 0.2 
µM. 
 
After the proof-of-principle experiments with the eFRET peptide, the characteristics of the 
smFRET peptides were investigated. Fluorescence experiments were carried out to determine 
whether there is FRET between the donor (HiLyte 488) and the acceptor (HiLyte or AlexaFluor 647) 
fluorophores, and to confirm that also the smFRET peptides can be recognised and hydrolysed by 
FMDV 3Cpro. Details of the experimental protocols for recording the fluorescence spectra for the 
smFRET peptides can be found in Chapter 4.4.4 of Materials and Methods. In brief, the peptide (20 
nM) was incubated with FMDV 3Cpro (approximately 6 µM) in a PBS buffer (pH 7.4) at 25 °C, and a 
fluorescence spectrum of the solution was recorded hourly (for 2 to 4 hours), until there was no 
change in fluorescence emissions from the donor and the acceptor. Constant value for HiLyte 488 
emission and disappearance of the FRET peak (HiLyte/Alexa 647 emission) were taken as an 
indication of essentially complete hydrolysis of the FRET peptide by the 3Cpro. 
 Figure 2.35 shows the fluorescence spectra of smFRET peptide 1 upon donor excitation (at 
480 nm) in the presence and absence of FMDV 3Cpro. The emission peak at approximately 525 nm is 
due to the FRET donor (HiLyte 488) whereas the peak at approximately 670 nm corresponds to the 
acceptor (HiLyte 647) fluorescence. As the acceptor dye cannot be directly excited at 480 nm, the 
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peak at 670 nm is only due to FRET from the donor to the acceptor. After adding the 3Cpro, there is a 
large increase in HiLyte 488 fluorescence as well as a decrease in HiLyte 647 fluorescence, indicating 
that the peptide is hydrolysed by the enzyme. Similar fluorescence spectra were obtained for all 
three smFRET peptides, indicating that all of them show FRET and are recognised and cleaved by the 
3Cpro (data not shown). 
 
Figure 2.35. Fluorescence spectra of smFRET peptide 1 upon donor excitation before and after hydrolysis. 
The figure shows the fluorescence emission spectra for smFRET peptide 1 in the absence (blue) and presence (green) of 
FMDV 3C
pro
 upon donor excitation (at 480 nm). The increase in donor fluorescence (at approximately 525 nm) and 
decrease in acceptor fluorescence (at approximately 670 nm) after adding the enzyme indicate that the enzyme has 
hydrolysed the peptide. The spectral changes also confirm that there is FRET from the donor to the acceptor and that FRET 
disappears when the peptide is hydrolysed. The inset shows how the FRET peak – the acceptor fluorescence peak at 670 
nm – essentially disappears when the peptide is cleaved. The spectra were recorded in PBS buffer (pH 7.4) containing BSA 
(0.3 mg mL
-1
) and Tween 20 (0.05 % v/v), and the peptide concentration in both solutions was the same, 20 nM. In the 
solution containing the 3C
pro
, the enzyme concentration was 6 µM. 
 
2.3.3 FRET efficiencies of the smFRET peptides 
FRET efficiency between two dyes can be defined as the fraction of the donor fluorescence that is 
transferred to the acceptor as FRET. It can be determined, for example, from the fluorescence 
intensity of the FRET donor in the presence and in the absence of the FRET acceptor (  
  and   , 
respectively) using Equation 30 shown below. [81] 
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In the current work the FRET efficiencies of the smFRET peptides were determined by comparing the 
donor fluorescence emission before and after hydrolysis by the 3Cpro – so effectively in the presence 
and absence of the acceptor. Fluorescence spectra for determining the FRET efficiency of smFRET 
peptide 1 are shown in Figure 2.36. The experimental procedure that was described in Chapter 
2.3.2.2 was used to record the spectra. 
 
Figure 2.36. Fluorescence emission spectra of smFRET peptide 1 for FRET efficiency determination. 
The figure shows the fluorescence spectra of smFRET peptide 1 upon HiLyte 488 excitation (at 480 nm) before and after 
hydrolysis by FMDV 3C
pro
. The spectra can be used to determine the FRET efficiency between the HiLyte 488 donor and the 
HiLyte 647 acceptor by using the donor emission peaks (at 525 nm) before and after hydrolysis. As indicated in the figure, 
donor emission in the presence (  
 ) and in the absence (   ) of the acceptor can easily be determined from the spectra and 
inserted into Equation 30 (also displayed in the figure) to calculate the FRET efficiency. This method for determining FRET 
efficiency assumes that there is no singly labelled donor-only peptide present. The spectra were recorded in PBS buffer (pH 
7.4) containing BSA (0.3 mg mL
-1
) and Tween 20 (0.05 % v/v), and the peptide concentration in both solutions was the 
same, 20 nM. In the solution containing the 3C
pro
, the enzyme concentration was 6 µM.
 
 
 When the FRET efficiencies are calculated using Equation 30 as described in Figure 2.36, it is 
assumed that there is no singly labelled donor-only peptide present in the smFRET peptide stock 
solutions. However, as discussed in Chapter 2.3.2.1, the UV/Vis absorption spectra of the smFRET 
peptides indicated the presence of singly-labelled HL488-APAKQLLCFDLLKK in all three smFRET 
peptide stocks. If this was the case, some of the HiLyte 488 emission in the spectra in Figure 2.36 
would come from the singly labelled donor-only peptide. This would lead to a smaller value of    
while        
   would stay the same, which would yield a higher      . The FRET efficiencies 
calculated as shown in Figure 2.36 using Equation 30 are therefore the minimum limits of the actual 
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FRET efficiencies of the smFRET peptides, and the actual       values depend on the proportion of 
singly labelled HL488-peptide in each smFRET peptide stock solution. The minimum       values for 
the three smFRET peptides are shown in Table 2.11. As seen from the table, the FRET efficiency is 
higher in smFRET peptides 1 and 2 compared to smFRET peptide 3. This could be due to the fact that 
the same fluorophore was used as the FRET acceptor (HiLyte 647) in smFRET peptides 1 and 2. 
Table 2.11. FRET efficiencies for the smFRET peptides. 
The table shows the FRET efficiencies for the smFRET peptides as determined from the fluorescence emission spectra of 
the peptides before and after hydrolysis by the 3C
pro
 using Equation 30. The calculations assume that there is no singly 
labelled HL488-peptide present in the smFRET peptide stock solutions and are therefore the minimum limits of the actual 
FRET efficiencies, the actual       depending on the amount of singly labelled donor-only peptide that is present. 
Name of the peptide The peptide sequences Min FRET efficiency / % 
smFRET peptide 1 HL488-APAKQLLC(HL647)FDLLKK 90 
smFRET peptide 2 HL488-APAKQLLNFDLC(HL647)KK 94 
smFRET peptide 3 HL488-APAKQLLC(AF647)FDLLKK 53 
 
 The spectra in Figure 2.36 can also be used to determine the maximum possible amount of 
singly labelled donor-only peptide in the smFRET peptide 1 stock solution. The change in HiLyte 488 
emission (at 525 nm) can be assumed to be solely due to the hydrolysis of the FRET peptide – as no 
change in HiLyte 488 emission in the singly labelled peptide should occur upon hydrolysis. If 100% of 
the donor emission was transferred to the acceptor as FRET, the donor emission before hydrolysis 
would only be due to the singly labelled peptide, whereas donor emission after hydrolysis would be 
the sum of the HiLyte 488 emission from the hydrolysed singly labelled peptide and that from the 
hydrolysed FRET peptide. Hence, the maximum percentage of singly labelled peptide present can be 
determined using the equation 
 
                       
       
      
                       
 
where         is the donor emission (at 525 nm) before hydrolysis and        is the donor emission 
after hydrolysis. The maximum possible percentage of singly labelled peptide in each smFRET 
peptide stock, as calculated using Equation 31, is given in Table 2.12.  
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Table 2.12. Maximum amount of singly labelled HL488-peptide in the smFRET peptide stock solutions. 
The table shows the highest possible portions of singly labelled donor-only peptide in each smFRET peptide stock solution. 
The values are calculated from the fluorescence emission spectra before and after hydrolysis using Equation 31. 
Name of the peptide The peptide sequences 
Max portion of HL488-
peptide / % 
smFRET peptide 1 HL488-APAKQLLC(HL647)FDLLKK 10 
smFRET peptide 2 HL488-APAKQLLNFDLC(HL647)KK 6 
smFRET peptide 3 HL488-APAKQLLC(AF647)FDLLKK 47 
 
It should, however, be noted that the presence of small amounts of donor-only peptide in 
the smFRET peptide stock solutions is not likely to cause major issues in the FRET experiments. This 
is because the fluorescence changes upon FRET peptide hydrolysis are characteristic only to the FRET 
peptides, whereas the fluorescence properties of the singly labelled peptide are likely to be 
unaffected by hydrolysis. 
2.3.4 Brightness of the FRET acceptors in the smFRET peptides 
Brightness is one of the most important properties of a single-molecule dye and is determined by 
the dye’s extinction coefficient and quantum yield. When the three smFRET peptides were looked at 
under single-molecule fluorescence conditions, the donor fluorescence was always easily detectable. 
However, the fluorescence signal from the two acceptor dyes was significantly weaker than donor 
fluorescence for all three smFRET peptides. The single-molecule fluorescence results are discussed in 
more detail in Chapters 2.4 and 2.5. 
The relatively weak acceptor fluorescence could potentially be explained – at least partly – 
by the low quantum yields of the dyes used as the FRET acceptor (HiLyte Fluor 647 and Alexa Fluor 
647). The quantum yield of the HiLyte 488 donor is reported by the supplier (AnaSpec, Seraing, 
Belgium) as 0.91, whereas the QY of both HiLyte 647 (AnaSpec, Seraing, Belgium) and Alexa 647 
(Invitrogen, Carlsbad, CA, USA) is 0.33. In addition, it was shown that upon direct excitation of the 
acceptor, the fluorescence emission from the acceptor is lower in the intact peptide compared to 
the hydrolysed peptide for all three smFRET peptides. Ensemble fluorescence experiments were 
done to quantify the change in acceptor fluorescence before and after hydrolysis by FMDV 3Cpro for 
each smFRET peptide. This was done by directly exciting the acceptor fluorophore (at 630 nm) and 
measuring the fluorescence emission from the fluorophore before and after hydrolysis. As the 
acceptor was excited directly, there was no FRET involved. The detailed protocol for these 
experiments is described in Chapter 4.4.5 of Materials and Methods. 
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For all three smFRET peptides, it was shown that the fluorescence emission from the 
acceptor fluorophore is significantly lower in the intact peptide compared to the hydrolysed peptide. 
This is demonstrated in Figure 2.37 for smFRET peptide 1. As can be seen from the graph, acceptor 
fluorescence more than doubles when the FRET peptide is hydrolysed. This might be an indication 
that the donor dye is somehow enhancing the quenching and/or bleaching of the acceptor. 
Furthermore, interactions between the FRET donor and acceptor might affect the extinction 
coefficients of the dyes, possibly due to the formation of excimers [58, 209], as was discussed in 
Chapter 2.3.2.1.  
The relative values for fluorescence emission of the acceptor in the intact and hydrolysed 
smFRET peptides are listed in Table 2.13. As shown in the table, the apparent quenching of the FRET 
acceptor was characteristic of all three smFRET peptides. The effect was most prominent in smFRET 
peptide 2, HL488-APAKQLLNFDLC(HL647)KK, in which the HiLyte 647 emission intensity in the intact 
peptide is only 15 % of that in the hydrolysed peptide. The relatively low brightness of the FRET 
acceptors in the smFRET peptides had major implications on the single-molecule FRET experiments, 
as will be discussed in Chapter 2.4. 
 
Figure 2.37. Fluorescence spectra of smFRET peptide 1 upon acceptor excitation before and after hydrolysis. 
The figure shows the fluorescence emission spectra for smFRET peptide 1 in the absence (red) and presence (purple) of 
FMDV 3C
pro
 upon HiLyte 647 excitation (at 630 nm). The two fluorescence spectra provide a direct measure of the 
brightness of the acceptor in the unhydrolysed peptide and the hydrolysed peptide. As can be seen from the graph, the 
fluorescence emission from the acceptor dye more than doubles upon peptide hydrolysis. This could be an indication that 
the HiLyte 488 fluorophore somehow enhances the quenching and/or photobleaching of HiLyte 647. The spectra were 
recorded in PBS buffer (pH 7.4) containing BSA (0.3 mg mL
-1
) and Tween 20 (0.05 % v/v), and the peptide concentration in 
both solutions was the same, 20 nM. In the solution containing the 3C
pro
, the enzyme concentration was 6 µM.  
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Table 2.13. The relative brightness of the FRET acceptor in the intact and hydrolysed smFRET peptides. 
The table shows the relative fluorescence emission intensities of the FRET acceptor dye (IA) in the intact peptide and the 
cleaved peptide fragment for the three smFRET peptides when the FRET acceptor is directly excited at 630 nm. 
Intact peptide 
Relative IA in 
intact peptide 
Cleaved peptide 
fragment 
Relative IA in cleaved 
peptide fragment 
HL488-APAKQLLC(HL647)FDLLKK 0.45 LLC(HL647)FDLLKK 1.0 
HL488-APAKQLLNFDLC(HL647)KK 0.15 LLNFDLC(HL647)KK 1.0 
HL488-APAKQLLC(AF647)FDLLKK 0.38 LLC(AF647)FDLLKK 1.0 
 
 Similar problems with single-molecule FRET peptides have also been observed by another 
group using FRET peptides labelled with AlexaFluor 555 and AlexaFluor 647. They used the two dyes 
to label a peptide of twenty-one amino acids in which the inter-dye separation was nineteen 
residues.  It was suggested that due to the random coil structure of the peptide, the donor and 
acceptor fluorophores are in such close proximity to each other that interactions between the two 
dyes induce photobleaching and quenching. [203] This could also be the cause of the lowered FRET 
acceptor brightness in the present project. Nevertheless, it should be noted that the relatively low 
fluorescence intensity of the FRET acceptor does not necessarily significantly affect the single-
molecule fluorescence experiments. This is because FRET changes in the smFRET peptides can easily 
be detected by monitoring the changes in the HiLyte 488 donor fluorescence. 
Because the acceptor quenching/bleaching effect was less significant for smFRET peptide 1 
compared to the other two smFRET peptides, and also because smFRET peptide 1 was shown to 
have a relatively high FRET efficiency (see Chapter 2.3.3), this peptide was used in the binding 
experiments discussed in Chapter 2.3.5. In addition, smFRET peptide 1 was also shown to yield the 
best single-molecule fluorescence data out of the three smFRET peptides, as will be discussed in 
Chapter 2.4. 
2.3.5 Binding of smFRET peptide 1 to FMDV 3Cpro 
Fluorescence binding experiments for smFRET peptide 1 and FMDV 3Cpro were done to find out if the 
fluorescence tags affect binding and also to see whether there is any change in FRET upon binding. 
Fluorescence anisotropy was used to evaluate the binding affinity between the enzyme and the 
peptide, whereas fluorescence emission experiments were done to see if binding changes the 
fluorescence transfer from the donor and the acceptor. 
Single-molecule FRET peptide 1 was run on the direct fluorescence anisotropy binding assay 
that was described in Chapter 2.2.2.2 to determine the dissociation constant (Kd) for the peptide and 
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the 3Cpro. The average Kd from three experiments was (44 ± 4) µM. This value is comparable to those 
obtained for the fluorescein-labelled peptides discussed in Chapter 2.2.5.1, indicating that the 
second label on the P3’ residue does not hinder the binding of smFRET peptide 1 to the 3Cpro. This 
peptide can therefore be used in FRET experiments to probe the binding interaction between the 
enzyme and the peptide on single-molecule level. The single-molecule fluorescence experiments are 
discussed in Chapters 2.4 and 2.5. 
It was also speculated that there might be a change in the relative positions of the two dyes – 
and hence a change in FRET – when smFRET peptide 1 binds to the enzyme. The reasoning behind 
this theory was that the free unbound peptide potentially has a different conformation to the 
enzyme-bound peptide which might be expected to have less freedom for conformational 
fluctuation. Fluorescence emission spectra were recorded for the free unbound smFRET peptide 1 
and the enzyme-bound peptide, as described in Chapter 4.4.6 of Materials and Methods. The spectra 
are shown in Figure 2.38. As can be seen from the figure, there is no change in the relative 
fluorescence emissions from the donor and the acceptor, and hence no change in FRET when the 
peptide binds to the enzyme. Similar results were obtained from single-molecule level fluorescence 
experiments as will be discussed in Chapter 2.4. 
 
Figure 2.38. Fluorescence spectra of smFRET peptide 1 before and after binding to FMDV 3C
pro
. 
The figure shows the fluorescence emission spectra after FRET donor (HiLyte 488) excitation (at 480 nm) for the free 
unbound smFRET peptide 1 (green) and the enzyme-bound FRET peptide (purple). As can be seen from the spectra, there is 
no change in FRET when the peptide binds to FMDV 3C
pro
. The rise in fluorescence at approximately 490 nm in the 
spectrum of the bound peptide is likely to be caused by scattering by the enzyme. The spectra were recorded in PBS buffer 
(pH 7.4) containing BSA (0.3 mg mL
-1
), Tween 20 (0.05 % v/v) and TCEP (1 mM). The peptide concentration was 
approximately 45 nM and 30 nM in the absence and presence of the enzyme, respectively. In the solution containing the 
3C
pro
, the enzyme concentration was 110 µM. The emission spectra for the two solutions were normalised with respect to 
emission at 525 nm to make the two spectra comparable. 
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2.3.6 Summary of the properties of FMDV 3Cpro peptide substrates 
Before carrying out fluorescence experiments on single-molecule level, it was important to look at 
the spectral properties of the labelled peptides on the ensemble level. First of all, UV/Vis and 
fluorescence emission spectra of the single-molecule fluorescence peptides were recorded for 
characterisation purposes, and it was shown that the singly labelled HiLyte 488 peptide as well as 
the three smFRET peptides had all been successfully synthesised. 
 In addition, it was shown that FRET between the donor dye and the acceptor dye could be 
detected for all the FRET peptides – the eFRET peptide and the three smFRET peptides. It was also 
demonstrated that the four FRET peptides were all recognised and hydrolysed by FMDV 3Cpro and – 
as expected – showed a significant increase in donor fluorescence upon hydrolysis; this change in 
fluorescence was due to a decrease in FRET when the peptides were cleaved. FRET efficiencies were 
determined for the smFRET peptides, and it was shown that smFRET peptides 1 and 2 each have a 
relatively high FRET efficiency: at least approximately 90 % of the donor emission is transferred to 
the acceptor as FRET in both peptides. Single-molecule FRET peptide 3, on the other hand, showed a 
lower FRET efficiency, possibly as low as 50 %. The implications of the FRET efficiencies of the three 
peptides on the single-molecule fluorescence experiments will be discussed in Chapter 2.4. 
 Another important property of the smFRET peptides was the brightness of the FRET acceptor 
dye, HiLyte 647 or AlexaFluor 647. It was shown that in all three smFRET peptides, the FRET acceptor 
has a considerably lower brightness in the intact peptide compared to the hydrolysed peptide 
fragment. In other words, the acceptor dye seems to be less bright when the HiLyte 488 donor is 
present. This might be an indication that the FRET donor somehow enhances the quenching and/or 
photobleaching of the acceptor, possibly due to the close proximity of the two dyes in the FRET 
peptides. This issue of low acceptor brightness has significant impact on the single-molecule 
fluorescence experiments, as will be discussed in Chapter 2.4. 
 Because the acceptor quenching/bleaching effect was less significant for smFRET peptide 1 
compared to the other two smFRET peptides, and also because smFRET peptide 1 was shown to 
have a relatively high FRET efficiency, this peptide was used in binding experiments with FMDV 3Cpro. 
The aim of the binding experiments was to find out if the FRET dyes affect the binding of the peptide 
to the enzyme and also to see if FRET between the two dyes changes upon binding. Fluorescence 
anisotropy experiments were used to determine the dissociation constant, Kd, for the peptide and 
the enzyme. The Kd that was obtained – (44 ± 4) µM – is comparable to the values obtained for the 
fluorescein-labelled peptides (Chapter 2.2.5.1), indicating that the HiLyte 647 dye at the P3’ position 
does not hinder binding of the peptide to the 3Cpro. Finally, fluorescence spectra of the free unbound 
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smFRET peptide 1 and the enzyme-bound FRET peptide showed that there is no change in FRET 
when the peptide binds to the 3Cpro. 
2.4 Single-Molecule FRET in Solution 
2.4.1 Introduction to solution-based smFRET experiments 
Solution-based single-molecule FRET experiments were done with the three smFRET peptides that 
were introduced in Chapter 2.1. The aim was to, first of all, establish whether single-molecule 
sensitivity could be reached using the FRET peptides and to find out which one of the peptides is the 
most suitable for single-molecule work. Another important objective was to compare the single-
molecule fluorescence data with the ensemble data that were discussed in Chapter 2.3. For each 
FRET peptide the fluorescence emission intensities from the FRET donor and the FRET acceptor were 
monitored using a confocal microscope system (Chapter 2.4.2). FRET efficiency histograms were 
then constructed for smFRET peptides 1 and 2 to explore their smFRET properties. 
2.4.2 The experimental protocol for the solution-based smFRET studies 
The solution-based smFRET experiments were done on a custom-built confocal microscope system 
based on an inverted microscope. A schematic of the setup is shown in Figure 2.39. The principles of 
a confocal microscope were discussed in Chapter 1.5.1 of Introduction, and the experimental 
procedures used in the present work are described in detail in Chapter 4.5 of Materials and 
Methods. In brief, the smFRET peptide solution (5-20 pM) was placed into a sample chamber of a 
multi-well microscope cover slide and the FRET donor (HiLyte 488) was excited at 480 nm using an 
argon ion laser. The filtered excitation beam was directed to the sample with mirrors and an oil-
immersion objective, the laser power reaching the sample generally being approximately 200 µW. 
The fluorescence emission from the analytes was passed through a pinhole to reject out-of-focus 
light, and then split by a dichroic mirror and directed into two channels, the donor channel (for 
HiLyte 488 emission) and the acceptor channel (for HiLyte 647 or AlexaFluor 647 emission). The 
photon bursts from the dyes were detected by two separate single-photon avalanche diode (SPAD) 
detectors and recorded by two multichannel scaler cards (MCS’s). 
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Figure 2.39. The confocal microscope setup used in the solution-based smFRET experiments. 
A confocal microscope setup based on an inverted microscope was used in the solution-based single-molecule 
fluorescence experiments. The sample was excited with an argon ion laser, and the excitation beam was filtered, and 
directed to the sample using mirrors and an oil-immersion objective. The laser excitation beam was also passed through an 
aperture to reduce the beam size in order to avoid over-filling the back aperture of the objective. The fluorescence 
emission from the sample was passed through a pinhole to reject out-of-focus light. It was then split with a dichroic mirror 
and passed through emission filters before being collected by two single-photon avalanche diode (SPAD) detectors. 
 
In each smFRET run, photon bursts from the donor and acceptor dyes were recorded for 800 
s, using a bin time of 1 ms. The FRET efficiency for each burst was then determined from the donor 
and acceptor signals according to Equation 32 below using MCS-32 software (EG&G ORTEC). 
 
       
  
      
                  
 
where    is the number of photons from the donor and    the number of photons from the 
acceptor per burst. The parameter   compensates for the differences in quantum yields and optical 
detection efficiencies for the donor and the acceptor, and was assumed to be approximately 1.0. 
(The correction factor   can be determined as described in [115]). Finally, FRET efficiency histograms 
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were constructed using Origin 7.0 data analysis software. A more detailed description of the data 
analysis protocol is given in Chapter 4.5.2 of Materials and Methods. 
Due to its low fluorescence background and pH range suitable for FMDV 3Cpro, all the samples 
for the smFRET experiments were made up in phosphate-buffered saline (PBS) with the pH adjusted 
to 7.4. A detergent, Block Ace (0.4 mg mL-1), was added to the buffer to prevent the non-specific 
attachment of the peptide and the 3Cpro onto the microscope cover slide. All experiments were done 
at room temperature. 
 
2.4.3 Results from the solution-based smFRET experiments 
2.4.3.1 Comparing the FRET donor and acceptor signals for the three smFRET peptides 
The suitability of the three smFRET peptides for single-molecule FRET experiments was tested by 
simply comparing the photon bursts in the donor and acceptor channels for each peptide. The donor 
and acceptor signals for the peptides are shown in Figure 2.40. As can be seen from the figure, a 
good donor fluorescence emission signal is observed for all three peptides. However, there are 
noticeable differences between the acceptor signals. The acceptor emission is stronger in smFRET 
peptide 1 compared to the other two peptides, while hardly any acceptor bursts are detected for 
smFRET peptide 3.  
The relatively weak acceptor emission from smFRET peptide 3 is consistent with the 
ensemble fluorescence data which suggest that the FRET efficiency of the peptide (approximately 
50%) is significantly lower than that of smFRET peptides 1 and 2 (approximately 90% for both) 
(Chapter 2.3.3). Furthermore, the bulk fluorescence data also suggest that the acceptor dyes in the 
smFRET peptides are quenched by the donor, and the quenching effect is more significant in smFRET 
peptide 2 compared to the other two peptides. (Chapter 2.3.4) This might explain why the acceptor 
emission from smFRET peptide 2 is relatively weak despite the high FRET efficiency of the peptide. 
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Figure 2.40. FRET donor and FRET acceptor signals for the three smFRET peptides. 
The figure shows the FRET donor (green) and acceptor (red) signals for smFRET peptides 1, 2 and 3. As seen from the 
figure, the donor signal is good for all three peptides. However, as shown in (c), virtually no acceptor photon bursts are 
detected for smFRET peptide 3. This is likely to be caused by the low FRET efficiency of the peptide and the quenching of 
the acceptor dye by the donor. The acceptor signals for smFRET peptides 1 and 2 are better but still quite low considering 
the high FRET efficiency of the peptides, as shown in (a) and (b). The low acceptor bursts are likely to result from the 
quenching of the acceptor by the donor dye. The concentrations of smFRET peptides 1, 2 and 3 were approximately 20 pM, 
10 pM and 5 pM, respectively, and the laser power reaching each sample was between 140 and 200 µW. 
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2.4.3.2 FRET efficiency histograms for intact smFRET peptides 1 and 2 
FRET efficiency histograms were constructed for smFRET peptides 1 and 2, and the information 
contained in the histograms was compared with the ensemble fluorescence results. As discussed in 
Chapter 2.4.3.1, the fluorescence emission from the acceptor fluorophore was relatively poor for 
smFRET peptide 3, and therefore, histogram analysis was not done for this peptide.  
The FRET histograms for smFRET peptides 1 and 2 are shown in Figure 2.41. As can be seen 
from the figure, there is a high FRET population at approximately 90 % energy transfer efficiency in 
both histograms. This is consistent with the ensemble fluorescence results: when the FRET 
efficiencies for the smFRET peptides were determined on the ensemble level, the values obtained 
for smFRET peptides 1 and 2 were approximately 90 % (see Chapter 2.3.3). Figure 2.42 shows the 
high FRET efficiency peaks for both peptides fitted with a Gaussian function to show that there is 
only one high FRET population in the case of each peptide. 
The low FRET population at approximately 0 % FRET efficiency in both histograms in Figure 
2.41 is the so called zero peak. This peak is likely to be caused by donor-only peptide molecules in 
which the acceptor fluorophore is absent. In addition, FRET peptide molecules in which the acceptor 
dye is inactive, for instance photobleached, can contribute to the zero peak. In general, it can be 
difficult to tell whether the zero peak is masking any low FRET populations underneath it. However, 
as the high FRET efficiency population at approximately 90 % energy transfer for both smFRET 
peptides 1 and 2 is consistent with the ensemble fluorescence data for the peptides, it is not likely 
that there are any significant low FRET populations present. 
As can be observed from Figure 2.41, the 90 % FRET efficiency peak is clearer and more 
prominent for smFRET peptide 1 compared to smFRET peptide 2. This can be explained in terms of 
the acceptor fluorophore brightness. As was discussed in Chapter 2.3.4, the donor fluorophore 
seems to quench the acceptor fluorophore in all three smFRET peptides, and this quenching effect 
was found to be more significant in smFRET peptide 2 than it was in the other two peptides. 
Consequently, it is no surprise that the single-molecule data for smFRET peptide 1, in which the 
acceptor dye is relatively bright, are of better quality than the data for smFRET peptide 2. Therefore, 
only smFRET peptide 1 was used in further single-molecule fluorescence experiments. 
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Figure 2.41. FRET efficiency histogram for smFRET peptides 1 and 2. 
The figure shows the FRET efficiency histograms for smFRET peptide 1 (a) and smFRET peptide 2 (b). The high FRET 
population at approximately 0.9 FRET efficiency in both histograms is consistent with the energy transfer efficiencies 
calculated for the two peptides from the ensemble fluorescence data. The low FRET population around zero FRET 
efficiency in both histograms is likely to be due to singly labelled donor-only peptide or FRET peptide molecules in which 
the acceptor dye is inactive. The histogram for smFRET peptide 1 is of better quality compared to the smFRET peptide 2 
histogram – probably because the acceptor dye is less affected by the donor dye in smFRET peptide 1 (see Chapter 2.3.4). 
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Figure 2.42. Gaussian fitting of the high FRET efficiency peaks of smFRET peptides 1 and 2. 
The figure shows the high FRET efficiency peaks for smFRET peptides 1 (a) and 2 (b) fitted with a Gaussian function. The 
data used in the above figures are the same as the data used in Figure 2.41. R
2
 for the Gaussian fit for smFRET peptide 1 is 
approximately 0.97, indicating only one FRET population within the FRET efficiency range 0.6-1.0. The R
2
 value for smFRET 
peptide 2 is approximately 0.86, again indicating only one population between FRET efficiency 0.6 and FRET efficiency 1.0. 
2.4.3.3 FRET efficiency histograms for intact and hydrolysed smFRET peptide 1  
The hydrolysis of smFRET peptide 1 was monitored by solution-based smFRET to confirm that the 
peptide is hydrolysed by the enzyme and that the hydrolysis can be detected under the single-
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molecule conditions. The experimental protocol was similar to the protocol used for the free intact 
peptides (Chapter 2.4.2), apart from the addition of the catalytically active FMDV 3Cpro (1.6 µM) to 
the smFRET peptide solution. A detailed description of the experimental procedure is given in 
Chapter 4.5 of Materials and Methods. 
The FRET efficiency histograms for the intact and hydrolysed smFRET peptide 1 are shown in 
Figure 2.43. The histogram for the intact FRET peptide shows the 90 % FRET efficiency peak that is 
due to energy transfer from the FRET donor to the FRET acceptor. In the histogram for the peptide 
and the 3Cpro after four hours of incubation, the 90 % FRET efficiency peak has virtually disappeared, 
and only the zero FRET efficiency peak remains. This is an indication that the peptide has been 
hydrolysed by the enzyme, causing the separation of the FRET donor and acceptor and hence the 
loss of FRET.  
133 
 
 
 
Figure 2.43. FRET efficiency histograms for the intact and hydrolysed smFRET peptide 1. 
Figures (a) and (b) show the FRET efficiency histograms for the intact and hydrolysed smFRET peptide 1, respectively. In the 
intact peptide a high FRET efficiency peak is clearly observed at approximately 90 % FRET efficiency due to energy transfer 
from the donor dye to the acceptor dye. After incubating the peptide with FMDV 3C
pro
 for four hours, the high FRET 
efficiency peak has virtually disappeared, and only the zero FRET efficiency peak remains. This indicates that the peptide 
has been hydrolysed by the 3C
pro
. 
 
2.4.3.4 FRET efficiency histograms for the free and enzyme-bound smFRET peptide 1 
The final aim of the solution-based smFRET experiments was to find out if the conformation and 
hence the FRET efficiency of smFRET peptide 1 changes when the peptide binds to FMDV 3Cpro. The 
experiments were carried out as described in Chapter 2.4.2, except that the catalytically inactive 
mutant of FMDV 3Cpro was added to the peptide solution at 95 µM. At this enzyme concentration 
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virtually all of the FRET peptide was bound to the enzyme, as the dissociation constant for smFRET 
peptide 1 and the 3Cpro is approximately 44 µM (see Chapter 2.3.5). 
 The FRET efficiency histograms for the free and enzyme-bound smFRET peptide 1 are shown 
in Figure 2.44. As can be seen from the histograms, the high FRET population at approximately 90 % 
energy transfer efficiency remains nearly unchanged when the peptide binds to the 3Cpro. The small 
changes in the FRET histogram upon adding the enzyme are more likely to be caused by changes in 
fluorescence background rather than actual changes in the FRET efficiency when smFRET peptide 1 
binds to the enzyme. This is because a relatively large volume of the 3Cpro stock solution had to be 
added to the peptide solution to ensure that virtually all of the peptide is bound to the enzyme, and 
the 3Cpro stock was made up in HEPES buffer and not in the PBS that was used in the smFRET 
experiments. Consequently, after adding the enzyme, the analyte solution contained both PBS and 
HEPES, in approximately 2:1 ratio. Nevertheless, the virtually unchanged FRET for smFRET peptide 1 
upon binding to the 3Cpro is consistent with the ensemble fluorescence data which also indicated 
that FRET does not change when the peptide binds to the enzyme, as was discussed in Chapter 2.3.5. 
 
 
Figure 2.44. FRET efficiency histograms for the free and enzyme-bound smFRET peptide 1. 
The figure shows the FRET efficiency histograms for the free unbound smFRET peptide 1 (purple) and the enzyme-bound 
smFRET peptide 1 (black and white). As can be seen from the figure, the histograms for the free and bound FRET peptide 
do not significantly differ from each other, suggesting there is virtually no change in FRET when the peptide binds to FMDV 
3C
pro
. 
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2.4.4 Summary of the solution-based smFRET results 
Single-molecule FRET experiments in solution were done on smFRET peptides 1, 2 and 3, and it was 
demonstrated that the peptides could be detected under the single-molecule conditions. FRET 
efficiency histograms were constructed for smFRET peptides 1 and 2, and the histograms showed a 
high FRET population at approximately 90 % energy transfer efficiency for both peptides. These 
results are consistent with the FRET efficiencies obtained for the two peptides using ensemble 
fluorescence methods. 
However, the high FRET peak in the FRET histogram was narrower and more prominent for 
smFRET peptide 1 than it was for smFRET peptide 2. This is thought to be due to the high FRET 
efficiency and a relatively bright FRET acceptor dye in smFRET peptide 1 compared to the other two 
FRET peptides. Single-molecule FRET peptide 1 was therefore used in the single-molecule 
fluorescence experiments with FMDV 3Cpro. When the catalytically active mutant of the 3Cpro was 
added to smFRET peptide 1 solution, the high FRET population essentially disappeared from the 
histogram, indicating that the enzyme has hydrolysed the peptide.  
 The binding of smFRET peptide 1 to the inactive mutant of FMDV 3Cpro was also looked at on 
single-molecule level. It was shown that the FRET efficiency between the donor and the acceptor 
does not change when the peptide binds to the 3Cpro. This result is also consistent with the ensemble 
fluorescence results which indicated that there is no change in FRET when the peptide binds to the 
enzyme. 
 In conclusion, solution-based smFRET experiments were done to show that single-molecule 
sensitivity can be achieved using the FRET peptides that were synthesised. Single-molecule FRET 
peptide 1 proved to have the best properties for smFRET work and was hence used in the 
experiments with FMDV 3Cpro. It was demonstrated that the single-molecule FRET properties and 
changes in FRET when the peptide interacts with the enzyme are in good correlation with the 
ensemble fluorescence data. Single-molecule FRET peptide 1 was then taken forward to look at the 
interaction of the peptide with surface-immobilised FMDV 3Cpro using TIRF, which will be discussed 
in the following chapter (Chapter 2.5). 
 
2.5 Single-Molecule TIRF with Surface-Immobilised FMDV 3Cpro 
2.5.1 Introduction to smTIRF experiments 
The aim of the single-molecule TIRF (total internal reflection fluorescence) experiments was to 
investigate the details of the interaction between FMDV 3Cpro and its peptide substrate. Single-
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molecule FRET peptide 1 was used in the TIRF experiments due to its high FRET efficiency (Chapters 
2.3.3 and 2.4.3.2) and the relatively high fluorescence intensity of the FRET acceptor dye in this 
peptide compared to the other two smFRET peptides (Chapters 2.3.4 and 2.4.3.1). The His-tagged 
3Cpro was immobilised onto a microscope cover slide surface that had been functionalised with NTA 
and Ni, and the fluorescence from the HiLyte 488 donor was monitored as the FRET peptide 
substrate interacted with the immobilised protein. Both, binding of the peptide to the catalytically 
inactive 3Cpro and hydrolysis of the peptide by the active enzyme were investigated. In addition, the 
yellow fluorescent protein (YFP) was used in proof-of-principle experiments testing the surface 
functionalisation and protein immobilisation protocols. 
 
2.5.2 Summary of the experimental conditions for the TIRF experiments 
2.5.2.1 The TIRF microscope systems 
Two different objective-type TIRF microscope setups were used in the TIRF experiments, both of 
which were based on an inverted microscope. The setup used in the photobleaching experiments 
and the TIRF experiments with FMDV 3Cpro is shown in Figure 2.45. The sample was excited with an 
argon ion laser at 488 nm which excites the FRET donor, HiLyte 488. In the 3Cpro experiments the 
laser power reaching the sample was set to approximately 2.4 mW, as this power was found to 
sufficiently excite the HiLyte 488 dye without causing rapid photobleaching (Chapter 2.5.4). Different 
laser powers were tested in the photobleaching experiments. (Chapter 2.5.4)  
The excitation beam was filtered, and it was directed to the sample using mirrors and a high 
numerical aperture oil-immersion objective. The fluorescence emitted from HiLyte 488 – the 
maximum emission being at approximately 525 nm (Chapter 2.3.2.2) – was collected by the 
objective, and finally detected and recorded with an EMCCD camera. The camera was controlled and 
the TIRF images observed using Image-Pro Express software (Media Cybernetics). More details on 
the TIRF system and the experimental procedures can be found in Chapter 4.5 of Materials and 
Methods. 
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Figure 2.45. The TIRF setup used in the photobleaching experiments and the FMDV 3C
pro
 experiments. 
The schematic shows the inverted microscope system used in the photobleaching experiments and the TIRF experiments 
with FMDV 3C
pro
. The sample was excited with an argon ion laser, and the excitation beam was passed through various 
filters and directed to the sample using mirrors and an oil-immersion objective. The fluorescence emission from the sample 
was collected by the objective, and then passed through emission filters before being detected and recorded by an EMCCD 
camera. 
 
In the proof-of-principle experiments with yellow fluorescent protein (YFP), a similar setup 
was used with only a few differences. The sample was excited at 473 nm using a diode-pumped solid 
state laser, the laser power reaching the sample being approximately 0.5 mW. The fluorescence 
emission from YFP – the emission maximum being at approximately 535 nm – was, again, collected 
and recorded with an EMCCD camera.  However, the camera was controlled and the TIRF images 
observed using Andor IG imaging software (Andor Technology). 
2.5.2.2 The flow chamber and the buffer conditions 
All TIRF experiments were done in a flow chamber that was specifically constructed for these 
experiments. The use of a flow cell allowed the reactions that were observed using TIRF to be done 
in microlitre volumes at the microscope cover slide surface. In addition, the reactants and buffers 
could easily be injected into the reaction chamber in a controlled manner that enabled the 
experiments to be carried our rapidly and accurately. A photograph and a schematic of the TIRF flow 
chamber are shown in Figure 2.46. 
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Figure 2.46. The flow chamber used in the TIRF experiments. 
The figure shows the flow cell that was constructed for the TIRF experiments, (a) showing a photograph of the flow cell and 
(b) a schematic of the cell. The flow chamber was built from two microscope slides, one of which had holes drilled into it 
for the inlet and outlet; this is the top slide in the photo and the schematic. Tubing was inserted and glued into the holes to 
enable the injection of analyte solution into the cell (although tubing is not shown in the photograph). The bottom slide, 
which had been functionalised with NTA and nickel, was attached to the top slide with a square-shaped adhesive frame 
(light blue) to form a 25 µL space into which the peptide and protein solutions were injected.  
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All the peptide and protein solutions for the TIRF experiments were made up in the same 
PBS buffer (pH 7.4) that was used in the solution-based smFRET work, for reasons discussed 
previously (Chapter 2.4.2) In most of the TIRF experiments, a detergent was added to the buffer to 
prevent the non-specific attachment of the peptide and the 3Cpro onto the microscope slide and the 
other components of the flow chamber. BSA (0.3 mg mL-1) and Tween 20 (0.05 % v/v) were used in 
the YFP experiments (Chapter 2.5.3.3). However, in the FMDV 3Cpro experiments Block Ace (0.4 mg 
mL-1) was used instead of BSA and Tween 20, as Block Ace (AbD Serotec) was found to give a lower 
fluorescence background signal under the single-molecule conditions. In the photobleaching 
experiments without FMDV 3Cpro, no detergent was used in the buffer (see Chapter 2.5.4). All 
experiments were carried out at room temperature. 
2.5.2.3 The His-tagged FMDV 3Cpro mutants 
His-tagged FMDV 3Cpro mutants from the A1061 viral strain were used in the TIRF experiments. A 
catalytically active mutant with two mutations that enhance the solubility of the protein (C95K and 
C142L) was used in the experiments looking at hydrolysis by the enzyme (Chapter 2.5.5). The 
substrate binding experiments, on the other hand, involved the use of inactive FMDV 3Cpro with an 
additional third mutation at the active site of the enzyme (C163A) to eliminate the enzyme’s 
catalytic activity. Both mutants of the 3Cpro contained an N-terminal His-tag which was used for 
surface immobilisation of the enzymes, as will be described in Chapter 2.5.3. 
 Both mutants, the active and inactive FMDV 3Cpro, were expressed and purified applying 
previously described protocols [53, 54, 56], and the active enzyme preparation was done with the 
help of Nicholas Milton. Details of the protein expression and purification procedures can be found 
in Chapter 4.2 of Materials and Methods. In short, FMDV 3Cpro (A1061 viral strain) with an N-terminal 
His-tag was expressed in Escherichia coli and purified using TALON metal affinity resin. The inactive 
enzyme was further purified using gel filtration. After purification, the protein was concentrated to 
approximately 10 mg mL-1 in a buffer containing HEPES (50 mM, pH 7.1), NaCl (400 mM), β-
mercaptoethanol (1 mM) and sodium azide (0.01 %). 
2.5.3 Surface functionalisation and immobilisation of FMDV 3Cpro 
As discussed in Chapter 1.5.3, an important aspect of TIRF experiments with immobilised protein is 
the attachment of the protein onto the surface. The immobilisation has to be done in a manner that 
does not disrupt the native structure of the biomolecule or affect its function. In addition, the 
surface attachment process needs to be specific with minimal non-specific binding of the analyte or 
any impurities that might be present. 
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 One immobilisation method that has been shown to result in the specific and reversible 
binding of proteins onto a surface is the interaction between His-tag, a metal ion – commonly Ni2+ – 
and nitrilotriacetic acid (NTA). [148, 149, 210] This approach was chosen in the present project as 
the FMDV 3Cpro mutants used in this work already contained a His-tag (of six histidine residues) on 
the N-termini for purification purposes, and therefore no further functionalisation of the protein was 
necessary before surface attachment. The advantages of the His-tag immobilisation strategy are 
discussed in more detail in Chapter 1.5.3.1. 
2.5.3.1 Microscope slide functionalisation with NTA and nickel 
The microscope slides for the TIRF experiments were functionalised using a method adapted from 
two existing protocols [150, 151]. In brief, microscope cover slides were first cleaned following the 
protocol described in Chapter 4.6.3 of Materials and Methods. The slides were then incubated in 1% 
(v/v) 3-glycidyloxypropyl-trimethoxysilane for 20 minutes to silanise the surface and to form a layer 
of epoxy groups. After this, 2% (wt/v) Nα,Nα-bis(carboxymethyl)-L-lysine was  added to the slides for 
16 hours for NTA functionalisation of the surface. Finally, the NTA-functionalised slides were 
incubated in 10 mM NiCl2 solution to form the Ni-NTA complex that can interact with the His-tag. A 
schematic for the functionalisation steps is shown in Figure 2.47. The full experimental procedure for 
functionalising the microscope slides is given in Chapter 4.6.3 of Materials and Methods. 
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Figure 2.47. Surface functionalisation with NTA and nickel. 
The schematic above shows the different stages for obtaining the Ni-NTA-functionalised surface for His-tag binding. The 
cleaned microscope cover slides (light blue) were first incubated with 3-glycidyloxypropyl-trimethoxysilane to form a layer 
of epoxy groups. After this, Nα,Nα-bis(carboxymethyl)-L-lysine was  added to the slides for NTA (purple) functionalisation 
of the surface. Finally, the NTA-functionalised slides were incubated in NiCl2 to form the Ni-NTA complex that can interact 
with the His-tagged FMDV 3Cpro. In the bottom structure only the Ni-NTA complex is shown for simplicity. After binding to 
NTA, the nickel ion has two coordination sites left for binding to histidine. In the absence of histidine, these two sites are 
occupied by water molecules. 
 
2.5.3.2? Immobilisation of FMDV 3Cpro via His-tag binding 
To enable the easy immobilisation of the His-tagged FMDV 3Cpro onto the functionalised microscope 
slides, a flow chamber was constructed, as was described in Chapter 2.5.2 and illustrated in Figure 
2.46. The 3Cpro was attached onto the Ni-NTA surface by first injecting 200 μL of the protein solution 
(3.6 μM for the catalytically active mutant, 1.8 μM for the inactive one) into the flow cell. After 15 
minutes of incubation, 600 μl of the PBS buffer was used to wash off any unbound protein. A 
schematic illustrating the Ni-NTA-His-tag interaction is shown in Figure 2.48. 
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Figure 2.48. Interaction between an Ni-NTA surface and a His-tagged protein. 
The microscope slides for the TIRF experiments were functionalised with NTA and Ni. The His-tagged FMDV 3Cpro mutants 
were then able to specifically bind to the functionalised surface via a complex formation between the imidazole of the 
histidine and the nickel and NTA (purple), as shown in the figure. The microscope cover slide is shown in light blue, and the 
wavy line represents the linker between the slide and NTA. 
 
2.5.3.3? Testing the protein immobilisation protocol with His-tagged YFP 
The surface immobilisation protocol employing the interaction between NTA, Ni and a histidine tag 
was tested using His-tagged YFP. YFP was used instead of FMDV 3Cpro as the fluorescent protein can 
be directly detected using its inherent fluorescence. It was shown that the protein can bind to the 
functionalised Ni-NTA surface, and it was also demonstrated that the His-tagged YFP specifically 
binds to the Ni-NTA complex rather than non-specifically adsorbing onto the microscope slide 
surface. 
 The YFP experiment was carried out as follows. 200 μL of YFP solution (approximately 700 
pM) was injected into the flow cell and left to bind for 15 minutes. 200 μL of the TIRF buffer (with 
BSA and Tween 20) was then used to wash off the unbound protein. After this, fluorescence from 
the YFP was monitored for 200 s upon excitation at 473 nm, as further 200 μL of buffer was added. 
Another measurement was recorded as 200 μL of imidazole solution (100 mM) was injected into the 
flow chamber. The same procedure, from the 3Cpro attachment through to the imidazole injection, 
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was then repeated with an NTA-functionalised slide that had not been treated with NiCl2. The results 
are summarised in Figure 2.49. 
 
Figure 2.49. Surface attachment and release of His-tagged YFP. 
The figure shows the TIRF results for surface-immobilised His-tagged YFP. The YFP was first attached to the NTA-Ni surface, 
and it was shown that adding buffer into the flow cell only causes a modest decrease in fluorescence (blue). This decrease 
in signal can be attributed to the slow dissociation of the protein from the surface over long periods of time. Addition of 
imidazole, on the other hand, causes a rapid decrease in fluorescence (purple), indicating a rapid release of the YFP from 
the surface. The buffer/imidazole was added 20 seconds into the run, as indicated by the blue dashed line. When the His-
tagged YFP is incubated on a surface that has not been treated with NiCl2, no fluorescence above the background level is 
detected, and there is no difference between the buffer wash (green) and the imidazole release (pink). These results 
indicated that the His-tagged YFP specifically binds to the NTA-Ni complex on the microscope slide surface and that the 
binding interaction can be reversed with imidazole. 
 
 As can be seen from the figure, the His-tagged YFP cannot be immobilised on the 
microscope slide surface if the slide has not been treated with NiCl2, indicating that the surface 
immobilisation is specific. In addition, when the surface is washed with buffer after attaching the 
protein to the NTA-Ni-functionalised surface, only a relatively modest decrease in fluorescence is 
observed. This decrease in signal over time is likely to be caused by the dissociation of the protein 
from the functionalised surface. Protein dissociation from the surface can affect the single-molecule 
TIRF experiments done on the 3Cpro, as will be discussed in section 2.5.4. Addition of imidazole, on 
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the other hand, results in a relatively rapid fall in fluorescence. This suggests that the His-tagged YFP 
is bound to the surface via NTA-Ni-His-tag interaction that can be reversed with imidazole. 
2.5.4 Photobleaching of HiLyte 488 in smFRET peptide 1 
As mentioned in Chapter 1.6.1, photobleaching – the irreversible loss of fluorescence from a 
fluorophore – is a common problem in single-molecule fluorescence experiments. Even though new 
classes of single-molecule dyes, such as the Alexa Fluor range, have better photophysical properties 
than traditional ensemble fluorophores, photobleaching can still be a problem. In particular, it may 
sometimes be difficult to distinguish photobleaching events from fluorescence fluctuations that are 
caused by biological changes in the system of interest. 
Therefore, bleaching experiments were carried out on the TIRF setup to determine the mean 
photobleaching lifetime of HiLyte 488 at different laser powers. The aim was to find the ideal laser 
power to be used in the smTIRF experiments. The laser excitation power had to be high enough to 
be able to sufficiently excite the HiLyte 488 fluorophore so that smFRET peptide 1 could easily be 
detected under the TIRF conditions. On the other hand, using too high a laser power would lead to 
faster than tolerable photobleaching rate of the dye. Therefore, a laser power that would suitably 
balance the two factors was determined. 
2.5.4.1 Experimental protocol for the photobleaching experiments 
The photobleaching of HiLyte 488 in smFRET peptide 1 was investigated in two different 
environments – on a Ni-NTA microscope slide with FMDV 3Cpro immobilised on the surface, and on a 
cleaned unfunctionalised slide in the absence of the 3Cpro. In both experiments, 5 nM smFRET 
peptide 1 solution was made up in PBS buffer (pH 7.4). In the absence of the 3Cpro, no detergent was 
used in the buffer, as it was shown that adding a detergent greatly diminishes the binding of the 
peptide onto the surface. For the photobleaching experiments in the presence of the 3Cpro, Block Ace 
(0.4 mg mL-1) was used. 
 For the unfunctionalised slide, 200 µL of the smFRET peptide solution was placed onto the 
slide, and fluorescence was monitored as a function of time for four different laser powers – 1.1, 2.4, 
3.7 and 5.0 mW. Three different measurements, in three different areas of the surface, were taken 
for each laser power. 1000 frames of data were recorded in each measurement, using an exposure 
time of 200 ms per frame. The fluorescence decay curves that were obtained were then fitted using 
exponential decay functions to determine the mean photobleaching lifetime for HiLyte 488 in 
smFRET peptide 1 under different laser powers, as will be described in Chapter 2.5.4.2. 
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 In the photobleaching experiments using a Ni-NTA surface and the 3Cpro, the flow chamber 
was used and the protein was immobilised onto the Ni-NTA microscope slide as described in Chapter 
2.5.3.2. The procedure described above for the unfunctionalised slide was then followed to record 
the photobleaching data. 
2.5.4.2 Photobleaching results 
To determine the mean photobleaching lifetime for HiLyte488 in smFRET peptide 1 under different 
laser excitation powers, the fluorescence decay curves were fitted using exponential decay 
functions. Mono-, bi- and tri-exponential functions were tested, and the first two were found to 
yield the best fitting of the data when the 3Cpro was absent. Only the bi-exponential function gave 
reasonable data fitting when the 3Cpro was present. The mono- and bi-exponential decay functions 
are shown below, in Equations 33 and 34, respectively. 
 
           
                       
 
           
                               
 
     is the fluorescence intensity as a function of time, and    is the ‘offset’ which describes the final 
fluorescence intensity after photobleaching (and any other processes that contribute to the 
fluorescence decay), i.e. the background fluorescence. A and B are the initial fluorescence intensities 
(above the background fluorescence   ) of the different fluorophore populations (with different 
fluorescence decay processes) in the sample. Equation 33 describes a sample in which there is only 
one fluorescent population present, whereas Equation 34 defines a sample with two different 
populations. The terms ta and tb represent the mean lifetimes of the fluorophore populations A and 
B, respectively. 
 Figure 2.50 shows the fluorescence decay curve for HiLyte 488 in smFRET peptide 1 in the 
absence of the 3Cpro, when excited at 2.4 mW. As can be seen, the data can be modelled reasonably 
well with both mono- and bi-exponential decay functions, the bi-exponential function giving a 
somewhat better fit. As will be discussed later on in the chapter, parameters A and ta are likely to 
define photobleaching of HiLyte 488. The mean photobleaching lifetime, ta, obtained with the mono-
exponential fitting equation is in good correlation with the value of ta that is obtained with the bi-
exponential function, the two values being 3.2 s and 2.7 s, respectively. The other population that 
can be observed using the bi-exponential model is characterised by the mean lifetime tb with a value 
of (73.8 ± 5.3) s. This is thought to be due to dissociation of the FRET peptide from the surface, as 
will be discussed below. 
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The values of A and B represent the initial intensities of the fluorescent populations that are 
characterised by the mean lifetimes ta and tb, respectively. Hence, comparing the values of A and B 
in Figure 2.50b shows how much of the fluorescence decay is due to photobleaching and how much 
of it is caused by dissociation of the FRET peptide from the surface. As can be seen from the figure, 
the predominant process is photobleaching (A ≈ 1290), whereas dissociation contributes relatively 
little (B ≈ 80). 
The fluorescence decay curve for HiLyte 488 in smFRET peptide 1 in the presence of the 
3Cpro, when excited at 2.4 mW, is shown in Figure 2.51. As can be seen from the figure, the data is 
modelled considerably better by the bi-exponential decay function compared to the mono-
exponential one, suggesting that there are two processes that contribute significantly to the 
decrease in fluorescence. One of these processes is photobleaching, characterised by the mean 
lifetime ta which has a value of (2.7 ± 0.1) s. The other process is thought to be dissociation of either 
the smFRET peptide or the whole enzyme-peptide complex from the surface. This dissociation is 
characterised by the mean lifetime tb with a value of (139.9 ± 3.0) s. As was discussed for the YFP in 
section 2.5.3.3, the protein seemed to dissociate from the microscope cover slide surface over long 
periods of time. It is therefore possible that also the 3Cpro dissociates from the surface over time. The 
fluorescence decay data are discussed in more detail below.  
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Figure 2.50. The fluorescence decay curve for HiLyte 488 in smFRET peptide 1 in the absence of FMDV 3C
pro
. 
The figure shows the fluorescence decay curve for HiLyte 488 in smFRET peptide 1 on an unfunctionalised surface when 
excited at 2.4 mW, fitted with the mono-exponential decay function (a) and the bi-exponential decay function (b). As can 
be seen from the graphs, the data can be modelled reasonably well with both functions, the bi-exponential function giving 
slightly better fitting. The parameters A and ta are thought to represent photobleaching of HiLyte 488. The mean 
photobleaching lifetime, ta, obtained with the monoexponential fitting equation is in good correlation with ta that is 
obtained with the bi-exponential function, the values being 3.2 s and 2.7 s, respectively. The other population that can be 
observed in (b) is characterised by the mean lifetime tb with a value of (73.8 ± 5.3) s. This is thought to be due to 
dissociation of the FRET peptide from the surface. Comparison of the values of A (≈1290) and B (≈80) reveals that most of 
the fluorescence decay in the sample is due to photobleaching, and dissociation contributes relatively little. 
 
  
 
148 
 
 
 
Figure 2.51. The fluorescence decay curve for HiLyte 488 in smFRET peptide 1 in the presence of FMDV 3C
pro
. 
The figure shows the fluorescence decay curve for HiLyte 488 in smFRET peptide 1 on a functionalised surface with 
immobilised FMDV 3C
pro
 when excited at 2.4 mW, fitted with the mono-exponential decay function (a) and the bi-
exponential decay function (b). As can be seen from the graphs, the data can be modelled significantly better with the bi-
exponential function. The two processes contributing to the decrease in fluorescence are thought to be photobleaching 
and dissociation of either the FRET peptide or the whole enzyme-peptide complex from the surface, characterised by the 
mean lifetimes ta (2.7 s) and tb (139.9 s), respectively. Comparison of the values of A (≈420) and B (≈430) reveals that both 
photobleaching and dissociation contribute significantly to the fluorescence decay. 
 
The full fluorescence decay results with the bi-exponential decay function in the absence 
and presence of FMDV 3Cpro are shown in Table 2.14 and Table 2.15, respectively. Several 
observations can be made by looking at the tables. In both tables, one of the lifetimes, ta, steadily 
decreases with increasing laser power. In addition, the values of ta for each laser power are quite 
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similar in the presence and absence of the 3Cpro. Furthermore, there is little variation in the ta values 
for measurements done with the same laser power but in different areas of the microscope slide. 
These factors indicate that the mean lifetime ta and the initial intensity A represent fluorescence 
decay due to photobleaching of HiLyte 488. The mean photobleaching lifetimes at different laser 
powers with and without FMDV 3Cpro are shown in Figure 2.52. A laser power of 2.4 mW was used in 
the TIRF experiments for FMDV 3Cpro and smFRET peptide 1 discussed in the following chapters, as 
this laser power was shown to give a good fluorescence signal (Chapter 2.5.5) and did not cause 
faster than tolerable photobleaching of HiLyte 488. 
The second process contributing to the fluorescence decay, and characterised by the mean 
lifetime tb and the initial intensity B, is thought to be dissociation of either the smFRET peptide 1 or, 
when the 3C protease is present, the whole enzyme-peptide complex from the surface. In the case 
of the unfunctionalised surface without the 3Cpro (Table 2.14), this process contributes relatively 
little to the decrease in fluorescence, the values of B being significantly lower than the values of A. 
This might be an indication that the peptide sticks to the surface quite tightly, and hence no 
significant amount of unbinding is observed. Furthermore, there is quite a lot of variation in the 
value of tb, and this variation seems to be independent of the laser power used. The differences in tb 
in different areas of the microscope slide might reflect different mechanisms of non-specific binding 
of the smFRET peptide onto the unfunctionalised surface. Alternatively, the population B is so small 
compared to the population A, that it might be difficult to accurately define the mean lifetime tb.  
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Table 2.14. Bi-exponential fitting of the fluorescence decay curves in the absence of the 3C
pro
. 
The table shows that values of ta, A, tb, B and R
2
 at different laser powers determined for HiLyte 488 in smFRET peptide 1 
using Equation 34. The experiments were done on a clean unfunctionalised microscope slide in the absence of the 3C
pro
. As 
can be seen, the ta values consistently decrease with increasing laser power, suggesting that ta represents the mean 
photobleaching lifetime. The other fluorescence lifetime, tb, is more independent of laser power and is thought to be due 
to unbinding of the peptide from the surface. The variations in tb might be an indication that the peptide can adsorbs onto 
the surface via several different mechanisms, or that tb is not very well defined due to its very small contribution to the 
fluorescence decay of the sample. Comparison of the values of A and B shows that the predominant process leading to 
fluorescence decay of the sample is photobleaching. 
Laser power / mW ta / s A tb / s B R
2 
1.1 5.8 ± 0.1 681.0 ± 4.0 55.4 ± 2.2 134.6 ± 2.8 0.993 
1.1 6.6 ± 0.1 630.6 ± 3.1 75.4 ± 4.4 94.4 ± 1.8 0.994 
1.1 5.8 ± 0.1 742.2 ± 3.3 79.7 ± 2.7 170.2 ± 1.6 0.995 
2.4 2.7 ± 0.0 1294.8 ± 6.0 73.8 ± 5.3 83.6 ± 1.7 0.990 
2.4 2.7 ± 0.0 1257.7 ± 6.4 51.5 ± 2.5 107.2 ± 2.4 0.990 
2.4 2.7 ± 0.0 1245.5 ± 5.1 43.1 ± 1.6 110.3 ± 2.2 0.993 
3.7 1.6 ± 0.0 659.9 ± 4.3 65.9 ± 5.8 33.9 ± 1.0 0.980 
3.7 1.2 ± 0.0 519.2 ± 7.7 7.6 ± 0.4 117.2 ± 7.6 0.977 
3.7 1.8 ± 0.0 568.3 ± 3.8 77.1 ± 10.7 22.7 ± 0.9 0.978 
5.0 1.2 ± 0.0 742.1 ± 4.1 62.6 ± 5.8 25.8 ± 0.8 0.985 
5.0 1.3 ± 0.0 629.0 ± 3.8 327.1± 116.0 51.9 ± 13.1 0.982 
5.0 1.3 ± 0.0 576.9 ± 3.6 38.3 ± 1.8 39.1 ± 1.0 0.983 
 
The situation is quite different when the surface-immobilised 3Cpro is present. As can be seen 
from Table 2.15, the two processes affecting the fluorescence decay and defined by the initial 
intensities A and B, both make a significant contribution towards the decrease in fluorescence, as 
the values of A and B are relatively close to each other. The process characterised by ta and A is 
thought to be photobleaching of HiLyte 488, because the value of ta decreases with increasing laser 
power. The value of tb, on the other hand, is much less affected by laser power. The process 
characterised by tb and B is, therefore, likely to be dissociation of either the FRET peptide or the 
whole enzyme-peptide complex from the surface. 
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Table 2.15. Bi-exponential fitting of the fluorescence decay curves in the presence of the 3C
pro
. 
The table shows that values of ta, A, tb, B and R
2
 at different laser powers determined for HiLyte 488 in smFRET peptide 1 
using Equation 34. The experiments were done on a functionalised microscope slide in the presence of surface-immobilised 
FMDV 3C
pro
. As can be seen, the ta values consistently decrease with increasing laser power, suggesting that ta represents 
the mean photobleaching lifetime. The other fluorescence lifetime, tb, is not affected by laser power as much and is 
thought to be due to dissociation of either the peptide or the enzyme-peptide complex from the surface. Comparison of 
the values of A and B shows that both photobleaching and dissociation contribute significantly to the fluorescence decay of 
the sample. 
Laser power / mW ta / s A tb / s B R
2 
1.1 5.7 ± 0.2 182.3 ± 3.3 153.6 ± 6.0 313.4 ± 4.8 0.988 
1.1 3.8 ± 0.1 188.9 ± 2.9 135.9 ±1.4 387.9 ± 1.2 0.996 
1.1 3.3 ± 0.1 163.0 ± 3.2 135.5 ± 1.5 360.5 ± 1.2 0.995 
2.4 2.7 ± 0.1 417.9 ± 4.7 139.9 ± 3.0 427.6 ± 3.7 0.993 
2.4 3.0 ± 0.1 399.2 ± 3.9 139.1 ± 2.8 402.3 ± 3.2 0.994 
2.4 2.7 ± 0.0 445.9 ± 4.4 122.2 ± 2.4 357.5 ± 2.5 0.993 
3.7 1.5 ± 0.0 403.1 ± 3.4 108.4 ± 1.6 239.7 ± 1.2 0.994 
3.7 1.5 ± 0.0 362.5 ± 3.3 102.6 ± 1.5 229.3 ± 1.0 0.994 
3.7 1.5 ± 0.0 331.2 ± 3.2 100.9 ± 1.5 215.7 ± 1.0 0.993 
5.0 0.9 ± 0.0 473.9 ± 4 106.2 ± 1.6 248.8 ± 1.3 0.993 
5.0 1.1 ± 0.0 424.9 ± 3.8 107.4 ± 1.5 234.6 ± 1.1 0.994 
5.0 1.1 ± 0.0 473.7 ± 4.5 102.3 ± 1.3 288.4 ± 1.2 0.994 
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Figure 2.52. The mean photobleaching lifetime of HiLyte 488 at different laser powers. 
The figure shows the mean photobleaching lifetime, ta, of HiLyte 488 (in smFRET peptide 1) at different laser powers in the 
presence (green) and absence (red) of FMDV 3C
pro
. As can be seen from the chart, the values of ta are quite similar with 
and without the 3C
pro
. In addition, as would be expected, the mean photobleaching lifetime decreases with increasing laser 
power. 
 
2.5.5 Single-molecule TIRF with FMDV 3Cpro and smFRET peptide 1 
Two different sets of smTIRF experiments were done with FMDV 3Cpro and smFRET peptide 1. First, 
the binding of the FRET peptide to the surface-immobilised catalytically inactive 3Cpro was looked at. 
Following from this, TIRF experiments were done to probe the interaction between the catalytically 
active 3Cpro and the FRET peptide. In all the experiments, only fluorescence from the FRET donor 
(HiLyte 488) was monitored, as the fluorescence intensity of the acceptor (HiLyte 647) was too weak 
for efficient detection.  
The aim of the TIRF experiments was to compare the interaction of the FRET peptide and the 
inactive 3Cpro to the interaction of the peptide and the active 3Cpro. The duration of peptide binding 
and the fluorescence intensity of the FRET donor were looked at in the case of each enzyme by 
monitoring the fluorescence emission intensity of HiLyte 488 over time. Depending on the time 
scales of the binding and hydrolysis events, it was anticipated that changes in fluorescence emission 
intensity from individual FRET peptide molecules might be detectable that are due to separate 
binding and cleavage events. 
 
153 
 
2.5.5.1 An overview of the TIRF experiments 
As mentioned in Chapter 2.5.4, a laser power of 2.4 mW was used in the FMDV 3Cpro experiments, as 
this laser power gave an easily detectable fluorescence signal and did not cause significant 
photobleaching of HiLyte 488. In each of the two 3Cpro experiment, 250 frames of data were 
recorded for a minimum of 10 different areas (40 µm × 40 µm) of the microscope cover slide, using 
an exposure time of 70 ms per frame. In other words, 10 videos each with 250 images were 
recorded for the inactive 3Cpro and the FRET peptide, and also for the active 3Cpro and the peptide. In 
addition, control experiments were done in which there was no enzyme present. Table 2.16 shows 
the four sets of TIRF conditions used. More details on the experimental procedures can be found in 
Chapter 4.6.7 of Materials and Methods. 
Table 2.16. Single-molecule TIRF experiments to monitor smFRET peptide 1 interacting with FMDV 3C
pro
. 
The table shows a comparison of the number of peptide binding events per frame for the inactive and active 3C
pro
 and the 
control experiments without enzyme. The highest number of binding events was observed with the surface-immobilised 
inactive protease, whereas in the control experiments relatively few binding events were detected. 
Experiment type [Peptide] / pM The immobilised enzyme No. of observed peptide 
binding events per frame 
Peptide and the 
inactive 3Cpro 
100 Inactive 3Cpro Approximately 50 
Control with no 
enzyme 
100 No enzyme present Approximately 0 
Peptide and the 
active 3Cpro 
200 Active 3Cpro Approximately 5 
Control with no 
enzyme 
200 No enzyme present Approximately 0.5 
 
It was shown that following the cover slide functionalisation and protein immobilisation 
procedures described in Chapter 2.5.3.1  and Chapter 2.5.3.2, respectively, an even coverage of 
smFRET peptide 1 as well as single-molecule resolution were achieved after adding 100 pM (for the 
inactive 3Cpro) or 200 pM (for the active 3Cpro) of the peptide. Figure 2.53a shows a TIRF image of the 
FRET peptide interacting with the surface-immobilised inactive 3Cpro. The white marks, which are 
roughly equal in size and scattered fairly evenly, are due to fluorescence emission from individual 
HiLyte 488 dye molecules (that are attached to the FRET peptide). This demonstrates that single-
molecule resolution has been achieved. Furthermore, when the 3Cpro was not present, it could 
clearly be seen that the number of fluorescent spots was significantly lower, as shown in Table 2.16. 
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This indicates that the FRET peptide is binding to the surface-immobilised inactive 3Cpro specifically 
rather than non-specifically adhering onto the cover slide surface. 
For smFRET peptide 1 and the catalytically active FMDV 3Cpro fewer peptide binding events 
(fluorescent molecules in the video) were observed compared to the inactive enzyme, even when a 
higher concentration of peptide (200 pM) was used. This difference might reflect differences in the 
active concentrations of the two 3Cpro mutants. Alternatively, it is also possible that the lifetime of 
the enzyme-substrate complex, in the case of the active enzyme, is so short that all of the binding 
events cannot be detected using the 70 ms exposure time per frame. Another possibility is that the 
surface immobilisation affects the catalytically active 3Cpro, leading to reduced activity. Nevertheless, 
more fluorescent molecules were observed in the presence of the active 3Cpro than in a control 
experiment with 200 pM of smFRET peptide 1 and no enzyme, as shown in Table 2.16. 
As mentioned above, 250 TIRF images were recorded for a minimum of 10 different areas in 
each of the two TIRF experiments – the experiment with smFRET peptide 1 and the inactive 3Cpro, 
and the experiment with smFRET peptide 1 and the active 3Cpro. Initial TIRF data analysis was 
performed using ImageJ image processing software. Fluorescence intensity against time (or video 
frame) was plotted for 300 9×9 pixel areas containing a fluorescent molecule, first for the 
catalytically inactive 3Cpro, and then the active 3Cpro. One such graph for smFRET peptide 1 and the 
inactive FMDV 3Cpro is shown in Figure 2.53b. The peak starting at approximately frame 125 
corresponds to a FRET peptide molecule binding to and then unbinding from a surface-immobilised 
3Cpro molecule. A Python data analysis script, which was named Peak finder, was used to find peaks 
in the intensity versus time graphs, and to determine peak widths and peak heights. The Peak finder 
script is discussed in more detail in the following chapter. 
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(a) 
 
(b) 
 
Figure 2.53. TIRF image of smFRET peptide 1 bound on a Ni-NTA surface with immobilised FMDV 3C
pro
. 
Figure (a) shows a TIRF image for smFRET peptide 1 on a functionalised microscope cover slide surface with immobilised 
inactive FMDV 3C
pro
 when excited at 2.4 mW. The white marks, which are roughly equal in size and scattered quite evenly, 
are due to fluorescence emission from individual HiLyte 488 dye molecules (attached to the FRET peptide), demonstrating 
that single-molecule resolution has been achieved. The image was recorded using an exposure time of 70 ms per frame, 
and a video of 250 such images was recorded for ten different areas of the surface. The inset in the top right corner shows 
a magnification of the 9×9 pixel area selected around the centre of the image. The TIRF data was analysed by plotting 
graphs of fluorescence intensity versus time for 300 such 9×9 pixel areas (with a fluorescent molecule). Figure (b) shows 
one such graph. The increase in fluorescence at approximately frame 125 is due to a FRET peptide molecule binding to a 
surface-immobilised FMDV 3C protease molecule. Unbinding of the peptide from the enzyme leads to a fall in fluorescence 
back to the background level. 
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2.5.5.2 The Peak finder TIRF data analysis script 
The details of the Peak finder script – which was kindly written by Stefano Franz, Ville Glad and 
Heikki Juva using Python programming language – can be found in Chapter 4.6.8 of Materials and 
Methods. In brief, the script was programmed to do the following: 
 
o To plot mean intensity (in grey value) versus time (in ms) graphs for the 9×9 pixel areas that 
were selected manually from the TIRF videos and contained a fluorescent molecule 
o To find and locate peaks above a certain threshold (discussed below) in the intensity versus 
time graphs, i.e. to distinguish peaks that were due to real peptide binding events from the 
background fluorescence signal 
o For each located peak, to determine the peak width, which corresponds to the duration of 
FRET peptide binding to the 3Cpro, i.e. to determine the dwell times for individual smFRET 
peptide 1 molecules 
o For each located peak, to determine the average peak height, which corresponds to the 
brightness of the FRET donor (HiLyte 488) fluorophore 
 
Figure 2.54 shows an intensity versus time graph for one 9×9 pixel area that was created by the 
Peak finder script. The detected peak is highlighted in green, the width of the green area 
corresponding to the width of the peak – or the dwell time – as determined by the script. The 
average height of the peak is obtained by subtracting the average background signal from the 
average signal intensity over the width of the peak. The average background was determined 
separately for each experiment, as described below. 
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Figure 2.54. An intensity versus time graph for a FRET peptide molecule binding to the inactive FMDV 3C
pro
. 
The figure shows fluorescence intensity (in grey value) plotted against time (in ms) for a smFRET peptide 1 molecule 
binding to a surface-immobilised inactive FMDV 3C
pro
 molecule. The plot was created by the Peak finder data analysis 
script. The green area represents the portion of the graph that is above the threshold level, and the width of the green 
area corresponds to the width of the peak, i.e. the duration of peptide binding to the 3C protease, as determined by the 
data analysis script. The script also determines the average height of the peak (within the green area) above the 
background level, as indicated in the figure. 
 
Before analysing the TIRF data using the Peak finder script, a threshold intensity value above 
which fluorescence intensity has to rise to be considered as a real peak (due to a peptide binding 
event) was determined. The threshold values were determined separately for the two experiments, 
the inactive 3Cpro experiment and the active 3Cpro one. This was done manually from the average 
fluorescence intensity in areas with no FRET peptide binding. For each experiment, the average 
background fluorescence and the standard deviation of the background were determined for three 
9×9 pixel areas from three videos. The average background fluorescence and standard deviation of 
the background were then calculated from these nine areas. After this, the threshold value for a 
fluorescence event to be considered as a peptide binding event was calculated using the equation 
below. 
 
                                             
 
in which         represents the average background fluorescence intensity and         stands for 
the standard deviations of the background fluorescence intensity. Different values for N were tested, 
as will be discussed in the following chapter. Any peaks above the threshold level were considered 
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as peptide binding events and included in further data analysis. For all the peaks that were 
considered to be ‘real’, the average dwell times and the average fluorescence intensities were 
determined. 
2.5.5.3 Single-molecule TIRF results for inactive and active FMDV 3Cpro 
One of the main aims of the smTIRF experiments was to compare the interaction of smFRET peptide 
1 with the catalytically active FMDV 3Cpro to the interaction with the inactive mutant of the 3Cpro. 
This was done by determining the average dwell time and the average fluorescence intensity of the 
FRET donor in the case of each enzyme, as described in the previous chapters. The TIRF data for each 
3C protease was analysed with different threshold values, varying the value of N (Equation 35) 
between 5 and 10.  
Choosing the appropriate threshold value for the TIRF data analysis was not a trivial matter. It 
was found that using too low a threshold (N = 5, 6 or 7) resulted in a lot of background peaks to be 
counted as real and analysed by the Peak finder script. This is illustrated in Figure 2.55a. A relatively 
high threshold (N = 9 or 10), on the other hand, can lead to an underestimation of the peak widths, 
as shown in Figure 2.55b. The best compromise between these two factors was reached using N = 8. 
However, even with this threshold, the Peak finder script still included several false positive peaks in 
the data analysis that were not likely to be due to real peptide binding events. These peaks were 
discarded before determining the average dwell times and fluorescence intensities from the inactive 
and active 3Cpro experiments.  
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(a) 
 
 
(b) 
 
Figure 2.55. Peak detection at different thresholds. 
The figure illustrates the challenge of choosing the right threshold value for detecting peaks in the intensity versus time 
graphs. In (a) too low a threshold (N = 5) was used, resulting in background events to be counted as peaks, as indicated in 
the figure. In (b), on the other hand, too high a threshold (N = 10) was used. This lead to the underestimation of the peak 
width, as only a small portion of the peak was above the set threshold. The best results were obtained with N = 8, as shown 
in Figure 2.54. 
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Table 2.17 shows the average dwell times and fluorescence intensities of the FRET donor 
when smFRET peptide 1 interacts with the surface-immobilised inactive and active FMDV 3Cpro. Even 
though the best results were obtained with N = 8, the results with three different thresholds (N = 8, 
9 or 10) are shown to demonstrate how the threshold value affects the average dwell time and the 
average fluorescence intensity. For each threshold, the number of peaks included in the final 
analysis for the inactive and active 3Cpro is the same. 319, 394 and 331 peaks, for both inactive and 
active 3Cpro, were analysed for N = 8, N = 9, and N = 10, respectively. 
The number of peaks included in the final data analysis was different for each threshold for 
the following reasons. The same number of 9×9 pixel areas – 300 – was initially analysed in both 
experiments, the inactive 3Cpro one and the active 3Cpro one. However, the number of peaks found 
by the Peak finder script was different for the two enzymes, as some graphs contained more than 
one peak, and some contained none. In addition, the value of the threshold also affected the 
number of peaks detected, lower thresholds yielding more peaks. Furthermore, as mentioned 
above, some of the graphs were not included in the final data analysis because of false positive 
peaks. To make the results from the inactive and active 3Cpro experiments comparable for each 
threshold value, the same number of peaks from each of the two experiments was included in the 
final analysis. 
Table 2.17. Average dwell times and fluorescence intensities of smFRET peptide 1 in different TIRF experiments. 
The table shows the average dwell times (tD) and fluorescence intensities of HiLyte 488 (IF) for smFRET peptide 1 with the 
inactive FMDV 3C
pro
 and the active 3C
pro
, using three different threshold values (N = 8, 9 or 10). As expected, the average 
dwell times decrease with increasing threshold, whereas the fluorescence intensities increase with increasing threshold. 
The results also show that the average dwell time is slightly longer for the inactive protease compared to the active one, 
indicating that the peptide is bound to the inactive 3C protease for longer, on average, compared to duration of binding to 
the active protease. There are no significant differences in fluorescence intensity of HiLyte 488 between the inactive and 
active 3C
pro
 experiments. 
Value of N tD with inactive 
3C
pro
 / ms 
tD with active 
3C
pro
 / ms 
IF with inactive 3C
pro
 IF with active 3C
pro
 
8 279 ± 15 244 ± 13 89 ± 1 87 ± 2 
9 245 ± 12 210 ± 11 95 ± 1 89 ± 1 
10 211 ± 11 201 ± 11 99 ± 1 96 ± 1 
 
Figure 2.56 shows a simplified schematic for peptide hydrolysis by FMDV 3Cpro, assuming 
that the mechanism is similar to a typical serine/cysteine protease mechanism (Chapters 1.1.2 and 
1.1.3). In the case of the inactive 3Cpro, only the formation of the enzyme substrate complex (E·S) is 
observed, and the presence of this complex can be detected under TIRF. Before carrying out the TIRF 
experiments with the catalytically active 3Cpro, it was hypothesised that the acyl-enzyme 
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intermediate (EA) would be detected under TIRF if the lifetime of the complex was long enough 
under the conditions used. As the acyl-enzyme intermediate only contains the N-terminal portion of 
the FRET peptide substrate (HL488-APAKQ) and hence only the FRET donor dye and no FRET 
acceptor, the fluorescence intensity of the donor in this complex is considerably higher compared to 
the intensity in the E·S complex in which there is FRET from the donor to the acceptor. Therefore, if 
the acyl-enzyme complex is present and has a long enough lifetime for detection, this will lead to a 
higher average fluorescence intensity in the active 3Cpro TIRF experiments compared to the 
experiments with the inactive 3Cpro. 
 
Figure 2.56. Schematic for the interaction between smFRET peptide 1 and FMDV 3Cpro. 
The figure shows a simplified representation of the enzymatic mechanism of FMDV 3Cpro. The first step in the catalysis 
reaction is the formation of the enzyme substrate complex (E·S). k1 and k-1 represent the association rate constant for the 
complex formation and the dissociation rate constant for the E·S complex dissociation into the free enzyme (E) and 
substrate (S), respectively. The enzyme then helps convert the peptide substrate into the cleavage products P1 and P2, P1 
representing the N-terminal part of the peptide substrate and P2 the C-terminal part. k2 is the rate constant for the peptide 
hydrolysis step. The conversion of the E·S complex into the products and the free enzyme occurs via the acyl-enzyme 
intermediate (EA), as was discussed in Chapters 1.1.2 and 1.1.3. Since EA only contains the HL488-labelled N-terminal 
portion of the FRET peptide substrate (HL488-APAKQ), this complex has a significantly higher fluorescence intensity 
compared to the intact FRET peptide and hence also the E·S complex. The presence of the acyl-enzyme complex should, 
therefore, be easily detectable under TIRF, provided that the lifetime of the complex is long enough for detection. k3 
represents the dissociation rate constant for the dissociation of EA into the free enzyme and the free cleavage product P1. 
k-3, on the other hand, denotes the association rate constant for the association of E and P1 into the EA complex. 
 
Table 2.17 shows that the average fluorescence intensity is approximately the same for both 
TIRF experiments, the active 3Cpro and the inactive 3Cpro ones, indicating that the acyl-enzyme 
intermediate is not detected with the TIRF setup. There are two potential explanations for this. 
Firstly, it is possible that the EA complex is so short-lived that it cannot be detected under the 
conditions used (70 ms exposure time per frame). In other words, the peptide cleavage product is 
released from the enzyme as soon as the complex is formed, and there is no accumulation of the 
acyl-enzyme complex. In this case, the rate-liming step in the hydrolysis reaction would be the acyl-
enzyme formation, for which the rate constant is k2. This is consistent with previous work with 
chymotrypsin, which has shown that for amide hydrolysis the rate-limiting step is the EA formation 
whereas for ester substrates the deacylation reaction – with a rate constant k3 – is rate-determining. 
[211] 
It is also possible that the conversion of the enzyme substrate complex, E·S, into the acyl-
enzyme, EA, is a relatively rare event and only a small number of the E·S complexes that are formed 
are converted into hydrolysis products. In any case, because the acyl-enzyme complex is not 
detected, the fluorescent species seen under TIRF, for both the inactive as well as the active 3Cpro, is 
the E·S complex. 
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From Table 2.17 it can also be seen that irrespective of which threshold is used, the dwell 
time for smFRET peptide 1 seems to be slightly longer with the inactive 3Cpro compared to the active 
one. In other words, the FRET peptide seems to bind to the inactive 3Cpro for longer than it binds to 
the active 3Cpro. Although the difference is not large, it might be an indication that the E·S complex 
has a shorter average lifetime in the case of the active 3Cpro, as the substrate is turned into the 
hydrolysis products after forming the E·S complex. Alternatively, the different dwell times could be 
due to the difference between the active sites of the two 3Cpro mutants. Furthermore, the dwell 
times for both active and inactive protease increase with decreasing threshold (or decreasing value 
of N), as expected. In addition, as would be anticipated, the mean fluorescence intensity from HiLyte 
488 seems to increase with increasing threshold. 
Histograms of the dwell times with the inactive and active 3C protease, with N = 8, are 
shown in Figure 2.57. Even though there are no large differences in the distribution of dwell times 
with the two enzymes, it can be seen that the number of longer dwell time events is slightly higher 
for the inactive 3Cpro. This is also reflected in the slightly higher average dwell time of the FRET 
peptide with the inactive protease compared to that with the active protease (Table 2.17). 
Furthermore, the histograms were fitted with a single exponential decay function to find out the 
mean lifetime of the peptide binding events and hence the dissociation rate constant for the 
dissociation of the FRET peptide from the surface: 
           
                      
     represents the number of events at time  ,    the number of events when    , and   is the 
mean lifetime.    is the ‘offset’ or the number of events at dwell times approaching infinity, and 
should approach zero, as can be seen from the histograms in Figure 2.57. The dissociation rate 
constant for the dissociation of the FRET peptide from the surface-immobilised FMDV 3Cpro is simply 
the reciprocal of the mean lifetime.  The fitting of the dwell time histograms for the inactive and 
active 3C proteases is illustrated in Figure 2.58. 
From the fitted histograms in Figure 2.58 it can be seen that, as expected,    is 
approximately zero for both enzymes. The mean lifetimes for peptide binding to the inactive and 
active 3Cpro are (166.4 ± 10.9) ms and (124.1 ± 9.4) ms, respectively. The overall dissociation rate 
constants can easily be calculated from the mean lifetimes, as the rate constant is the reciprocal of 
the mean lifetime. For the catalytically inactive 3Cpro the dissociation rate constant is (6.0 ± 0.8) s-1 
whereas for the active 3Cpro the rate constant is (8.1 ± 0.8) s-1. For the inactive protease – which only 
binds to the peptide substrate but does not hydrolyse it – the overall dissociation rate constant, (6.0 
± 0.8) s-1, is the same as k-1 in Figure 2.56. 
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(a) 
 
(b) 
 
Figure 2.57. Single-molecule FRET peptide 1 dwell time histograms with inactive and active FMDV 3C
pro
. 
The figure shows the dwell time histograms for smFRET peptide 1 with the inactive (a) and active (b) 3C
pro
, using N = 8, and 
a bin size of 20 ms. Even though the histograms do not differ from each other significantly, it can be seen that there are 
slightly more longer dwell time events in the histogram for the catalytically inactive enzyme. This is also reflected in the 
calculated average dwell times – the calculated average dwell time is slightly longer for the inactive 3C
pro
 compared to the 
active protease (Table 2.17). In theory, dwell times shorter than 70 ms should not be detected with the setup used 
(because the exposure time per frame is 70 ms). However, as can be seen from the histograms, dwell times below 70 ms 
are present. These are due to inaccuracies caused by the thresholding in the Peak finder script, as was illustrated earlier in 
this chapter. 
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(a) 
 
(b) 
 
 
Figure 2.58. Single-molecule FRET peptide 1 dwell time histograms fitted with an exponential decay function. 
The figure shows the fitting of the dwell time histograms for smFRET peptide 1 with the inactive (a) and active (b) 3C 
proteases, using Equation 36. The dwell time data with N = 8 was used, and the bin size was 20 ms. Dwell times below 80 
ms are not included in the data fitting. As expected, NF is approximately zero for both the inactive and the active 3C
pro
. The 
mean lifetime, τ, is slightly higher for the inactive 3C
pro
 (166.4 ms ± 10.9 ms) compared to the active one (124.1 ms ± 9.4 
ms). (Dwell times below 70 ms were not included in the data fitting, because in theory it should not be possible to detect 
them using an exposure time per frame of 70 ms.) 
 
For the catalytically active protease, there are two possible routes of decay for the E·S 
complex: it can either dissociate back to the free enzyme and intact substrate, or be converted into 
the EA complex (and subsequently the free enzyme and the hydrolysis products). (Figure 2.56) It is 
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the overall rate of decay that is observed in the TIRF experiments, and this rate is the sum of the 
rates of the two decay processes. Therefore, if k-1 is assumed to be the same for the inactive and 
active 3Cpro, k2 for the active FMDV 3C
pro can be obtained by subtracting k-1 from the overall decay 
rate constant. This gives a value of (2.1 ± 1.6) s-1 for k2. While this assumption of k-1 being the same 
for both mutants of the protease might not be strictly valid (because of the mutation of the active 
site cysteine into an alanine in the inactive enzyme), the results can still be viewed as an estimate of 
how fast hydrolysis by the 3Cpro is. As the acyl-enzyme appears to be relatively short-lived, it can be 
assumed that the k2 calculated here represents the overall hydrolysis rate, kcat, of the enzyme. 
As mentioned in Chapter 1.3.2, the specificity constant (kcat/KM) for FMDV 3C
pro and a 
labelled peptide substrate – DABCYL-APAKQLLD(EDANS)FDLLK – has previously been determined 
using a solution-based FRET assay [7]. If it is assumed that the specificity constant for smFRET 
peptide 1 is approximately the same – (57.6 ± 2.0) M-1 s-1 – KM for smFRET peptide 1 can be 
calculated, since kcat can estimated to be approximately 2.1 s
-1. An approximate value for KM is 
therefore 36 mM. This result is in agreement with results from previous work on FMDV 3Cpro which 
suggest that KM is significantly higher than 100 µM [7]. 
2.5.6 Summary of the smTIRF results 
Single-molecule TIRF experiments were done with surface-immobilised FMDV 3Cpro and smFRET 
peptide 1, by monitoring the fluorescence intensity from the FRET donor (HiLyte 488). The His-
tagged enzyme was immobilised onto a microscope cover slide that had been functionalised with 
NTA and nickel. Before carrying out the 3Cpro experiments, yellow fluorescent protein was first used 
in proof-of-principle experiments to demonstrate that the His-tag/NTA/Ni surface functionalisation 
and protein immobilisation approach can lead to specific protein immobilisation. Furthermore, 
photobleaching experiments were done with smFRET peptide 1 to find an optimal laser power for 
the smTIRF experiments. Laser power of 2.4 mW was found to give a good fluorescence signal 
without causing significant photobleaching of HiLyte 488. 
The interaction of the FRET peptide with the surface-immobilised catalytically inactive 3Cpro 
as well as the catalytically active 3Cpro was looked at. With both enzymes it was shown that the 
peptide interacts specifically with the protein rather than non-specifically adsorbing onto the 
microscope cover slide surface. This indicated that the surface functionalisation and protein 
immobilisation approach employing the interaction between NTA, nickel and the His-tagged protein 
had been successful. 
 After demonstrating that the surface functionalisation and 3Cpro immobilisation protocols 
resulted in specific interaction of the FRET peptide with the two different mutants of FMDV 3Cpro, a 
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partially automated protocol for analysing the TIRF data was successfully developed. This involved 
the manual selection of fluorescent molecules from the TIRF videos, and these fluorescent molecules 
were subsequently analysed using an automated Python data analysis script, named Peak finder. The 
script was used to detect peaks above a certain user-defined threshold that corresponded to real 
peptide binding events, and to determine the dwell times and fluorescence intensities for individual 
FRET peptide molecules as they associated with and dissociated from the 3Cpro. 
The main aim of the TIRF experiments was to compare the interaction of the FRET peptide 
with the inactive and the active 3Cpro, and to get more detailed insight into the catalytic mechanism 
of the enzyme. The acyl-enzyme complex that is assumed to be part of the catalytic cycle of the 3Cpro 
was not detected under the TIRF conditions used. This indicated that either the complex is relatively 
short lived (less than 70 ms), or that the conversion of the enzyme-substrate complex, E·S, into the 
acyl-enzyme, EA, is a relatively rare event. The transient nature of the EA complex is consistent with 
previous work on chymotrypsin, which suggested that for amide substrates the acylation step is the 
rate-limiting one in the hydrolysis by the enzyme and hence the acyl-enzyme complex does not 
accumulate but is converted into products as soon as it’s formed. [211] 
The overall dissociation rate constants for the E·S complex in the case of the inactive and 
active 3Cpro mutants were also determined. For the catalytically active protease there are two routes 
for the decay of the complex, whereas there is only one route of decay in the case of the inactive 
enzyme. Hence the overall dissociation rate of the E·S complex for the active 3Cpro can be expected 
to be higher than that for the inactive 3Cpro. This was, indeed, what the TIRF results suggested, the 
values of the overall dissociation rate constant for the inactive and active FMDV 3C
pro being (6.0 ± 
0.8) s-1 and (8.1 ± 0.8) s-1, respectively. Therefore, k2 for the active FMDV 3C
pro can be estimated to be 
approximately (2.1 ± 1.6) s-1. As the acyl-enzyme appears to be relatively short-lived, it can be 
assumed that acylation is the rate-determining step and hence the k2 calculated here represents the 
overall hydrolysis rate, kcat, of the enzyme. 
The rate constant (kcat) for the 3C
pro was then used to determine an approximate value for 
the Michaelis constant KM for smFRET peptide 1 and the enzyme. The estimated value of KM was 36 
mM. This value is consistent with previous results from a solution-based FRET assay [7], indicating 
that the immobilisation of the 3Cpro does not hamper its enzymatic activity – at least not 
significantly. It was therefore demonstrated that the new smTIRF protocol developed here can be 
used to study the details of the enzymatic mechanism of FMDV 3Cpro. In addition, the smTIRF 
experiments were able to reveal new details of the enzymatic mechanism of the 3Cpro not previously 
known.  
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3 Conclusions and Future Directions 
The main objective of this work was to gain new information on the catalytic mechanism and 
substrate specificity of Foot-and-Mouth Disease Virus 3C protease (FMDV 3Cpro) using both 
ensemble and single-molecule fluorescence techniques. This was done with a view to obtaining a 
better understanding of how the enzyme works, which would, in turn, aid FMDV 3Cpro inhibitor 
design and development. FMDV is the causative agent of foot-and-mouth disease which affects 
cloven-hoofed animals, such as cattle and sheep, and has the potential of causing substantial losses 
to farmers as well as whole economies. Vaccines against foot-and-mouth disease virus exist, but 
there are major limitations associated with vaccine use, and therefore antiviral drugs have the 
potential to offer a better control measure against the disease. Due to its vital role in the viral 
lifecycle of FMDV, FMDV 3Cpro is an excellent antiviral drug target. 
 Fluorescence anisotropy (FA) on the ensemble level and fluorescence (or Förster) resonance 
energy transfer (FRET) on the single-molecule level were used to probe the interactions of FMDV 
3Cpro with its peptide substrates. Fluorescence techniques were chosen because they offer a non-
invasive and sensitive way to probe biomolecules. Fluorescence anisotropy assays were done to look 
at the substrate binding specificity of the 3Cpro on the ensemble level, whereas smFRET was used to 
probe the enzyme-substrate interactions on the single-molecule level. Single-molecule experiments 
have the capability of yielding extraordinarily detailed information on biological systems, and can 
reveal information that would not be attainable from ensemble level experiments. 
 The fluorescence anisotropy assays were used to probe the substrate binding specificity of 
FMDV 3Cpro using both unlabelled and fluorescein-labelled peptide substrates. It was shown that the 
enzyme prefers the labelled substrates over the unlabelled ones – most likely because the labelled 
peptides are more similar in size to the natural polypeptide substrates of the enzyme. The 
anisotropy assays also revealed that the substrate binding specificity and cleavage specificity of the 
3Cpro seem to be different. This interesting, and perhaps surprising, finding might indicate that the 
amino acid residues in the FMDV 3Cpro peptide substrates that are important for binding to the 
enzyme are different from residues important for hydrolysis. Another possibility is that the 
catalytically inactive 3Cpro and the active 3Cpro have different substrate specificities due to the 
difference in the amino acid residue in the enzyme active site (Cys163 of the active 3Cpro has been 
mutated into an alanine in the inactive enzyme). Nevertheless, the anisotropy work yielded novel 
information on the substrate binding specificity of FMDV 3Cpro, as previously the main focus has 
been on the cleavage specificity of the enzyme. The anisotropy results, together with the existing 
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cleavage specificity data for FMDV 3Cpro, can come in very useful when designing inhibitors for the 
enzyme.  
Solution-based single-molecule FRET experiments were done on three different smFRET 
peptides that had been synthesised, and it was demonstrated that single-molecule sensitivity could 
be reached. The peptide HL488-APAKQLLC(HL647)FDLLKK (smFRET peptide 1) was shown to have 
the best single-molecule fluorescence properties, although all three smFRET peptides suffered from 
low FRET acceptor (HiLyte or AlexaFluor 647) brightness, possibly due to the close proximity of the 
FRET donor (HiLyte 488) leading to enhanced quenching of the acceptor. Encouragingly, it was also 
shown that the single-molecule fluorescence data was consistent with data from ensemble 
fluorescence experiments. For example, the FRET efficiencies obtained from the single-molecule and 
bulk level experiments were in good correlation, the FRET efficiency for smFRET peptide 1 being 
approximately 90%. Due to its high FRET efficiency and relatively high FRET acceptor brightness 
compared to the other two smFRET peptides, HL488-APAKQLLC(HL647)FDLLKK was taken forward to 
single-molecule TIRF experiments. 
Single-molecule TIRF experiments were done to look at the interaction of the catalytically 
active and the catalytically inactive FMDV 3Cpro with HL488-APAKQLLC(HL647)FDLLKK. TIRF was used 
instead of solution-based smFRET, as surface immobilisation of biomolecules allows longer 
observation times compared to freely diffusing molecules. Previously established surface 
functionalisation and protein immobilisation techniques based on the interaction between NTA, 
nickel and a histidine tag were successfully employed to achieve selective immobilisation of the His-
tagged 3Cpro mutants. It was also demonstrated that the 3Cpro retains its activity after surface 
immobilisation. Fluorescence from HiLyte 488 was monitored, and the dwell times and fluorescence 
intensities were compared for HL488-APAKQLLC(HL647)FDLLKK when it interacted with the two 
FMDV 3Cpro mutants. An automated data analysis script was used to determine the dwell times and 
fluorescence intensities for individual FRET peptide molecules as they associated with and 
dissociated from the 3Cpro. 
The smTIRF experiments yielded novel information on the catalytic mechanism of FMDV 
3Cpro. The acyl-enzyme complex that is assumed to be part of the catalytic cycle of the 3Cpro was not 
detected under the TIRF conditions used. This indicated that either the complex is relatively short 
lived (less than 70 ms), or that the conversion of the enzyme-substrate complex into the acyl-
enzyme is a relatively rare event. In addition, the overall dissociation rate constants for the enzyme-
substrate complex in the case of the inactive and active 3Cpro mutants were also determined, and the 
TIRF results suggested that the values for the inactive and active FMDV 3Cpro are (6.0 ± 0.8) s-1 and 
(8.1 ± 0.8) s-1, respectively. Therefore, k2 for the active FMDV 3C
pro can be estimated to be 
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approximately (2.1 ± 1.6) s-1. As the acyl-enzyme appears to be relatively short-lived, it can be 
assumed that acylation is the rate-liming step in the hydrolysis reaction and hence the k2 calculated 
here represents the overall hydrolysis rate, kcat, of the enzyme. This hydrolysis rate constant was 
then used to determine an approximate value for the Michaelis constant KM for smFRET peptide 1 
and the 3Cpro. The estimated value of KM was 36 mM. This value is consistent with previous results, 
suggesting that the surface-immobilised 3Cpro has retained its biological function. It was therefore 
demonstrated that the new smTIRF protocol developed here can be used to study the details of the 
enzymatic mechanism of FMDV 3Cpro. In addition, the smTIRF experiments were able to yield novel 
and detailed data on the enzymatic mechanism FMDV 3Cpro which is consistent with existing 
ensemble data. 
All in all, this work is the first demonstration of single-molecule level experiments of FMDV 
3Cpro. A convenient and quick smTIRF protocol was developed, and the smFRET experiments done 
using this protocol yielded new information on the mechanism of the enzyme. This information will 
undoubtedly be a step towards more rational FMDV 3Cpro inhibitor design. Furthermore, the smTIRF 
protocol has great potential to produce more data on how the protease works. For example, it 
would be exciting as well as useful to look at how the 3Cpro interacts with inhibitors on the single-
molecule level.  
Another obvious way forward would be to design and synthesise new smFRET peptides in 
which the acceptor quenching is not as significant. This could potentially be done by making longer 
peptides and increasing the inter-dye distance between the donor and the acceptor dyes. FRET 
peptides in which the acceptor is bright enough to be easily detected under single-molecule 
conditions would enable the FRET donor and FRET acceptor signals to be monitored simultaneously. 
This would allow fluorescence changes due to FRET to be distinguished from changes caused by 
other phenomena, such as quenching and photobleaching. Furthermore, if the reaction between 
surface-immobilised FMDV 3Cpro and a FRET-labelled substrate could somehow be slowed down – 
for example by changing the pH – this might allow FRET changes to be detected when a substrate is 
bound to the enzyme. Controlling the reaction in this manner could reveal even more details on the 
interactions between the 3Cpro and its substrates and inhibitors.  
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4 Materials and Methods 
4.1 Synthesis of FMDV 3Cpro Peptide Substrates 
4.1.1 Solvents and reagents 
All amino acid derivatives and the Fmoc-Lys(Boc)-Wang resin used in solid phase peptide synthesis 
were purchased from Novabiochem (Nottingham, UK), and the 5-(And 6-)carboxyfluorescein, 
succinimidyl ester (or NHS ester) was purchased from Pierce Biotechnology, Inc. (Rockford, USA). 
Tetramethylrhodamine-5- (and -6) C2 maleimide, HiLyte Fluor 488 acid, SE, and HiLyte Fluor 647  C2 
maleimide were obtained from AnaSpec (Seraing, Belgium), whereas AlexaFluor 647 C2 maleimide 
was from Invitrogen (Carlsbad, CA, USA) . All other reagents and solvents used in the peptide 
synthesis and modification reactions were purchased from Sigma-Aldrich (Dorset, UK), Bioproducts 
Ltd (Hessle, USA), and Melford Laboratories Ltd (Suffolk, UK). All buffers were made up in MilliQ 
ultrapure water obtained from Millipore (Billerica, MA, USA).  
4.1.2 Automated Fmoc/tBu solid phase peptide synthesis 
Two different peptide synthesisers were used in the automated SPPS: an Advanced ChemTech Apex 
396 multiple peptide synthesiser purchased from Activotec (Cambridge, UK) and an Intavis ResPep 
SL peptide synthesizer from INTAVIS Bioanalytical Instruments AG (Cologne, Germany). With both 
synthesisers, the peptides were made using standard Fmoc/tBu protocols and a pre-loaded Fmoc-
Lys(Boc)-Wang resin. The amino acids that were used were protected with Fmoc on the α-amine and 
standard acid-labile side chain protecting groups based on tertiary butyl on the reactive amino acid 
side chains.[193] 
For the ChemTech Apex synthesiser, the following automated procedure was followed. The 
pre-loaded resin (25 µmol for each peptide) was placed in the peptide synthesiser well and swelled 
in dimethylformamide (DMF) for 1 hour. The DMF was then drained from the well, and the Fmoc 
protecting group was removed by treating the resin with 20% piperidine in DMF (3 × 15 min), after 
which the resin was washed with DMF (3 × 5 min). The next amino acid (5 eq, 125 mM in DMF, 1 
mL), activated in situ with HBTU (5 eq) and N,N-diisopropylethylamine (DIPEA) (5 eq), was then 
coupled onto the N-terminus of the resin-bound lysine for 30 minutes, after which the amino acid 
solution was drained from the well. The resin was then washed with DMF (3 × 5 min). The Fmoc 
removal / amino acid activation and coupling cycle was repeated until the desired peptide had been 
synthesised. Finally, the N-terminal Fmoc was removed as described above. 
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With the Intavis ResPep SL synthesiser, the peptides were synthesised as follows. The pre-
loaded lysine resin (20 µmol for each peptide) was placed in the synthesiser well and swelled with 
DMF (30 min), after which the DMF was drained from the well. The Fmoc was then removed from 
the N-terminus of the lysine by treating the resin with 20% piperidine in DMF for 25 minutes, before 
washing the resin with DMF (3-4 mL). The next amino acid (5 eq, 250 mM in N-methyl-2 pyrrolidone 
(NMP), 400 µL), pre-activated with HBTU (5 eq) and N-methylmorpholine (NMM) (5 eq), was then 
coupled onto the N-terminus of the resin-bound lysine for 30-50 minutes, after which the amino acid 
solution was drained from the well. To cap any unreacted N-terminal amines, the resin was then 
treated with 5% Ac2O in DMF (400 µL), before washing the resin with DMF (3 mL). The Fmoc removal 
/ amino acid activation and coupling / N-terminal capping cycle was repeated until the desired 
peptide had been synthesised. Finally, the N-terminal Fmoc was removed as described above. 
After the peptide synthesis was complete – with either one of the synthesisers – the peptidyl 
resin was transferred into a plastic syringe fitted with a frit, and washed with DMF, DCM, methanol 
and diethyl ether (3 × 5 mL, each). The resin was then dried under vacuum and stored in a 
refrigerator until the peptide was either further modified on resin or cleaved off the resin. 
4.1.3 Manual Fmoc/tBu solid phase peptide synthesis 
The peptides Cys(Mmt)-Leu-Cys(Trt) and Gln(Trt)-Cys(Mmt)-Leu-Cys(Trt) were made using manual 
SPPS, and the procedure was the same for both peptides.  The pre-loaded Fmoc-Cys(Trt)-Wang resin 
(20 µmol for each peptide) was placed in a 5 mL syringe fitted with a frit and swelled in DMF (3 mL) 
for 30 minutes. The DMF was then drained from the syringe, and the Fmoc protecting group was 
removed by treating the resin with 20% piperidine in DMF (3 × 5 min), while shaking. The piperidine 
solution was then drained from the syringe, after which the resin was washed with DMF, DCM and 
again with DMF (4 × 3 mL, each). The next amino acid – leucine – (5 eq, 100 mM in DMF, 1 mL), 
activated in situ with HBTU (5 eq) and DIPEA (10 eq), was then coupled to the N-terminus of the 
resin-bound cysteine for 30 minutes, while shaking. After this, the resin was washed with DMF (3 × 3 
mL), and the leucine coupling step was repeated. The resin was then washed with DMF, DCM and 
DMF, as above, and the Fmoc removal / amino acid activation and double coupling cycle was 
repeated until the desired peptide had been fully synthesised. 
After the manual peptide synthesis, the peptidyl resin was washed with DMF, DCM, 
methanol and diethyl ether (3 × 5 mL, each). The resin was then dried under vacuum and stored at 4 
°C until further use. 
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4.1.4 Benzoylation of APAKALLNFDLLKK 
After SPPS and removal of the Fmoc protecting group from the N-terminus, the peptide 
APAKALLNFDLLKK was benzoylated on the N-terminal α-amine. The peptidyl resin (approximately 20 
µmol of peptide) was placed in a 5 mL syringe fitted with a frit, and then swelled in DMF for a 
minimum of 30 minutes. Benzoic anhydride (10 eq, 200 µmol, 45.2 mg) was dissolved in DMF (1 mL), 
to which DIPEA (10 eq, 200 µmol, 35 µL) was added. The benzoylation solution was then added to 
the peptidyl resin, and the resin suspension was left on a shaker for 2 hours. After this, the 
benzoylation solution was removed and the resin was washed with DMF, DCM, methanol and diethyl 
ether (3 × 5 mL, each), before drying the resin under vacuum. The amino acid side chains were 
deprotected and the peptide was cleaved off the resin as described in Chapter 4.1.11. 
4.1.5 Labelling of the peptide N-terminal α-amine 
The N-terminal α-amine labelling was done after SPPS and the removal of the Fmoc protecting group 
from the N-terminus, but while the peptide was still attached to the resin. The peptidyl resin (2-20 
µmol of peptide) was placed in a 5-mL syringe fitted with a frit, and then swelled in DMF for a 
minimum of 30 minutes. 5-(And 6-)carboxyfluorescein, succinimidyl ester or HiLyte Fluor 488 acid, SE 
(4 eq) was dissolved in DMF (just enough to dissolve the dye), and the dye solution was added to the 
resin, along with DIPEA (approximately 30 eq). The syringe containing the resin suspension was then 
wrapped in aluminium foil and left on a shaker at room temperature for 17 hours. If necessary, more 
DMF was added so that all of the resin remained suspended in DMF while shaking. The dyes were 
protected from light as much as possible. 
 After the reaction, the dye solution was removed from the syringe and the resin was washed 
with copious amounts of DMF, at least until the DMF was clear and did not seem to contain any 
fluorophore. The resin was then washed with DCM, methanol and diethyl ether (3 × 5 mL, each), 
before drying it under vacuum. The labelled peptides were protected from light at all times by 
wrapping them in aluminium foil. 
4.1.6 Mmt removal from APAKQLLCFDLLKK and Flu-APAKQLLCFDLLKK 
The Mmt protection strategy was used in the synthesis of two peptides – APAKQLLC(TMR)FDLLKK 
and Flu-APAKQLLC(TMR)FDLLKK. In these peptides the cysteine side chain thiol was protected with 
Mmt. The Mmt removal was done after SPPS, and for the doubly labelled peptide, also after 
fluorescein labelling of the N-terminal α-amine. The dry, fully side chain protected peptidyl resin (5 × 
2 µmol of peptide, each in a separate syringe) was placed in a 5-mL syringe fitted with a frit, and 
treated with 3 mL of 0.5% TFA in DCM/triisopropylsilane (TIS) (95:5) for 30 minutes. This removed 
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the Mmt protecting group from the cysteine thiol but left all other amino acid side chain protecting 
groups intact.  
After the thiol deprotection reaction, the resin was washed with DCM, DMF, MeOH and 
diethyl ether (3 × 5 mL, each), before drying it under vacuum. In addition, before labelling the 
peptides with tetramethylrhodamine, the extent of Mmt removal was tested by treating a small 
amount of the peptidyl resin with N-ethylmaleimide, as described in Chapter 4.1.8. Furthermore, the 
Mmt removal conditions had been optimised as described in Chapter 4.1.7. 
4.1.7 Optimisation of the Mmt removal conditions 
The peptides Cys(Mmt)-Leu-Cys(Trt) and Gln(Trt)-Cys(Mmt)-Leu-Cys(Trt) were used to optimise the 
conditions for Mmt removal. A small amount of the Cys(Mmt)-Leu-Cys(Trt)resin (approximately 2 
µmol of peptide) was treated with 1 mL of 0.5%, 1.0% and 2.0% TFA in DCM/TIS (95:5) for 30 
minutes to find the optimal TFA concentration, whereas a small amount of the Gln(Trt)-Cys(Mmt)-
Leu-Cys(Trt)  resin was treated with 1 mL of 0.5% TFA for 30 minutes, 1 hour, 1 h 30 min, and 2 hours 
to determine the best reaction time. After the Mmt removal reaction (with different TFA 
concentrations and different reaction times), the TFA mixture was removed from the syringe, and 
the peptidyl resin was washed with DCM and DMF (3 × 3 mL, each). The resin was then swelled in 
DMF for a minimum of 30 minutes, after which it was reacted with iodoacetamide. Iodoacetamide (3 
or 10 eq) was dissolved in the smallest possible volume of DMF, and added to the resin. The syringes 
containing the reaction mixture were left on a shaker for 17 (for 3 eq) or 5 hours (for 10 eq). 
After the iodoacetamide reaction, the reaction mixture was drained from the syringe, and 
the resin was washed with DMF, DCM, methanol and diethyl ether (3 × 5 mL, each), before drying it 
under vacuum. Full amino acid side chain deprotection and cleavage off the resin were then done as 
described in 4.1.11, and the extent and specificity of the Mmt removal reaction was assessed by 
LC/MS as described in 4.1.13. 
4.1.8 N-ethylmaleimide reaction to test the extent of Mmt removal 
After removing the Mmt protecting group from APAKQLLCFDLLKK and Flu-APAKQLLCFDLLKK and 
before reacting the peptides with tetramethylrhodamine, the extent of Mmt removal was tested 
using N-ethylmaleimide (NEM). A small amount of peptidyl resin (a few beads) from which Mmt had 
been removed was swelled in DMF for a minimum of 30 minutes. NEM (at least 40 equivalents) was 
dissolved in the smallest possible volume of DMF and added to the resin, along with DIPEA 
(approximately 40 eq). The syringe containing the reaction mixture was left on a shaker for 17 hours. 
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After the NEM reaction, the reaction mixture was drained from the syringe, and the resin 
was washed with DMF, DCM, methanol and diethyl ether (3 × 5 mL, each), before drying it under 
vacuum. Full amino acid side chain deprotection and cleavage off the resin were then done as 
described in Chapter 4.1.11, and the extent and specificity of the Mmt removal reaction was 
assessed by LC/MS as described in 4.1.13. 
4.1.9 On-resin cysteine labelling of peptides 
The on-resin cysteine labelling strategy was used in making the peptides APAKQLLC(TMR)FDLLKK and 
Flu-APAKQLLC(TMR)FDLLKK. The peptidyl resin (approximately 2 µmol of peptide) from which Mmt 
had been removed was swelled in DMF for a minimum of 30 minutes. Tetramethylrhodamine-5-(and 
-6) C2 maleimide (8 eq, 16 µmol, 8.8 mg) was then dissolved in a DMF (just enough to dissolve the 
dye), and the dye solution was added to the resin, along with DIPEA (40 eq, 80 µmol, 14 µL). The 
syringe containing the resin suspension was wrapped in foil and left of a shaker at room 
temperature for 17 hours. If necessary, more DMF was added so that all of the resin remained 
suspended in DMF while the reaction was on. 
After the labelling reaction, the dye solution was removed from the syringe and the resin 
was washed with copious amounts of DMF, at least until the DMF was clear and did not seem to 
contain any dye. Finally, the resin was washed with DCM, methanol and diethyl ether (3 × 5 mL, 
each), before drying it under vacuum. 
4.1.10 Solution-based cysteine labelling of peptides 
The solution-based cysteine labelling strategy was used in the synthesis of three peptides: HL488-
APAKQLLC(HL647)FDLLKK, HL488-APAKQLLNFDLC(HL647)KK and HL488-APAKQLLC(AF647)FDLLKK. 
After the N-terminal labelling reaction with HiLyte 488 (Chapter 4.1.5), each of the three peptides 
was fully deprotected and cleaved off the solid support as described in Chapter 4.1.11. The crude 
peptide (approximately 0.4 µmol) was then dried before re-dissolving in HEPES buffer (100 mM, pH 
7.5, 400 µL) in a plastic eppendorf tube. After this, the maleimide-derivatised dye (2-3 eq) was 
dissolved in the smallest possible volume of DMF and added to the peptide solution. The eppendorf 
containing the reaction mixture was wrapped in foil and left shaking for two hours. After this, the 
reaction was stopped by adding glutathione (30 eq, 3.8 mg dissolved in 405 µL of water) to 
inactivate the remaining excess maleimide dye. (Leaving the cysteine labelling reaction on for longer 
was shown to results in multiple additions of the maleimide fluorophore.) The reaction mixture was 
then desalted using a Sep-Pak Plus Short tC18 cartridge (Waters, Milford, MA, USA) attached to a 
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syringe – the desalting step also removed most of the excess dye. Final purification of the peptide 
was done using LC/MS. The purification protocols are described in more detail in Chapter 4.1.12. 
4.1.11 Amino acid side chain deprotection and peptide cleavage off the resin 
For all peptides, the cleavage of the peptide off the resin and the removal of the amino acid side 
chain protecting groups (apart from the Mmt in the peptides containing an Mmt-protected cysteine) 
were done simultaneously. For peptides not containing a trityl-protected cysteine, the following 
cleavage/deprotection cocktail was used. To the peptidyl resin, which had been dried under vacuum, 
a solution of trifluoroacetic acid (TFA) (95%), TIS (2.5 %) and water (2.5%) was added, and the resin 
was left on a shaker at room temperature for 3 hours. For peptides containing a trityl-protected 
cysteine residue, the cleavage mixture contained TFA (94%), TIS (2.5%), water (2.5%) and 
ethanedithiol (EDT) (1%). The volume of the cleavage/deprotection mixture depended on the 
amount of resin being used, but generally enough solution was added to keep all the resin 
suspended during the 3 hours of shaking. All fluorescently labelled peptides were protected from 
light as much as possible. 
 After peptide cleavage off the resin and side chain deprotection, each peptide was 
precipitated from cold tert-butyl methyl ether (TBME). This was done by adding TBME into the 
cleavage/deprotection mixture containing the peptide, using just enough TBME to see peptide 
precipitation. The precipitated peptide was then separated by centrifugation (15 minutes, 4000 
RPM, 4 °C, Jouan BR4 I centrifuge), after which it was dried under vacuum. 
4.1.12 Purification of the FMDV 3Cpro peptide substrates 
All the labelled and unlabelled peptides were purified using preparative LC/MS. For the ensemble 
fluorescence peptides, each peptide was dissolved in MilliQ water, and filtered with a syringe filter 
(Acrodisc 25 mm Syringe Filter with 0.45 µm Supor Membrane, Pall Corporation, Washington, NY, 
USA) before LC/MS purification. The smFRET peptides, on the other hand, were pre-purified and de-
salted using a Sep-Pak Plus Short tC18 cartridge (Waters, Milford, MA, USA) attached to a syringe 
before final purification by LC/MS. After the solution-based cysteine labelling reaction, the protocol 
below was followed in the Sep-Pak C18 pre-purification and de-salting step: 
 
 The peptide sample  was diluted with 0.1% formic acid in MilliQ water to get 1 mL of peptide 
solution 
 The Sep-Pak C18 column was conditioned with 10 mL of 0.1% formic acid in MeOH 
 The column was washed with 10 mL of 0.1% formic acid in MilliQ water 
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 The peptide sample was loaded onto the column and left to bind for approximately 2 
minutes to allow enough time for the peptide binding 
 The sample washed/desalted with 3.5 mL of 0.1% formic acid in MilliQ – this done over 
approximately 3 minutes, so that the flow rate remained slow enough not to disrupt the 
peptide binding onto the column 
 Elution 1 – 1:1 MeOH/MilliQ water (both with 0.1% formic acid) 
o 1.6 mL of the above eluent was run through the column over a period of 
approximately 2 minutes, and the eluted fractions were collected 
 Elution 2 – 98:2 MeOH/MilliQ water (both with 0.1% formic acid) 
o  1.6 mL of the above eluent was run through the column over a period of 
approximately 2 minutes, and the eluted fractions were collected 
 All eluted fractions were vacuumed down and run on the analytical LC/MS to determine 
which fraction(s) contained the desired labelled peptide 
o Generally, the unreacted dye came off the column in Elution 1, whereas the desired 
peptide came off in Elution 2 
 Any fractions containing the desired labelled peptide were first filtered using a syringe filter 
(details above), then purified using preparative LC/MS 
 
The preparative LC/MS runs were done on a Waters HPLC system (Waters, Milford, MA, USA) 
fitted with a 2767 autosampler, a 515 pump, a 2998 Photodiode Array Detector (detection at 200-
600 nm), and a 3100 mass spectrometer with electrospray ionisation (ESI). The system was equipped 
with a Waters XBridge preparative C18 column (19 mm × 100 mm), the flow rate was 20 mL min-1, 
and each run was 22 minutes long. LC/MS grade methanol and MilliQ water were used as eluents, 
both containing 0.1% formic acid. A linear gradient from either 2-98% methanol or 50-98% was used, 
depending on the polarity of the peptide being purified. 
4.1.13 Analytical LC/MS of the FMDV 3Cpro peptide substrates 
Analytical LC/MS was used in the detection and characterisation of the synthesised peptides. The 
analytical LC/MS system was identical to the preparative LC/MS system described above, with the 
following exceptions. In the analytical LC/MS runs a smaller Waters XBridge C18 column (4.6 mm × 
100 mm) was used. In addition, a flow rate of 1.2 mL min-1 was used. Again, a linear gradient from 
either 2 or 50 to 98% methanol was used, depending on the polarity of the peptide. All peptides 
were dissolved in water for the LC/MS analysis. 
4.2 Expression and Purification of FMDV 3Cpro Mutants 
The FMDV 3Cpro mutants used in this work corresponded to the viral strain A1061 and were expressed 
and purified using a previously established method [53, 54, 56]. Two mutants of the enzyme were 
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used – a catalytically active one with two mutations (C95K and C142L) and a catalytically inactive one 
with three mutations (C95K, C142L and C163A). Both enzymes contained a non-cleavable histidine 
tag (6 × His) on the N-terminus. The expression and purification of the active mutant was performed 
with the help of Nicholas Milton, and the inactive enzyme was expressed and purified by the author. 
The protocols for preparing the FMDV 3Cpro mutants are described below. 
4.2.1 Transformation of E. coli 
The expression vector used to produce the 3Cpro mutants was based on a pETm11 vector and had 
previously been modified by Patricia Zunszain to express the desired proteins with a polyhistidine 
tag (6 × His) on the N-terminus. The cell line BL21(DE3)pLysS was used in the transformation, and the 
procedure was carried out under flame sterilised atmosphere. For each mutant, suspensions (2 × 
200µL) of the competent bacteria were thawed on ice for approximately 20 minutes, after which the 
cells were placed into 8 pre-chilled 1.5 mL eppendorf tubes.  
0.5 µL (approximately 50 ng) of the plasmid stock was then added to each bacterial 
suspension, and the solutions were incubated on ice for 30 minutes. After this, each eppendorf was 
placed in a 42 °C water bath for 45 seconds for DNA to be taken up by the bacterial cells. 
Immediately after this, the solutions were placed back on ice for 5 minutes. 450 µL of warm LB broth 
(37 °C) was subsequently added into each eppendorf and the resulting cultures were incubated on a 
shaking plate at 37 °C for 1 hour.  
The cells were then pelleted at 13200 RPM for 1 minute using a bench top microcentrifuge 
(Centrifuge 5415, eppendorf, Cambridge, UK), and each pellet was re-suspended in LB broth 
(approximately 100 μL). After this, the cells were spread on LB agar plates with kanamycin and 
chloramphenicol (25 μg mL-1 and 35 μg mL-1, respectively). The plates were incubated overnight at 
37 °C and the colonies obtained were stored at 4 °C for subsequent use. 
4.2.2 Expression of FMDV 3Cpro mutants 
Eight colonies from the agar plates mentioned above were used to inoculate eight overnight E. coli 
cultures (50 mL of LB-broth each, with kanamycin and chloramphenicol at final concentrations of 25 
μg μL-1 and 35 μg μL-1, respectively). Each of the overnight cultures was then diluted with LB broth by 
a factor of 20 to obtain a total of 8 L of culture which was incubated on a shaking plate at 37 °C until 
an OD600 (optical density at 600 nm) of 0.6-0.8 was reached. After this, protein expression was 
induced with IPTG (final concentration of 1 mM). After 6 hours of incubation at 37 °C for the inactive 
enzyme, and 3 hours of incubation at 21°C for the active enzyme, the cells were harvested by 
178 
 
centrifugation at 4 °C (Beckman JS-4.2 centrifuge, 5000 g, 15 minutes) and the cell pellets obtained 
were stored at -80 °C until purification. 
4.2.3 Immobilised metal affinity chromatography (IMAC) 
TALON immobilised metal affinity chromatography (IMAC) resin (Clontech, California, USA) was used 
in the purification of both FMDV 3Cpro mutants. The catalytically inactive protease was further 
purified using gel filtration (Chapter 4.2.4).  A buffer containing 50 mM HEPES, pH 7.1, 400 mM NaCl, 
1 mM β-mercaptoethanol and 0.01% sodium azide was used in all the purification steps and will be 
referred to as buffer A.  
The TALON IMAC purification of the His-tagged 3C protease mutants was performed as 
follows. The bacterial cell pellets were incubated and thawed on ice with 35 mL of lysis buffer per 1 L 
of original E. coli culture for approximately 30 minutes. The lysis buffer contained buffer A with 0.1% 
Triton ×100, and for the inactive 3C protease also 1 mM pheynylmethylsulfonyl fluoride (PMSF), 
which is a serine protease inhibitor. The pellets were then dispersed by gentle agitation and 
pipetting. After this, the re-suspended pellets were transferred into 50-mL centrifuge tubes for 
sonication, and each tube was sonicated four times for 15 seconds, keeping the tubes on ice 
throughout the process. The sonicate was centrifuged at 4 °C in pre-chilled centrifuge tubes 
(Beckman F0850 centrifuge, 23000 g, 20 minutes) to separate insoluble material from the 
supernatant. To precipitate nucleic acids, protamine sulphate (at a final concentration of 1 mg mL-1) 
was gently mixed into the supernatant, and the tubes were, again, centrifuged at 4 °C (Beckman 
F0850 centrifuge, 30000 g, 20 minutes). Finally, the supernatant, containing all soluble proteins, was 
collected into a fresh container and filtered using a 1.2 µm syringe filter. 
 The TALON resin (approximately 0.5 mL per 1 L of original culture) was prepared by repeated 
centrifugation and dilution in buffer A to wash and equilibrate the resin. Four centrifugation cycles at 
4 °C were done (Beckman J6-HC centrifuge, 4500 g, 2 minutes per cycle). The supernatant containing 
the soluble proteins was then incubated with the resin at 4 °C for 1 hour with rotation. After this, the 
suspension was centrifuged (Beckman J6-HC centrifuge, 4500 g, 4 minutes) to pellet the TALON 
beads, and the supernatant which contained the unbound material was removed. The washing of 
the resin and the elution of the bound proteins were achieved by repeated centrifugation (Beckman 
J6-HC centrifuge, 4500 g, 4 minutes) and dilution in the washing and elution buffers described 
below.  
 Washing buffer W0: Buffer A 
 Washing buffer W5: Buffer A with 5 mM imidazole 
 Washing buffer W10: Buffer A with 10 mM imidazole 
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 Elution buffer E100: Buffer A with 100 mM imidazole 
 Elution buffer E250: Buffer A with 250 mM imidazole 
 Elution buffer E500: Buffer A with 500 mM imidazole 
 
The resin was first washed with washing buffers W0 (2 × 50 mL), W5 (2 × 50 mL) and W10 (2 × 50 
mL). The elution of the bound proteins was then achieved with the elution buffers E100 (35 mL and 
15 mL), E250 (20 mL) and E500 (10 mL). The eluted materials were analysed by SDS-PAGE (15% 
acrylamide gel, 240 V, 45 minutes) and the fractions containing the 3Cpro were combined and 
dialysed to remove imidazole. 10 kDa cut-off SnakeSkin dialysis tubing (Thermo Scientific, Waltham, 
MA, USA) was used, and the tubes containing the protein solution were left stirring overnight in 4 L 
of pre-chilled buffer A at 4 °C. 
 The TALON-purified protein was concentrated using a 10,000 MW cut-off centrifugal 
concentrator (Vivaspin, Aubagne, France) to a concentration of approximately 10 mg mL-1. The 
protein concentration was determined by absorbance at 280 nm, using E1% = 4.7 (absorbance of 4.7 
corresponds to 10 mg mL-1 of protein). This value was obtained using the ProtParam tool on the 
ExPASy Proteomics Server. [212] In the case of the catalytically active 3Cpro, no further purification 
was done, and the concentrated TALON-purified protein was stored at -80 °C until use. The final 
yield of the purified active FMDV 3Cpro was approximately 4 mg per 1 litre of original E. coli culture. 
The inactive 3Cpro was further purified using gel filtration, as will be described in the following 
chapter. 
4.2.4 Gel filtration 
After TALON IMAC purification, the inactive FMDV 3Cpro was further purified by gel filtration using an 
ÄKTA fast protein liquid chromatographer (Amersham Biosciences, Buckinghamshire, UK) with a Hi 
Load 16/60 Superdex 75 column (Amersham Biosciences). 1 mL of the concentrated protein solution 
was loaded onto the column in each run, after filtering the solution using a 0.22 µm cellulose acetate 
filter. A flow rate of approximately 0.75 mL min-1 was used and the purification was monitored by UV 
detection at 280 nm. The collected fractions were analysed by SDS-PAGE (15% acrylamide gel, 240 V, 
45 minutes) and fractions containing only the desired protein were pooled and concentrated to 
approximately 10 mg mL-1 in a 10,000 MW cut-off centrifugal concentrator. The final protein 
concentration was determined by absorbance at 280 nm, and the final yield of pure 3Cpro was 
approximately 5 mg per 1 L of original E. coli culture. 
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4.3  Assays for the Specificity Studies of FMDV 3Cpro 
4.3.1 Fluorescence anisotropy assay conditions 
For the fluorescence anisotropy assays the peptide and enzyme solutions were prepared by diluting 
the stock solutions with pH 7.4 PBS buffer (11.9 mM phosphates, 137 mM NaCl and 2.7 mM KCl, 
Fisher BioReagents, Loughborough, UK) containing bovine serum albumin (BSA) (0.3 mg mL-1) and 
Tween 20 (0.05% v/v). In some assays, BSA and Tween 20 were replaced by Block Ace (Raleigh, NC, 
USA) (0.4 mg mL-1). In addition, for Cys-containing peptides either dithiothreitol (DTT) (1.3 mM) or 
TCEP (1 mM) was added. All assays were done at room temperature, using a Jobin Yvon fluorometer 
obtained from Horiba Scientific (Stanmore, UK), and an Ultra-Micro fluorescence cell (Hellma 
Analytics, Müllheim, Germany) with a volume of 100 µL, light-path of 10 × 2 mm, and centre height 
of 15 mm. 
4.3.2 Direct fluorescence anisotropy (FA) binding assay 
The direct FA binding assays were done by titrating an approximately 110 nM fluorescein-peptide 
solution (initially 100 μL) with the catalytically inactive (C95K, C142L, C163A) FMDV 3Cpro. To keep 
the peptide concentration constant throughout the experiment, the 3Cpro solution also contained the 
labelled peptide at 110 nM. After each addition of the enzyme, the solution was left to equilibrate 
(2-10 minutes) before taking the anisotropy measurement, and the anisotropy of the solution was 
measured for at least 10 different enzyme concentrations in each assay. More enzyme solution was 
added until virtually constant anisotropy was reached. The results were then analysed by plotting 
anisotropy against enzyme concentration, and the data was fitted using Origin 7.0 data analysis 
software. (See Chapter 2.2.2.2 for data fitting.) The assay was done at least twice for each 
fluorescein-labelled peptide. 
4.3.3 Indirect fluorescence anisotropy competition assay 
The FA competition assays were done by titrating a solution (initially 100 μL) of the inactive 3Cpro (50 
μM) and Flu-APAKQLLNFDLLKK (110 nM) with an unlabelled peptide solution. To keep the 
fluorescein-peptide and enzyme concentrations constant throughout the experiment, the unlabelled 
peptide solution also contained Flu-APAKQLLKFDLLKK at 110 mM and the enzyme at 50 μM. After 
each addition of the unlabelled peptide, the solution was left to equilibrate (for approximately 5 
minutes) before taking the anisotropy measurement. More unlabelled peptide solution was added 
until constant anisotropy was reached, and at least ten different unlabelled peptide concentrations 
were measured for each assay. In addition, fluorescence anisotropy for a solution that only 
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contained the labelled peptide Flu-APAKQLLNFDLLKK (100 μL, 110 nM) was recorded, as this gave 
the value for the background fluorescence and was needed for data fitting. The results were 
analysed by plotting anisotropy against unlabelled peptide concentration, and the data was fitted 
using GraFit 7.0 data analysis software. (See Chapter 2.2.2.3 for data analysis.) The assay was done 
once for each unlabelled peptide. 
In the case of the benzoylated peptide Bz-APAKALLNFDLLKK and the control peptide 
SLLRVQAHIRKKHVAQ, the peptides were added to the Flu-APAKQLLKFDLLKK (110 mM) and 3Cpro (50 
μM) solution at a final concentration of 4 mM. Full assays were not done, but in both cases the 
fluorescence anisotropy of the assay solution was measured twice, before and after adding the 
unlabelled peptide. 
4.3.4 LC/MS cleavage assay 
The LC/MS cleavage assays were done by incubating each fluorescein-peptide with the catalytically 
active (C95K, C142L) FMDV 3Cpro at 37 °C, and taking samples out for LC/MS analysis at different time 
points. The peptide solutions were prepared by dilution of each stock solution to a concentration of 
24 µM with an assay buffer containing sodium phosphate (0.1 M, pH 7.4), EDTA (1 mM), glycerol (5% 
v/v) and DTT (0.01mM). Similarly, the enzyme solutions were prepared by diluting the enzyme stock 
solution with the assay buffer to give an enzyme concentration of 4 µM. 100 µL of the peptide 
solution was then combined with 100 µL of the enzyme solution to give final peptide and enzyme 
concentrations of 12 µM and 2 µM, respectively. This solution was then incubated at 37 °C. 
Hydrolysis was monitored by analysing the solution by LC/MS (using the 50-98% MeOH method 
outlined in Chapter 4.1.13) after 1h, 3 h, 5h and 23 h of incubation. Disappearance of the intact 
peptide and appearance of the P1’-P9’ cleavage product in the LC/MS trace indicated hydrolysis by 
the 3Cpro.  
4.4 Ensemble Characterisation of Labelled Peptides 
For all ensemble fluorescence characterisation experiments, the protein and peptide solutions were 
made up in pH 7.4 PBS buffer (11.9 mM phosphates, 137 mM NaCl and 2.7 mM KCl, Fisher 
BioReagents, Loughborough, UK). All experiments were carried out at room temperature. 
4.4.1 UV/Vis absorption spectra 
UV/Vis absorption spectra were recorded for all the single-molecule fluorescence peptides. The 
spectra were recorded in PBS buffer (pH 7.4) containing BSA (0.3 mg ml-1) and Tween 20 (0.05% v/v), 
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using a peptide concentration of approximately 2 µM. A NanoDrop ND-1000 spectrophotometer 
(Thermo Scientific, Waltham, MA, USA) was used to record the absorption spectra between 400 nm 
and 750 nm, with a 3 nm increment. 
4.4.2 Monitoring hydrolysis of Flu-APAKQLLC(TMR)FDLLKK by LC/MS 
The peptide (12 µM) was incubated with the catalytically active 3Cpro (2 µM) in a PBS buffer (pH 7.4) 
at 37 °C for 45 minutes, the total volume of the solution being 110 µL. Similarly, 110 µL of the 
peptide solution (12 µM) was incubated in the absence of the enzyme. After the incubation, both 
solutions were analysed by LC/MS using the 50-98% method outlined in Chapter 4.1.13, and the 
peaks in the MS spectra were able to show whether the peptide had been hydrolysed. The same 
peptide solutions were used to record the fluorescence spectra of the eFRET peptide before and 
after hydrolysis, as described in Chapter 4.4.3. 
4.4.3 Fluorescence spectra of the eFRET peptide before and after hydrolysis 
The eFRET peptide solutions with and without FMDV 3Cpro that had been used in the LC/MS cleavage 
assay (Chapter 4.4.2) were used to obtain fluorescence spectra for the eFRET peptide before and 
after hydrolysis. The two solutions were diluted approximately 10-fold, giving a peptide 
concentration of approximately 1.2 µM. A fluorescence spectrum of each solution (200 µL) was 
recorded in an Ultra-Micro fluorescence cell (Hellma Analytics, Müllheim, Germany) with a volume 
of 100 µL, light-path of 10 × 2 mm, and centre height of 15 mm, using a SpectraMax M2e Microplate 
Reader (Molecular Devices, Sunnyvale, CA, USA). The spectra were recorded between 500 nm and 
650 nm, upon sample excitation at 480 nm. 
4.4.4 Fluorescence spectra of the smFRET peptides before and after hydrolysis 
The procedure for recording the fluorescence spectra was the same for all the smFRET peptides. The 
peptide (20 nM) was incubated with the catalytically active FMDV 3Cpro (approximately 6 µM) in a 
PBS buffer (pH 7.4) at 25 °C, the total volume of the solution being 100 µL. A fluorescence spectrum 
of the solution was recorded hourly (for 2 to 4 hours), until there was no change in fluorescence 
emissions from the donor and the acceptor. Constant value for HiLyte 488 emission and 
disappearance of the FRET peak (HiLyte/Alexa 647 emission) were taken as an indication of 
essentially complete hydrolysis of the FRET peptide by the 3Cpro. All spectra were recorded in an 
Ultra-Micro fluorescence cell (Hellma Analytics, Müllheim, Germany) with a volume of 100 µL, light-
path of 10 × 2 mm, and centre height of 15 mm, using a SpectraMax M2e Microplate Reader 
(Molecular Devices, Sunnyvale, CA, USA). The spectra were recorded between 500 nm and 750 nm, 
183 
 
upon sample excitation at 480 nm. Emission spectra for the peptides in the absence of the protease 
were also recorded following the same protocol. 
4.4.5 Comparing the FRET acceptor brightness in the smFRET peptides 
The procedure for recording the fluorescence spectra of the smFRET peptides upon direct excitation 
of the FRET acceptor was similar to that described in the Chapter 4.4.4, apart from the following 
alteration. The peptide solutions, with and without FMDV 3Cpro, were excited at 630 nm, and the 
spectra were recorded between 650 nm and 750 nm. The comparison of FRET acceptor brightness 
was done as described in Chapter 4.4.5. 
4.4.6 Fluorescence spectra of free and enzyme-bound smFRET peptide 1 
The fluorescence spectra of the free and 3Cpro-bound smFRET peptide were recorded in an Ultra-
Micro fluorescence cell (Hellma Analytics, Müllheim, Germany) with a volume of 100 µL, light-path 
of 10 × 2 mm, and centre height of 15 mm, using a Jobin Yvon fluorometer obtained from Horiba 
Scientific (Stanmore, UK). The fluorescence spectrum of the free peptide (45 nM, 105 µL) in pH 7.4 
PBS buffer containing BSA (0.3 mg mL-1), Tween 20 (0.0 % v/v) and TCEP (1 mM) was first recorded. 
The sample was excited at 480 nm and the emission spectrum was recorded between 490 nm and 
750 nm. After this, 35 µL of catalytically inactive FMDV 3Cpro solution was added to give a final 
enzyme concentration of 100 µM. The solution was left to reach equilibrium for 15 minutes, after 
which the fluorescence emission spectrum was recorded as before. The recording of the two spectra 
were done in total three times (for three different sets of solutions). The spectra for the free and 
bound smFRET peptide 1 were compared after normalising the spectra with respect to emission at 
525 nm (FRET donor maximum emission wavelength). 
4.5 Single-Molecule Fluorescence Experiments in Solution 
4.5.1 Setup and general conditions for solution-based smFRET experiments 
The solution-based smFRET experiments were done on a custom-built confocal microscope system 
based on an inverted microscope. A schematic of the setup was shown in Figure 2.39 in Chapter 
2.4.2. For each of the three smFRET peptides, the FRET peptide solution (5-20 pM, approximately 
400 µL) was placed into a sample chamber of a multi-well microscope cover slide (Lab-Tek 
Chambered #1.0 Borosilicate Coverglass System, 4 chambers, Thermo Scientific, Waltham, MA, USA) 
and the FRET donor (HiLyte 488) was excited at 488 nm using an argon ion laser (model 35LAP321-
230, Melles Griot, USA). The filtered excitation beam was directed to the sample with mirrors and an 
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oil-immersion objective (Plan Apo 100X NA 1.45 from Nikon), the laser power reaching the sample 
being approximately 200 µW (except for smFRET peptide 3 for which the laser power was 
approximately 140 µW). The fluorescence emission from the analytes was passed through a pinhole 
to reject out-of-focus light, and then split by a 585 nm long pass dichroic mirror and directed into 
two channels, the donor channel (for HiLyte 488 emission) and the acceptor channel (the HiLyte 647 
or AlexaFluor 647 emission). The photon bursts from the dyes were detected by two separate single-
photon avalanche diode (SPAD) detectors and recorded by two multichannel scaler (MCS) cards. 
Due to its low fluorescence background and pH range suitable for FMDV 3Cpro, all the samples 
for the smFRET experiments were made up in phosphate-buffered saline (PBS) with the pH adjusted 
to 7.4. A detergent, Block Ace (Raleigh, NC, USA) (0.4 mg mL-1), was added to the buffer to prevent 
the non-specific attachment of the peptide and the 3Cpro onto the microscope cover slide. All 
experiments were done at room temperature. 
The experimental procedure for obtaining the hydrolysed smFRET peptide 1 histogram data 
was similar to the protocol above, apart from the presence of the catalytically active FMDV 3Cpro in 
the sample solution. Before recording the FRET data for the hydrolysed smFRET peptide 1, the 
peptide was incubated with the catalytically active FMDV 3Cpro (2 µL of 3Cpro stock added to the 400 
µL of peptide solution to give a final enzyme concentration of 1.6 µM) for four hours. In addition, 
data was also collected for the 3Cpro (1.6 µM) in the absence of the peptide. No significant signal was 
detected in the donor and acceptor channels. Similarly, to collect FRET data for the enzyme-bound 
smFRET peptide 1, the peptide was first incubated with the catalytically inactive 3Cpro (170 µL of 3Cpro 
stock added to the 400 µL of peptide solution to give a final enzyme concentration of 95 µM). A 
solution only containing the inactive 3Cpro did not give a significant fluorescence (donor or acceptor) 
signal. 
Furthermore, before each smFRET experiment the fluorescence background of the buffer 
was measured. This was done to ensure there were no fluorescent impurities present in the buffer. 
For the buffer to be suitable for single-molecule fluorescence work, the signal had to be less than 
approximately 10 counts per ms. 
4.5.2 Data collection and analysis in solution-based smFRET experiments 
The procedure for constructing FRET efficiency histograms for the intact smFRET peptide was as 
follows. Photon bursts from the donor and acceptor dyes were recorded for 800 s, using a bin time 
of 1 ms. The FRET donor and acceptor fluorescence signals were detected by two APD’s and 
recorded by two separate MCS cards. The single-molecule FRET signals were recorded with MCS-32 
software (EG&G, ORTEC), using the following parameters: pass length – 8000; pass count pre-set – 1; 
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dwell – internal; bin width – 1 ms; trigger for channel 1 (donor channel) – internal; trigger for 
channel 2 (acceptor channel) – external; acquire mode – replace; input control discriminator – 50 
Ohm. 
 Number of photons per burst in both donor and acceptor channels (   and   , respectively) 
were determined, and the FRET efficiency for each burst was calculated using Equation 32 below. To 
be considered a real FRET event, the sum of photon counts in the two channels had to exceed a 
threshold of 28 photons per ms. 
       
  
      
                  
 
where    is the number of photons from the donor and    the number of photons from the 
acceptor per burst. The parameter   compensates for the differences in quantum yields and optical 
detection efficiencies for the donor and the acceptor, and was assumed to be approximately 1.0. 
Finally, FRET efficiency histograms were constructed using Origin 7.0 data analysis software using a 
bin width of 0.04. 
4.6 Single-Molecule TIRF Experiments 
4.6.1 Setup and general conditions for smTIRF experiments 
Due to its low fluorescence background and pH range suitable for FMDV 3Cpro, all the samples for the 
smTIRF experiments were made up in phosphate-buffered saline (PBS) with the pH adjusted to 7.4. A 
detergent, Block Ace (0.4 mg mL-1), was added to the buffer to prevent the non-specific attachment 
of the peptide and the 3Cpro onto the microscope cover slide (although Block Ace was not used in 
some of the photobleaching experiments, as will be discussed in Chapter 4.6.6). All experiments 
were done at room temperature. 
 The proof-of-principle experiments to test the surface functionalisation and protein 
immobilisation protocols using YFP were done using an objective-type TIRF microscope system 
based on A Nikon Eclipse TE2000-U inverted microscope. A Nikon Apo TIRF 60x/1.49 objective lens 
and a diode-pumped solid state MBL-III, 473 nm 50 mW laser (Laser 2000, Ringstead, UK) were used. 
The excitation laser beam was filtered using a Z473/10x filter and 473rdc dichroic mirror (Chroma 
Technology Corp., Vermont, USA). Fluorescence emission from the YFP sample (the maximum 
fluorescence emission being at approximately 535 nm) was filtered using an Hq525/50m filter 
(Chroma Technology Corp.), and collected by an Andor iXon electron multiplying CCD (EMCCD) 
camera. Images from the camera were displayed and analysed using Andor IQ software (Andor 
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Technology, Belfast, UK). The laser power reaching the sample was measured and it was 
approximately 0.5 mW. 
An objective-type TIRF setup slightly different to the one above was used in the 
photobleaching experiment and all the TIRF experiments with FMDV 3Cpro. A schematic of this setup 
is shown in Figure 2.45 in Chapter 4.6.1. The sample was excited with an argon ion laser (model 
35LAP321-240, Melles Griot, USA) at 488 nm which excites the FRET donor, HiLyte 488. In the 3Cpro 
experiments the laser power reaching the sample was set to approximately 2.4 mW, whereas 
different laser powers were tested in the photobleaching experiments (see Chapter 4.6.6). 
The excitation beam was filtered, and it was then directed to the sample using mirrors and a 
high numerical aperture oil-immersion Nikon Apo TIRF 60x/1.49 objective lens. The fluorescence 
emitted from HiLyte 488 – the maximum emission being at approximately 525 nm – was collected by 
the objective, separated from the acceptor emission with a 585 nm long pass dichroic mirror, and 
finally detected and recorded with an EMCCD camera. The camera was controlled and the TIRF 
images observed using Image-Pro Express software (Media Cybernetics). 
4.6.2 The TIRF flow chamber 
A photograph and a schematic of the flow chamber used in the smTIRF experiments is shown in 
Figure 2.46 in Chapter 2.5.2.2 The flow cell consisted of a relatively thick microscope slide 
(approximately 1 mm), an NTA-Ni functionalised microscope coverslip (Corning Cover Glass, No. 1 ½, 
24×50 mm, 0.13mm thickness, Corning Inc., NY, USA) and 25μL Gene Frame (Thermo Scientific, 
Waltham, MA, USA) adhesive that was placed between the two surfaces to provide a 25 μL volume 
into which analyte solutions could be injected. Inlet and outlet holes were drilled into the thicker 
microscope slide, and polyetheretherketone (PEEK) tubing was glued into the holes using 
Permabond Fe Rapid epoxy resin (Permabond Engineering Adhesives Ltd, Winchester, UK). PEEK 
finger-tight fitting connectors (Sigma-Aldrich, Dorset, UK) were used to connect the PTFE tubing 
mentioned below to the inlet and outlet. 
The flow chamber was always constructed straight after the nickel functionalisation of the 
microscope coverslip (Chapter 2.5.3.1) and used immediately after it had been put together. Sample 
solutions were injected into the flow cell using syringes (Myjector U-100 0.5 mL insulin syringe, 
Terumo Medical Products, Somerset, UK) and polytetrafluoroethylene (PTFE) Teflon tubing (Sigma-
Aldrich, Dorset, UK). After each TIRF experiment, the functionalised microscope coverslip and 
adhesive frame were removed from the flow chamber using a scalpel. The coverslip and frame were 
discarded, and the rest of the flow cell and the tubing were cleaned thoroughly with ethanol and 
MilliQ water. 
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4.6.3 Microscope cover slide functionalisation with NTA and nickel 
Before functionalisation, the microscope cover slides (Corning Cover Glass, No. 1 ½, 24×50 mm, 
0.13mm thickness, Corning Inc., NY, USA) were cleaned using the following protocol. The slides were 
first sonicated in acetone (30 min), then isopropanol (30 min). After this, they were left at 500 °C for 
1 hour. The cleaned slides were handled using tweezers and all equipment and containers used in 
the functionalisation were rinsed/wiped with ethanol before use.  
Following from the cleaning step, the slides were treated with 3-glycidyloxypropyl-
trimethoxysilane by immersing them in approximately 85 mM 3-glycidyloxypropyl-trimethoxysilane 
in toluene for 20 minutes. The slides were then rinsed well with toluene, and subsequently dried 
using a flow of N2 gas. 
 2% Nα,Nα-bis(carboxymethyl)-L-lysine solution was prepared by dissolving Nα,Nα-
bis(carboxymethyl)-L-lysine (1.2 mg per two  microscope slides) in 100 mM sodium carbonate buffer 
(pH 10) (70 µL per two microscope slides). 70 µL of this solution was then placed onto a slide, and 
another slide was carefully placed on top. The slides were then placed in a petri dish, along with a 
tissue soaked in water (to keep the slides in a humid environment), and the dish was sealed with 
parafilm. The slides were incubated at 60 °C for 16 hours. After incubation at 60 °C, the NTA-
functionalised slide sandwiches were dissembled, washed with copious amounts of MilliQ water 
(Millipore, Billerica, MA, USA), and dried under N2 gas. The slides were stored in a desiccator until 
further use. 
For the nickel functionalisation, NiCl2 was dissolved in a 5 mM glycine buffer (pH 8) to give a 
final NiCl2 concentration of 10 mM. The NTA-functionalised slides were then incubated in the NiCl2 
solution for a minimum of 2 hours to obtain microscope slides functionalised with NTA and Ni. The 
functionalised slides were washed with MilliQ water and dried under N2 gas, after which they were 
immediately used in TIRF experiments. 
4.6.4 Surface immobilisation of His-tagged FMDV 3Cpro 
The surface immobilisation of His-tagged FMDV 3Cpro was done straight after microscope coverslip 
functionalisation and/or flow chamber construction. After placing the flow cell onto the microscope 
objective, 200 µL of the 3Cpro solution (1.8 µM and 3.6 µM for the inactive and active protease, 
respectively) was injected into the flow cell, and the protein was left to bind onto the NTA-Ni-
functionalised surface for 15 minutes. After this, 600 µL of buffer was injected into the cell to 
remove any unbound enzyme. 
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4.6.5 Testing the protein immobilisation protocol with His-tagged YFP 
After constructing the flow chamber (Chapter 4.6.2) and placing it on the microscope objective, 200 
µL of 0.7 nM solution of His-tagged YFP (kindly provided by James Sudlow) was injected into the flow 
cell and left to bind for 5 minutes. 200 µL of buffer was then injected into the cell and fluorescence 
images were recorded for 200 s using a 2 s exposure time. The same procedure was then repeated 
but instead of buffer, 200 µL of 100 mM imidazole solution was injected into the flow cell. Similarly, 
fluorescence images were recorded for 200 s using a 2 s exposure time for the imidazole run. As a 
control, the buffer and imidazole runs were then repeated using a microscope coverslip that had 
only been functionalised with NTA but not Ni. The images were analysed using the ImageJ software. 
4.6.6 Photobleaching experiments with HL488-APAKQLLC(HL647)FDLLKK 
The photobleaching experiments were done to find out the photobleaching rate of HiLyte 488 in 
smFRET peptide 1. The experiments on a Ni-NTA microscope slide with FMDV 3Cpro immobilised on 
the surface were done using the TIRF flow chamber, and the procedure was as follows. The inactive 
FMDV 3Cpro was immobilised onto the slide as described in Chapter 4.6.4. After that, 200 µL of 5 nM 
smFRET peptide 1 solution was injected into the flow cell, and fluorescence images for a 40 µm × 40 
µm area were recorded for 200 s using an exposure time of 200 ms per frame. This was done for 
four different laser powers – 1.1, 2.4, 3.7 and 5.0 mW. For each laser power, three different 
measurements, in three different areas of the surface were taken. 
 The photobleaching experiments in the absence of the 3Cpro were done on a cleaned 
unfunctionalised coverslips and without the flow cell. 200 µL of 5 nM smFRET peptide 1 solution was 
placed onto the microscope slide, and fluorescence images for a 40 µm × 40 µm area were recorded 
for 200 s using an exposure time of 200 ms per frame. This was, again, done for four different laser 
powers – 1.1, 2.4, 3.7 and 5.0 mW. For each laser power, three different measurements, in three 
different areas of the surface were taken. In the experiments without the 3Cpro no detergent (Block 
Ace) was used in the buffer. 
The photobleaching data was analysed using the ImageJ software. 200 × 200 pixel areas of 
the recorded TIRF images were analysed by plotting fluorescence intensity against time. The 
fluorescence decay curves that were obtained were then fitted using exponential decay functions to 
determine the mean photobleaching lifetime for HiLyte 488 in smFRET peptide 1 under different 
laser powers (Chapter 2.5.4). 
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4.6.7 Single-molecule TIRF experiments with FMDV 3Cpro 
In each of the two 3Cpro experiments (with the inactive and active enzyme), 200 µL of the smFRET 
peptide 1 solution (100 pM and 200 pM for the inactive and active 3Cpro, respectively) was injected 
into the flow chamber after surface immobilisation of the enzyme (Chapter 4.6.4). 250 frames of 
data were recorded for a minimum of 10 different areas (40 µm × 40 µm) of the microscope cover 
slide, using an exposure time of 70 ms per frame. In other words, 10 videos each with 250 images 
were recorded for the inactive 3Cpro and the FRET peptide, and also for the active 3Cpro and the 
peptide. In addition, control experiments were done with the two FRET peptide concentrations (100 
pM and 200 pM) in which there was no enzyme present on the NTA-Ni-functionalised slide. The 
experimental procedure for the control experiments as described above. 
4.6.8 FMDV 3Cpro smTIRF data analysis 
For all FMDV 3Cpro TIRF experiments (both active and inactive enzyme), initial data analysis was 
performed using ImageJ image processing software. Fluorescence intensity against time (or video 
frame) was plotted for 300 9×9 pixel areas containing a fluorescent molecule. The areas to be 
analysed were selected manually. A Python data analysis script named Peak finder was used to find 
peaks in the intensity versus time graphs, and to determine peak widths and peak heights. The Peak 
finder script was kindly written by Stefano Franz, Ville Glad and Heikki Juva, with assistance from the 
author, using Python programming language. The script was programmed to do the following. 
 To plot mean intensity (in grey value) versus time (in ms) graphs for the 9×9 pixel areas that 
were selected manually from the TIRF videos and contained a fluorescent molecule 
 To find and locate peaks above a certain threshold (discussed below) in the intensity versus 
time graphs, i.e. to distinguish peaks that were due to real peptide binding events from the 
background fluorescence signal 
 For each located peak, to determine the peak width, which corresponds to the duration of 
FRET peptide binding to the 3Cpro, i.e. to determine the dwell time for individual smFRET 
peptide 1 molecules 
 For each located peak, to determine the average peak height (corresponding to the 
brightness of HiLyte 488) 
Before analysing the TIRF data using the Peak finder script, a threshold intensity value above 
which fluorescence intensity has to rise to be considered as a real peak (due to a peptide binding 
event) was determined. The threshold values were determined separately for the two experiments, 
the inactive 3Cpro experiment and the active 3Cpro one. This was done manually from the average 
fluorescence intensity in areas with no FRET peptide binding. For each experiment, the average 
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background fluorescence and the standard deviation of the background were determined for three 
9×9 pixel areas from three videos. The average background fluorescence and standard deviation of 
the background were then calculated from these nine areas. After this, the threshold value for a 
fluorescence event to be considered as a peptide binding event was calculated using the equation 
below. 
                                             
 
in which         represents the average background fluorescence intensity and         stands for 
the standard deviations of the background fluorescence intensity. Different values for N were tested 
to determine the most appropriate threshold values. Any peaks above the threshold level were 
considered as peptide binding events and included in further data analysis. 
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6 Appendices 
6.1 Peptide characterisation data 
Table 6.1. LC/MS characterisation data for purified ensemble fluorescence peptides. 
The table shows the retention times and the mass/charge ratios (m/z) observed in the LC/MS traces of the pure ensemble 
fluorescence peptides. The m/z values correspond to either once, twice, three times, four times or five times protonated 
species observed in the mass spectrum (positive mode). Also the molecular weights of the peptides are shown. All peptides 
were purified to a minimum of 90% purity using preparatory LC/MS. The preparatory and analytical LC/MS methods are 
described in detail in chapters 4.1.12 and 4.1.13 of Materials and Methods, respectively. Two different analytical LC 
methods were used for the peptides shown in the table. The 50-98% MeOH gradient analytical LC method was used for the 
peptides marked with an asterisk, whereas all the other peptides were run on a 5-98% MeOH gradient method.  
Peptide sequence Retention time / 
min 
m/z Molecular weight 
Flu-APAKQLLNFDLLKK 11.1 979, 653, 491 1957 
Flu-AAAKQLLNFDLLKK 12.1 645 1931 
Flu-APAAQLLNFDLLKK 12.1 951, 634 1900 
Flu-APAKALLNFDLLKK* 7.5 951, 635, 476 1900 
Flu-APAKQALNFDLLKK 11.7 639 1915 
Flu-APAKQLLNADLLKK 12.0 941, 628 1881 
Flu-APAKQLLCFDLLKK* 7.8 975, 650, 488 1946 
APAKQLLC(TMR)FDLLKK 11.8 1072, 715, 537 2141 
Flu-APAKQLLC(TMR)FDLLKK* 6.5 834, 626, 501 2499 
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HL488-APAKQLLCFDLLKK 
 
Figure 6.1. MALDI spectrum for the pure HL488-APAKQLLCFDLLKK. 
The figure shows the MALDI spectrum for HL488-APAKQLLCFDLLKK after LC/MS purification. The m/z ratio of 2058 
corresponds to the desired peptide. (Molecular weight of HL488-APAKQLLCFDLLKK = 2058) 
 
 
Figure 6.2. Fluorescence spectrum of the pure HL488-APAKQLLCFDLLKK. 
The figure shows the fluorescence emission spectrum for HL488-APAKQLLCFDLLKK upon donor excitation at 480 nm. The 
emission peak at 527 nm indicates the presence of HiLyte 488. The spectrum was recorded in PBS buffer (pH 7.4) 
containing BSA (0.3 mg mL
-1
) and Tween 20 (0.05 % v/v), and the peptide concentration was approximately 10 nM. 
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HL488-APAKQLLNFDLC(HL647)KK (smFRET peptide 2) 
 (a) 
 
(b) 
 
Figure 6.3. LC/MS trace for the crude smFRET peptide 2. 
The figure shows the LC/MS trace for the crude HL488-APAKQLLNFDLC(HL647)KK before the peptide was purified. The 
peaks at approximately 2.8 and 3.4 minutes in the diode array (top trace) and total ion count (TIC) (bottom trace) in (a) 
correspond to the desired doubly labelled peptide. There are two peaks because the HiLyte 488 dye that was used is a 
mixture of two isomers. The mass spectra of the TIC peaks at 2.8 and 3.4 minutes are shown in (b). The mass/charge (m/z) 
ratios 1626/1627 and 1084 correspond to the twice and three times deprotonated smFRET peptide 2, respectively. 
(Molecular weight of smFRET peptide 2 = 3267) 
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Figure 6.4. Absorption spectrum for smFRET peptide 2. 
The figure shows the absorption spectrum for the smFRET peptide HL488-APAKQLLNFDLC(HL647)KK. The peak on the left 
(at 502 nm) is due to HiLyte 488 absorption, whereas the peak on the right (at 655 nm) corresponds to HiLyte 647 
absorption. The two peaks indicate the presence of the two fluorophores. The peptide (approximately 4 µM) was dissolved 
in PBS buffer (pH 7.4) containing BSA (0.3 mg mL
-1
) and Tween 20 (0.05 % v/v). 
 
 
Figure 6.5. Fluorescence emission spectrum for smFRET peptide 2. 
The figure shows the fluorescence emission spectrum for HL488-APAKQLLNFDLC(HL647)KK upon excitation at 480 nm. The 
peak at 525 nm is due to fluorescence emission from HiLyte 488, whereas the peak at 670 nm corresponds to HiLyte 647 
emission. The peak at 670 nm is the FRET peak – there is no direct excitation of the HiLyte 647 acceptor at 480 nm, and 
hence the peak at 670 nm is solely due to FRET from the HiLyte 488 donor to the acceptor. This indicates that the FRET 
peptide is present. The spectrum was recorded in PBS buffer (pH 7.4) containing BSA (0.3 mg mL
-1
) and Tween 20 (0.05 % 
v/v), and the peptide concentration was approximately 20 nM.  
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HL488-APAKQLLC(AF647)FDLLKK (smFRET peptide 3) 
 (a) 
 
(b) 
 
Figure 6.6. LC/MS trace for the crude smFRET peptide 3. 
The figure shows the LC/MS trace for the crude HL488-APAKQLLC(AF647)FDLLKK before the peptide was purified. The 
peaks at approximately 6.7 and 6.9 minutes in the diode array (top trace) and total ion count (TIC) (bottom trace) in (a) 
correspond to the desired doubly labelled peptide. There are two peaks because the HiLyte 488 dye that was used is a 
mixture of two isomers. The mass spectra of the TIC peaks at 6.7 and 6.9 minutes are shown in (b). The mass/charge (m/z) 
ratios 1518 and 1012 correspond to the twice and three times deprotonated smFRET peptide 3, respectively. (Molecular 
weight of smFRET peptide 3 = 3039) 
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Figure 6.7. Absorption spectrum for smFRET peptide 3. 
The figure shows the absorption spectrum for the smFRET peptide HL488-APAKQLLC(AF647)FDLLKK. The peak on the left 
(at 502 nm) is due to HiLyte 488 absorption, whereas the peak on the right (at 655 nm) corresponds to AlexaFluor 647 
absorption. The two peaks indicate the presence of the two fluorophores. The peptide (approximately 4 µM) was dissolved 
in PBS buffer (pH 7.4) containing BSA (0.3 mg mL
-1
) and Tween 20 (0.05 % v/v). 
 
Figure 6.8. Fluorescence emission spectrum for smFRET peptide 3. 
The figure shows the fluorescence emission spectrum for HL488-APAKQLLC(AF647)FDLLKK upon excitation at 480 nm. The 
peak at 526 nm is due to fluorescence emission from HiLyte 488, whereas the peak at 667 nm corresponds to AlexaFluor 
647 emission. The peak at 667 nm is the FRET peak – there is no direct excitation of the AlexaFluor 647 acceptor at 480 nm, 
and hence the peak at 667 nm is solely due to FRET from the HiLyte 488 donor to the acceptor. This indicates that the FRET 
peptide is present. The spectrum was recorded in PBS buffer (pH 7.4) containing BSA (0.3 mg mL
-1
) and Tween 20 (0.05 % 
v/v), and the peptide concentration was approximately 20 nM. 
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6.2 LC/MS cleavage assay data 
(a) 
 
(b) 
 
Figure 6.9. The LC/MS trace for intact Flu-APAKQLLNFDLLKK. 
The figure shows the LC/MS trace for the peptide Flu-APAKQLLNFDLLKK in the absence of FMDV 3C
pro
. The top figure (a) 
shows the total ion count (TIC), the peak at 7.7 minutes corresponding to the peptide Flu-APAKQLLNFDLLKK. The mass 
spectrum for the peak is shown in (b), the mass/charge (m/z) ratio of 654 corresponding to the three times protonated 
peptide Flu-APAKQLLNFDLLKK. (Molecular weight of Flu-APAKQLLNFDLLKK = 1957) 
 
 
